View source for NL-14-0659, Enclosure 4: Hatch Offsite Dose Calculation Manual - Version 23

{{Adams
| number = ML14125A101
| issue date = 02/28/2013
| title = Enclosure 4: Hatch Offsite Dose Calculation Manual - Version 23
| author name = 
| author affiliation = Southern Nuclear Operating Co, Inc
| addressee name = 
| addressee affiliation = NRC/NRR
| docket = 05000321, 05000366
| license number = DPR-057, NPF-005
| contact person = 
| case reference number = NL-14-0659
| package number = ML14125A094
| document type = Calculation, Manual
| page count = 211
}}

=Text=
{{#Wiki_filter:Edwin I. Hatch Nuclear Plant Joseph M. Farley Nuclear Plant Vogtle Electric Generating Plant Annual Radioactive Effluent Release Reports and Offsite Dose Calculation Manuals for 2013 Enclosure 4 Hatch Offsite Dose Calculation Manual -Version 23 OFFSITE DOSE CALCULATION MANUAL FOR EDWIN I. HATCH NUCLEAR PLANT Version 23 (February 2013)Radiological Services Supervisor Environmental Affairs HNP ODCM EFFECTIVE PAGE LIST PAGE VERSION PAGE VERSION...... ...... ........... 
........ .... .................
23 ii ........................................................
23 i ...........................................................
23 iv ........................................................
23 v ..........................................................
23 vi ........................................................
23 vii ......................................................
23 viii .....................................................
23 ix ........................................................
23 x........................................................
23 xi ........................................................
23 xii ......................................................
23 1-1 .....................................................
23 2-1 ...................................................
23 2-2 .....................................................
23 2-3 .....................................................
23 2-4 .....................................................
23 2-5 .....................................................
23 2-6 ...................................................
23 2-7 ...................................................
23 2-8 .....................................................
23 2-9 .....................................................
23 2-10 ...................................................
23 2-11 ..................................................
23 2-12 ...................................................
23 2-13 ...................................................
23 2-14 ...................................................
23 2-15 ...................................................
23 2-16 ...................................................
23 2-17* .................................................
23 2-18 ...................................................
23 2-19 ...................................................
23 2-20 ...................................................
23 2-21 ..................................................
23 2-22 ...................................................
23 2-23 ...................................................
23 2-24 ...................................................
23 2-25 ...................................................
23 2-26 ...................................................
23 2-27 .................................................
23 2-28 .................................................
23 2-29 .................................................
23 2-30 .................................................
23 ,Version 23 2/13 HNP ODCM EFFECTIVE PAGE LIST PAGE VERSION PAGE VERSION 2-31 ...................................................
23 2-32 .................................................
23 2-33 ...................................................
23 2-34 .................................................
23 2-35 ...................................................
23 2-36 .................................................
23 2-37 .................................................
23 2-38 .................................................
23 2-39 .................................................
23 2-40 .................................................
23 2-41 ...................................................
23 2-42 .................................................
23 3-1 .....................................................
23 3-2 ...................................................
23 3-3 ...................................................
23 3-4 ...................................................
23 3-5 ...................................................
23 3-6 ...................................................
23 3-7 ...................................................
23 3-8 ...................................................
23 3-9 ...................................................
23 3-10 .................................................
23 3-11 ...................................................
23 3-12 .................................................
23 3-13 ...................................................
23 3-14 .................................................
23 3-15 ...................................................
23 3-16 .................................................
23 3-17 .................................................
23 3-18 .................................................
23 3-19 .................................................
23 3-20 .................................................
23 3-21 ...................................................
23 3-22 .................................................
23 3-23 .................................................
23 3-24 .................................................
23 3-25 .................................................
23 3-26 .................................................
23 3-27 .................................................
23 3-28 .................................................
23 3-29 .................................................
23 3-30 .................................................
23 3-31 ...................................................
23 ii Version 15 12/04 HNP ODCM EFFECTIVE PAGE LIST PAGE VERSION PAGE VERSION 3-32 .................................................
23 3-33 .................................................
23 3-34 .................................................
23 3-35 .................................................
23 3-36 .................................................
23 3-37 .................................................
23 3-38 .................................................
23 3-39 .................................................
23 3-40 ...................................................
23 3-41 ...................................................
23 3-42 .................................................
23 3-43 ...................................................
23 3-44 ...................................................
23 3-45 ...................................................
23 3-46 ...................................................
23 3-47 .................................................
23 4-1 ...................................................
23 4-2 ...................................................
23 4-3 ...................................................
23 4-4 ...................................................
23 4-5 ...................................................
23 4-6 ...................................................
23 4-7 ...................................................
23 4-8 ...................................................
23 4-9 ...................................................
23 4-10 .................................................
23 4-11 ...................................................
23 4-12 .................................................
23 4-13 .................................................
23 4-14 .................................................
23 4-15 .................................................
23 4-16 .................................................
23 4-17 .................................................
23 4-18 .................................................
23 4-19 .................................................
23 4-20 .................................................
23 4-21 ...................................................
23 5-1 ...................................................
23 5-2 ...................................................
23 5-3 ...................................................
23 5-4 ...................................................
23 6-1 ...................................................
23 6-2 ...................................................
23 6-3 ...................................................
23 6-4 ...................................................
23 6-5 ...................................................
23 7-1 ...................................................
23 7-2 ...................................................
23 7-3 ...................................................
23 7-4 ...................................................
23 7-5 ...................................................
23 7-6 ...................................................
23 8-1 ...................................................
23 8-2 ...................................................
23 8-3 ...................................................
23 8-4 ...................................................
23 8-5 ...................................................
23 8-6 ...................................................
23 8-7 ...................................................
23 8-8 ...................................................
23 8-9 ...................................................
23 8-10 .................................................
23 8-11 ...................................................
23 8-12 .................................................
23 8-13 .................................................
23 8-14 .................................................
23 8-15 .................................................
23 8-16 .................................................
23 8-17 .................................................
23 8-18 .................................................
23 8-19 .................................................
23 8-20 .................................................
23 9-1 ...................................................
23 9-2 ...................................................
23 9-3 ...................................................
23 9-4 ...................................................
23 9-5 ...................................................
23 9-6 ...................................................
23 9-7 ...................................................
23 9-8 ...................................................
23 9-9 ...................................................
23 9-10 .................................................
23 3Version 23 2/13 HNPODCM EFFECTIVE PAGE LIST PAGE VERSION PAGE VERSION 9-11 ...................................................
23 9-12 .................................................
23 9-13 .................................................
23 9-14 .................................................
23 9-15 .................................................
23 9-16 .................................................
23 9-17 .................................................
23 9-18 ...................................................
23 9-19 .................................................
23 9-20 .................................................
23 9-21 ...................................................
23 9-22 .................................................
23 9-23 .................................................
23 9-24 .................................................
23 9-25 .................................................
23 9-26 .................................................
23 9-27 .................................................
23 9-28 ...................................................
23 9-29 .................................................
23 9-30 .................................................
23 9-31 ...................................................
23 9-32 .................................................
23 9-33 .................................................
23 9-34 .................................................
23 9-35 .................................................
23 9-36 .................................................
23 9-37 .................................................
23 9-38 .................................................
23 9-39 .................................................
23 9-40 .................................................
23 9-41 ...................................................
23 10-1 ...................................................
23 10-2 .................................................
23 10-3 .................................................
23 10-4 .................................................
23 10-5 ...................................................
23 10-6 .................................................
23 10-7 .................................................
23 4Version 23 2/13 HNP ODCM TABLE OF CONTENTS PagIXe LIST OF TABLEES ......................................................................................................................
IXl LIST OF FIGURES ......................................................................................................................
Xi REFERENCES T.......... 
................................................................................................ 
.x1 CHAPTER I INTRODUCTION 
.......................................................................
1-1 CHAPTER 2 LIQUID EFFLUENTS 
..........................................................................................
2-1 2.1 LIMITS OF OPERATION 
.................................................................................................
2-1 2.1.1 Liquid Effluent Monitorinq Instrumentation Control .......................................................
2-1 2.1.2 Liquid Effluent Concentration Control ..........................................................................
2-7 2.1.3 Liquid Effluent Dose Control ........................................................................................
2-9 2.1.4 Liquid Radwaste Treatment System Control ..............................................................
2-10 2.1.5 MAJOR CHANGES TO LIQUID RADIOACTIVE WASTE TREATMENT SYSTEMS..
2-11 2.2 LIQUID RADWASTE TREATMENT SYSTEM ................................................................
2-12 2.3 LIQUID EFFLUENT MONITOR SETPOINTS 
.................................................................
2-16 2.3.1 General Provisions Regarding Setpoints 
...................................................................
2-16 2.3.2 Setpoints for Radwaste System Discharge Monitors ..................................................
2-18 2.3.3 Setpoints for Monitors on Normally Low-Radioactivity Streams .................................
2-24 2.4 LIQUID EFFLUENT DOSE CALCULATIONS 
................................................................
2-26 2.4 .1 C alculation of D ose ...................................................................................................
2-26 2 .4 .2 C a lcu latio n of A i ........................................................... 
..............................................
2 -2 7 2 .4 .3 C alculation of C .....................................................................................................
2-2 8 2.5 LIQUID EFFLUENT DOSE PROJECTIONS 
..................................................................
2-38 2.5.1 Thirty-One Day Dose Proiections 
..............................................................................
2-38 2.5.2 Dose Proiections for Specific Releases .....................................................................
2-38 2.6 DEFINITIONS OF LIQUID EFFLUENT TERMS .............................................................
2-39 CHAPTER 3 GASEOUS EFFLUENTS 
....................................................................................
3-1 3.1 LIMITS OF OPERATION 
.................................................................................................
3-1 3.1.1 Gaseous Effluent Monitoring Instrumentation Control ..................................................
3-1 3.1.2 Gaseous Effluent Dose Rate Control ...........................................................................
3-6 3.1.3 Gaseous Effluent Air Dose Control ............................................................................
3-10 3.1.4 Control on Gaseous Effluent Dose to a MEMBER OF THE PUBLIC ..........................
3-11 5Version 23 2/13 HNP ODCM 3.1.5 GASEOUS RADWASTE TREATMENT SYSTEM Control .........................................
3-12 3.1.6 MAJOR CHANGES TO GASEOUS RADIOACTIVE WASTE TREATMENT S Y S T E M ....................................................................................................................
3 -1 3 3.2 GASEOUS RADWASTE TREATMENT SYSTEM ..........................................................
3-14 3.3 GASEOUS EFFLUENT MONITOR SETPOINTS 
...........................................................
3-16 3.3.1 General Provisions Regarding Noble Gas Monitor Setpoints 
.....................................
3-16 3.3.2 Setpoint for the Final Noble Gas Monitor on Each Release Pathway .........................
3-18 3.3.3 Setpoints for Noble Gas Monitors on Effluent Source Streams ..................................
3-22 3.3.4 Determination of Allocation Factors, AG ....................................................................
3-24 3.3.5 Setpoints for Noble Gas Monitors with Special Requirements 
...................................
3-26 3.3.6 Setpoints for Particulate and Iodine Monitors .............................................................
3-27 3.4 GASEOUS EFFLUENT COMPLIANCE CALCULATIONS 
.............................................
3-28 3.4.1 Dose Rates at and Beyond the SITE BOUNDARY ....................................................
3-28 3.4.2 Noble Gas Air Dose at or Beyond SITE BOUNDARY ................................................
3-29 3.4.3 Dose to a MEMBER OF THE PUBLIC at or Beyond SITE BOUNDARY ....................
3-33 3.4.4 Dose Calculations to Support Other Requirements 
....................................................
3-36 3.5 GASEOUS EFFLUENT DOSE PROJECTIONS 
.............................................................
3-41 3.5.1 Thirty-One Day Dose Proiections 
..............................................................................
3-41 3.5.2 Dose Proiections for Specific Releases .....................................................................
3-42 3.6 DEFINITIONS OF GASEOUS EFFLUENT TERMS .......................................................
3-43 CHAPTER 4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM .....................
4-1 4 .1 LIM IT S O F O P E R A T IO N .................................................................................................
4-1 4.1.1 Radiological Environmental Monitoring 
........................................................................
4-1 4 .1.2 Land U se C e nsus ........................................................................................................
4 -9 4.1.3 Interlaboratory Comparision Program ........................................................................
4-10 4.2 RADIOLOGICAL ENVIRONMENTAL MONITORING LOCATIONS 
...............................
4-11 CHAPTER 5 TOTAL DOSE DETERMINATIONS 
....................................................................
5-1 5.1 LIM IT O F O P E R A T IO N ....................................................................................................
5-1 5 .1 .1 A p p lic a b ility .................................................................................................................
5 -1 5 .1 .2 A c tio n s ........................................................................................................................
5 -1 5.1.3 S urveillance R eauirem ents ..........................................................................................
5-1 6Version 23 2/13 HNP ODCM 5 .1 .4 B a s is ...........................................................................................................................
5 -2 5.2 DEMONSTRATION OF COMPLIANCE 
...........................................................................
5-3 CHAPTER 6 POTENTIAL DOSES TO MEMBERS OF THE PUBLIC DUE TO THEIR ACTIVITIES INSIDE THE SITE BOUNDARY .....................................................
6-1 6.1 REQUIREMENT FOR CALCULATION 
...........................................................................
6-1 6.2 CALCULATIONAL METHOD ..........................................................................................
6-1 CHAPTER 7 REPORTS ..........................................................................................................
7-1 7.1 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT .........................
7-1 7.1.1 Requirement for Report ...............................................................................................
7-1 7 .1 .2 R e p o rt C o nte nts ..........................................................................................................
7 -1 7.2 RADIOACTIVE EFFLUENT RELEASE REPORT ...........................................................
7-3 7.2.1 Requirement for Report ...............................................................................................
7-3 7.2.2 Report Contents ..........................................................................................................
7-3 7.3 MONTHLY OPERATING REPORT .................................................................................
7-6 7.4 SPECIAL REPORTS ......................................................................................................
7-6 CHAPTER 8 METEOROLOGICAL MODELS ..........................................................................
8-1 8.1 ATMOSPHERIC DISPERSION 
.......................................................................................
8-1 8.1.1 Ground-Level Releases ...............................................................................................
8-1 8.1.2 Elevated Releases .......................................................................................................
8-2 8.1.3 Mixed-Mode Releases .................................................................................................
8-3 8.2 RELATIVE DEPOSITION 
................................................................................................
8-5 8.2.1 Ground-Level Releases ...............................................................................................
8-5 8.2.2 Elevated Releases .......................................................................................................
8-5 8.2.3 Mixed-Mode Releases .................................................................................................
8-6 8.3 ELEVATED PLUME DOSE FACTORS ...........................................................................
8-7 CHAPTER 9 METHODS AND PARAMETERS FOR CALCULATION OF GASEOUS EFFLUENT PATHW AY DOSE FACTORS, Raipj .............................................
9-1 9.1 INHALATION PATHW AY FACTOR ................................................................................
9-1 7Version 23 2/13 HNP ODCM 9.2 GROUND PLANE PATHWAY FACTOR .........................................................................
9-2 9.3 GARDEN VEGETATION PATHWAY FACTOR ...............................................................
9-2 9.4 GRASS-COW-MILK PATHWAY FACTOR ......................................................................
9-5 9.5 GRASS-GOAT-MILK PATHWAY FACTOR ....................................................................
9-8 9.6 GRASS-COW-MEAT PATHWAY FACTOR ..................................................................
9-11 CHAPTER 10 DEFINITIONS OF EFFLUENT CONTROL TERMS .......................................
10-1 10.1 TERM S SPECIFIC TO THE O DCM ..............................................................................
10-1 10.2 TERMS DEFINED IN THE TECHNICAL SPECIFICATIONS 
.........................................
10-5 8Version 23 2/13 HNP ODCM LIST OF TABLES Page Table 2-1 Radioactive Liquid Effluent Monitoring Instrumentation 2-3 Table 2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements 2-5 Table 2-3 Radioactive Liquid Waste Sampling and Analysis Program 2-8 Table 2-4 Applicability of Liquid Monitor Setpoint Methodologies 2-17 Table 2-5 Parameters for Calculation of Doses Due to Liquid Effluent Releases 2-30 Table 2-6 Element Transfer Factor 2-31 Table 2-7 Adult Ingestion Dose Factors 2-32 Table 2-8 Site-Related Ingestion Dose Factors, A,, 2-35 Table 3-1 Radioactive Gaseous Effluent Monitoring Instrumentation 3-3 Table 3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements 3-5 Table 3-3 Radioactive Gaseous Waste Sampling and Analysis Program 3-8 Table 3-4 Applicability of Gaseous Monitor Setpoint Methodologies 3-17 Table 3-5 Dose Factors for Exposure to a Semi-Infinite Cloud of Noble Gases 3-31 Table 3-6 Dose Factors for Exposure to Direct Radiation from Noble Gases in an Elevated Finite Plume 3-32 Table 3-7 Attributes of the Controlling Receptor 3-35 Table 3-8 Raipj for Ground Plane Pathway, All Age Groups 3-38 Table 3-9 Raipj for Inhalation Pathway, Child Age Group 3-39 Table 3-10 Raipj for Garden Vegetation Pathway, Child Age Group. 3-40 Table 4-1 Radiological Environmental Monitoring Program 4-4 Table 4-2 Reporting Levels for Radioactivity Concentrations in Environmental Samples 4-7 Table 4-3 Values for the MINIMUM DETECTABLE CONCENTRATION 4-8 Table 4-4 Radiological Environmental Monitoring Locations 4-12 Table 4-5 Groundwater Monitoring Locations 4-14 Table 6-1 Attributes of MEMBER OF THE PUBLIC Receptor Locations Inside the SITE BOUNDARY 6-2 Table 8-1 Terrain Elevation Above Plant Site Grade 8-10 Table 9-1 Miscellaneous Parameters for the Garden Vegetation Pathway 9-4 Table 9-2 Miscellaneous Parameters for the Grass-Cow-Milk Pathway 9-7 Table 9-3 Miscellaneous Parameters for the Grass-Goat-Milk Pathway 9-10 9Version 23 2/13 HNP ODCM Table 9-4 Table 9-5 Table 9-6 Table 9-7 Table 9-8 Table 9-9 Table 9-10 Table 9-11 Table 9-12 Table 9-13 Table 9-14 Table 9-15 Miscellaneous Parameters for the Grass-Cow-Meat Pathway Individual Usage Factors Stable Element Transfer Data Inhalation Dose Factors for the Infant Age Group Inhalation Dose Factors for the Child Age Group Inhalation Dose Factors for the Teenager Age Group Inhalation Dose Factors for the Adult Age Group Ingestion Dose Factors for the Infant Age Group Ingestion Dose Factors for the Child Age Group Ingestion Dose Factors for the Teenager Age Group Ingestion Dose Factors for the Adult Age Group External Dose Factors for Standing on Contaminated Ground 9-13 9-14 9-15 9-16 9-19 9-22 9-25 9-28 9-31 9-34 9-37 9-40 lOVersion 23 2/13 HNPODCM LIST OF FIGURES Figure 2-1 Figure 2-2 Figure 2-3 Figure 3-1 Figure 4-1 Figure 4-2 Figure 4-3 Figure 4-4 Figure 4-5 Figure 4-6 Figure 4-7 Figure 8-1 Figure 8-2 Figure 8-3 Figure 8-4 Figure 8-5 Figure 8-6 Figure 8-7 Figure 8-8 Figure 8-9 Figure 8-10 Figure 10-1 Unit 1 LIQUID RADWASTE TREATMENT SYSTEM Unit 2 LIQUID RADWASTE TREATMENT SYSTEM Site Subsurface Drainage Systems Schematic Diagram of the Condenser Offgas Treatment System Sampling Location Map, Site Periphery Sampling Location Map Beyond Site Periphery, North and West of Site Sampling Location Map Beyond Site Periphery, South and West of Site Sampling Location Map Beyond Site Periphery, East of Site Location of Additional Control Station for TLDs and Vegetation Groundwater Monitoring Wells Deep Wells Vertical Standard Deviation of Material in a Plume (ar)Terrain Recirculation Factor (Kr)Plume Depletion Effect for Ground-Level Releases Plume Depletion Effect for 30-Meter Releases Plume Depletion Effect for 60-Meter Releases Plume Depletion Effect for 100-Meter Releases Relative Deposition for Ground-Level Releases Relative Deposition for 30-Meter Releases Relative Deposition for 60-Meter Releases Relative Deposition for 100-Meter (or Greater) Releases Site Map for Effluent Controls Page 2-13 2-14 2-15 3-15 4-15 4-16 4-17 4-18 4-19 4-20 4-21 8-11 8-12 8-13 8-14 8-15 8-16 8-17 8-18 8-19 8-20 10-7 1 IVersion 23 2/13 HNP ODCM REFERENCES
: 1. J. S. Boegli, R.R. Bellamy, W.L. Britz, and R.L. Waterfield, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," NUREG-0133, October 1978.2. "Calculation of Annual Doses to Man form Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR 50, Appendix I," U.S. NRC Regulatory Guide 1.109, March 1976.3. Federal Guidance Report (FGR) 11, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors for Inhalation, Submersion, and Ingestion," 1988.4. "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors, "U.S. NRC Regulatory Guide 1.111, March 1976.5. "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," U.S. NRC Regulatory Guide 1.111, Revision 1, July 1977.6. "Estimating Aguatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I,"U.S. NRC Regulatory Guide 1.113, April 1977.7. Edwin I. Hatch Nuclear Plant -Unit 1 Final Safety Analysis Report, Georgia Power Company.8. Edwin I. Hatch Nuclear Plant -Unit 2 Final Safety Analysis Report, Georgia Power Company.9. Hatch Nuclear Plant -Unit 2 Environmental Report -Operating License Stage, Georgia Power Company, July 1975 (including Appendix A, "Edwin I. Hatch Plant -Unit 1 Preoperational Environmental Surveillance Report Number 1," March 1975).10. Hatch Nuclear Plant Land Use Survey -1987, Georgia Power Company, February 1987.11. Hatch Nuclear Plant Land Use Survey, Georgia Power Company, November 1987.12. Hatch Nuclear Plant Land Use Survey -1988, Georgia Power Company, November 16, 1988, and December 20, 1988.13. Letter to Georgia Power Company from Pickard, Lowe, and Garrick, Inc., Washington, D.C., May I1, 1987.12Version 23 2/13 HNP ODCM 14. Letter to Georgia Power Company for Pickard, Lowe, and Garrick, Inc., Washington, D.C., June 3, 1987.15. Letter to Georgia Power Company from Pickard, Lowe, and Garrick, Inc., Washington, D.C., June 11, 1987.xiiiVersion 23 2/13 HNP ODCM REFERENCES (Continued)
: 16. Letter to Georgia Power Company from Pickard, Lowe, and Garrick, Inc., Washington, D.C., November 30, 1987.17. L. A. Currie, Lower Limit of Detection:
Definition and Elaboration of a Proposed Position of Radiological Effluent and Environmental Measurements, U.S. NRC Report NUREG/CR-4007, 1984.18. "Radiological Assessment Branch Technical Position," U.S. Nuclear Regulatory Commission, Revision 1, November 1979.19. D. H. Slade (ed.), Meteorology and Atomic Energy -1968, U.S. Department of Commerce, July 1968.20. M. Abramowitz and I. A. Stegun (eds.) Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables, National Bureau of Standards, U.S.Department of Commerce, 1965.21. M. C. Nichols and S. D. Holder, Plant Edwin I. Hatch Units I and 2 Thermal Plume Model Verification, Georgia Power Company Environmental Affairs Center, March 1981.22. Internal Memorandum, Bill Duval to Howard Rogers, Georgia Power Company, October 11, 1990.23. Internal Memorandum, W. H. Ollinger to D. M. Hopper, Georgia Power Company, June 9, 1987.24. Letter to Georgia Power Company from Quantum Technology, Inc., Marietta, Georgia, June 17, 1987.25. W. W. Meinke and T. H. Essig, "Offsite Dose Calculation Manual Guidance:
Standard Radiological Effluent Controls for Boiling Water Reactors," Generic Letter 89-01 Supplement No. 1, NUREG-1302, April 1991.26. D. C. Kocher, "Radioactive Decay Data Tables, "U.S. DOE Report DOE/TIC-11026, 1981.27. J. E. Till and H. R. Meyer, eds, Radiological Assessment, U.S. NRC Report NUREG/CR-3332, 1983.28. Letter to Geor-gia Power Company from J. H. Davis, Health Physics Consultant, Lilburn, Georgia, September 17, 1990.29. Letter to Geor-gia Power Company from J. H. Davis, Health Physics Consultant, Lilburn, Georgia, March 25, 1991.xivVersion 23 2/13 HNP ODCM CHAPTER 1 INTRODUCTION The Offsite Dose Calculation Manual is a supporting document of the Technical Specifications.
As such, it describes the methodology and parameters to be used in the calculation of offsite doses due to radioactive liquid and gaseous effluents, and in the calculation of liquid and gaseous effluent monitoring instrumentation alarm setpoints.
In addition, it contains the following:
The controls required by the Technical Specifications, governing the radioactive effluent and radiological environmental monitoring programs.Schematics of liquid and gaseous radwaste effluent treatment systems, which include designation of release points to UNRESTRICTED AREAS.A list and maps indicating the specific sample locations for the Radiological Environmental Monitoring Program.Specifications and descriptions of the information that must be included in the Annual Radiological Environmental Surveillance Report and the Annual Radioactive Effluent Release Report required by the Technical Specifications.
The ODCM will be maintained at the plant for use as a reference guide and training document of accepted methodologies and calculations.
Changes in the calculational methods or parameters will be incorporated into the ODCM in order to ensure that it represents current methodology in all applicable areas. Any computer software used to perform the calculations described will be maintained current with the ODCM.Equations and methods used in the ODCM are based on those presented in NUREG-0 133 (Reference 1), in Regulatory Guide 1.109 (References 2 and 3), in Regulatory Guide 1.111 (References 4 and 5), and in Regulatory Guide 1.113 (Reference 6).I-I Version 23 2/13 HNP ODCM CHAPTER 2 LIQUID EFFLUENTS 2.1 LIMITS OF OPERATION The following Liquid Effluent Controls implement requirements established by Technical Specifications Section 5.0. Terms printed in all capital letters are defined in Chapter 10.2.1.1 Liquid Effluent Monitoring Instrumentation Control In accordance with Technical Specification 5.5.4.a, the radioactive liquid effluent monitoring instrumentation channels shown in Table 2-1 shall be OPERABLE with their alarm/trip setpoints set to ensure that the limits specified in Section 2.1.2 are not exceeded.
The alarm/trip setpoints of these channels shall be determined in accordance with Section 2.3.2.1.1.1 Applicability As shown in Table 2-1.2.1.1.2 Actions With a radioactive liquid effluent monitoring instrumentation channel alarm/trip setpoint less conservative than required by the above control, immediately suspend the release of radioactive liquid effluents monitored by the affected channel, declare the channel inoperable, or change the setpoint to a conservative value.With less than the minimum number of radioactive liquid effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table 2-1. NOTE: One instrument channel may be inoperable for up to 6 hours to perform required surveillances prior to entering other applicable ACTIONS. Otherwise, restore the inoperable instrumentation to OPERABLE status within 30 days and, if unsuccessful, explain in the next Radioactive Effluent Release Report, per Technical Specification 5.6.3, why this inoperability was not corrected in a timely manner.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.2.1.1.3 Surveillance Requirements Each radioactive liquid effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION, and CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table 2-2.2-i Version 23 2/13 2-1 Version 23 2/13 HNP ODCM 2.1.1.4 Basis The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents.
The Alarm/Trip Setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in Section 2.3 to ensure that the alarm/trip will occur prior to exceeding the limits of Section 2.1.2. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.2-2 Version 23 2/13 2-2 Version 23 2/13 HNP ODCM Table 2-1 Radioactive Liquid Effluent Monitoring Instrumentation OPERABILITY Requirements3 Minimum Channels I Instrument OPERABLE Applicabilityb ACTION 1. Gross Radioactivity Monitors Providing Automatic Termination of Release Liquid Radwaste Effluent Line 1 (1) 1 100 2. Gross Radioactivity Monitors not Providing Automatic Termination of Release Service Water System Effluent Line 1 (2) 101 3. Flowrate Measurement Devicesc a. Liquid Radwaste Effluent Line 1 (1) 102 b. Discharge Canal 1 (1), (2) 102 4. Differential Pressure Measurement Devices Service Water System to Closed Cooling Water System 1 At all times 103 5. Groundwater Outfall Instrumentation
: a. Auto Sampler at Y22N008A I At all times 104 b. Flow Totalizer at At all times 105 Y22N008A a. All requirements in this Table apply to each unit.b. Applicability of requirements is as follows: (I) Whenever the radwaste discharge valves are not locked closed.(2) Whenever the Service Water System pressure is below the Closed Cooling Water System pressure, or AP indication is not available.
: c. Pump curves may be used to estimate flow; in such cases, ACTION statement 102 is not required.2-3 Version 23 2/13 HNP ODCM Table 2-1 (contd) Notation for Table 2-1 -ACTION Statements ACTION 100 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases may continue provided that prior to initiating a release: a. At least two independent samples are analyzed in accordance with Section 2.1.2.3, and b. At least two technically qualified individuals independently verify the discharge line valving and verify the release rate calculations.
Otherwise, suspend release of radioactive effluents via this pathway. If the channel remains inoperable for over 30 days, an explanation of the circumstances must be included in the next Radioactive Effluent Release Report.ACTION 101 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue, provided that once per shift grab samples are collected and analyzed for gross radioactivity at a MINIMUM DETECTABLE CONCENTRATION no higher than I x 10-7 [tCi/mL. If the channel remains inoperable for over 30 days, an explanation of the circumstances must be included in the next Radioactive Effluent Release Report.ACTION 102 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue, provided that the flowrate is estimated at least once per 4 hours during actual releases.
If the channel remains inoperable for over 30 days, an explanation of the circumstances must be included in the next Radioactive Effluent Release Report.ACTION 103 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, assure that the Service Water System effluent monitor is OPERABLE.ACTION 104- With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, obtain daily grab samples and composite for weekly tritium, monthly gamma, and quarterly Sr 89/90 analyses.ACTION 105 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, estimate outfall flow rate daily. If the channel remains inoperable for over 30 days, an explanation of the circumstances must be included in the next Radioactive Effluent Release Report.2-4 Version 23 2/13 2-4 Version 23 2/13 HNP ODCM Table 2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements Surveillance Requirementsa CHANNEL CHANNEL SOURCE CHANNEL FUNCTIONA INSTRUMENT CHECK CHECK CALIBRATIO L N TEST 1. Gross Radioactivity Monitors Providing Automatic Termination of Release Liquid Radwaste b I QC Effluent Line Db pe R QC 2. Gross Radioactivity Monitors not Providing Automatic Termination of Release Service Water System Effluent Line Db M R Qr 3. Flowrate Measurement Devices a. Liquid Radwaste I Effluent Line Db'd NA 18 M Q b. Discharge Canal Dbd NA 18 M Q 4. Differential Pressure Measurement Devices Service Water System to Closed Cooling Water System D NA R NA 5. Groundwater Outfall Instrumentation
: a. Auto Samplers at (1) Y22N008A Wg NA NA NA b. Flow Totalizer at Wg NA NA NA Y22N008A a. All requirements in this Table apply to each unit.b. During releases via this pathway.c. In addition to the basic functions of a CHANNEL FUNCTIONAL TEST (Section 10.2), the CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation occur if any of the following conditions exists: (1)(2)(3)Instrument indicates measured levels above the alarm/trip setpoint;Instrument indicates an isolation on high alarm; or Instrument controls are not set in operate mode.2-5 Version 23 2/13 2-5 Version 23 2/13 Hatch ODCM Table 2-2 (contd) Notation for Table 2-2 -Surveillance Requirements
: d. CHANNEL CHECK shall consist of verifying indication of flow during periods of release.CHANNEL CHECK shall be made at least once daily on any day on which CONTINUOUS, periodic, or BATCH releases are made.e. The SOURCE CHECK shall consist of verifying that the instrument is reading on scale.f. In addition to the basic functions of a CHANNEL FUNCTIONAL TEST (Section 10.2), the CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists: (1) Instrument indicates measured levels above the alarm setpoint;(2) Instrument indicates a downscale failure; or (3) Instrument controls are not set in operate mode.g. CHANNEL CHECK shall consist of verifying indication of operability at least once weekly during sample collection.
2-6 Version 23 2/13 HNP ODCM 2.1.2 Liquid Effluent Concentration Control In accordance with Technical Specifications 5.5.4.b and 5.5.4.c, the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS (see Figure 10-1) shall be limited at all times to ten times the concentrations specified in 10 CFR 20, Appendix B, Table 2, Column 2 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 1 x 1 0"4 total activity.2.1.2.1 Applicability This limit applies at all times 2.1.2.2 Actions With the concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS exceeding the limits stated in Section 2.1.2, immediately restore the concentration to within the stated limits.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.2.1.2.3 Surveillance Requirements The radioactivity content of each batch of radioactive liquid waste shall be determined by sampling and analysis in accordance with Table 2-3. The results of radioactive analyses shall be used with the calculational methods in Section 2.3 to assure that the concentration at the point of release is maintained within the limits of Section 2.1.2.2.1.2.4 Basis This control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than ten times the concentration levels specified in 10 CFR 20, Appendix B, Table 2, Column 2. This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix 1, 10 CFR 50, to a MEMBER OF THE PUBLIC, and (2) the limits of 10 CFR 20.1301 to the population.
The concentration limit for dissolved or entrained noble gases is based upon the assumption that Xe-135 is the controlling radioisotope and its MPC in air (submersion) was converted to an equivalent concentration in water using the methods described in International Commission on Radiological Protection (ICRP) Publication 2 (1959). The resulting concentration of 2 x 10.4 was then multiplied by the ratio of the effluent concentration limit for Xe-135, stated in Appendix B, Table 2, Column 1 of 10 CFR 20 (paragraphs 20.1001 to 20.2401), to the MPC for Xe-135, stated in Appendix B, Table II, Column 1 of 10 CFR 20 (paragraphs 20.1 to 20.601), to obtain the limiting concentration of 1 x 10-41Ci/mL.
2-7 Version 23 2/13 2-7 Version 23 2/13 HNP ODCM Table 2-3 Radioactive Liquid Waste Sampling and Analysis Program Sampling and Analysis Requirementsa'b MINIMUM DETECTABLE Minimum CONCENTRATION Liquid Sampling Analysis Type of Activity (MDC)Release Type FREQUENCY FREQUENCY Analysis (ptCi/mL)PRINCIPAL GAMMA EMITTERS 5 E-7c P P ach BATCH Each BATCH 1-131 1 E-6 Batch Waste Dissolved and Release Tanks P One M Entrained Gases BATCH/M (Gamma Emitters)
I E-5 H-3 1 E-5 P M Each BATCH COMPOSITE Gross Alpha 1 E-7 Sr-89, Sr-90 5 E-8 P Q Each BATCH COMPOSITE Fe-55 2 E-6 W H-3 d Groundwater Compositee Outfall Continuous M PRINCIPAL GAMMA d Y22N008A Release Compositee EMITTERS Q Sr 89, Sr 90 d Compositee
: a. All requirements in this table apply to each unit.b. Terms printed in all capital letters are defined in Chapter 10.c. For certain radionuclides with low gamma yield or low energies, or for certain radionuclide mixtures, it may not be possible to measure radionuclides at or near the required MINIMUM DETECTABLE CONCENTRATION.
Under these circumstances, the required MINIMUM DETECTABLE CONCENTRATION may be increased inversely proportionally to the magnitude of the gamma yield (i.e., 5 E-7/I, where I = photon abundance expressed as a decimal fraction).
In no case shall the MINIMUM DETECTABLE CONCENTRATION, as calculated in this manner for a specific radionuclide, be greater than 10 percent of the corresponding Effluent Concentration Limit value specified in 10 CFR 20 Appendix B, Table 2, Column 2.d. Refer to table 4-3 for environmental MDCs.2-8 Version 23 2/13 HNP ODCM e. Composite samples composed of aliquots taken from automatic sampler. Grab samples should be taken if autosampler is out of service.2.1.3 Liquid Effluent Dose Control In accordance with Technical Specifications 5.5.4.d and 5.5.4.e, the dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released, from each unit, to UNRESTRICTED AREAS (see Figure 10-1) shall be limited: a. During any calendar quarter to less than or equal to 1.5 mrem to the total body and to less than or equal to 5 mrem to any organ, and b. During any calendar year to less than or equal to 3 mrem to the total body and to less than or equal to 10 mrem to any organ.2.1.3.1 Applicability These limits apply at all times.2.1.3.2 Actions With the calculated dose from the release of radioactive materials in liquid effluents exceeding any of the limits of Section 2.1.3, prepare and submit to the Nuclear Regulatory Commission within 30 days a Special Report which identifies the cause(s) for exceeding the limit(s);
defines the corrective actions to be taken to reduce the releases; and defines the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the limits of Section 2.1.3. This report shall also include (1) the results of radiological analyses of the drinking water source, and (2) the radiological impact on finished water supplies with regard to the requirements of 40 CFR 141, the Safe Drinking Water Act.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.2.1.3.3 Surveillance Requirements At least once per 31 days, cumulative dose contributions from liquid effluents for the current calendar quarter and the current calendar year shall be determined, for each unit, in accordance with Section 2.4.2-9 Version 23 2/13 HNP ODCM 2.1.3.4 Basis This control is provided to implement the requirements of Sections II.A, IlI.A and IV.A of Appendix 1, 10 CFR Part 50. The limits stated in Section 2.1.3 implement the guides set forth in Section II.A of Appendix I. The ACTIONS stated in Section 2.1.3.2 provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as is reasonably achievable." Also, for fresh water sites with drinking water supplies that can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR Part 141. The dose calculations in Section 2.4 implement the requirements in Section III.A of Appendix I, which state that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.
The equations specified in Section 2.4 for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109 (Reference 
: 3) and Regulatory Guide 1.113 (Reference 6).This control applies to the release of liquid effluents from each unit at the site. The liquid effluents from shared LIQUID RADWASTE TREATMENT SYSTEMS are to be proportioned between the units.2.1.4 Liquid Radwaste Treatment System Control In accordance with Technical Specification 5.5.4.f., the LIQUID RADWASTE TREATMENT SYSTEM shall be OPERABLE.
The appropriate portions of the system shall be used to reduce radioactivity in liquid wastes prior to their discharge when the projected doses due to the liquid effluent, from each unit, to UNRESTRICTED AREAS (see Figure 10-1) would exceed 0.06 mrem to the total body or 0.2 mrem to any organ of a MEMBER OF THE PUBLIC in 31 days.2.1.4.1 Applicability This limit applies at all times.2.1.4.2 Actions With radioactive liquid waste being discharged without treatment and in excess of the above limits and any portion of the LIQUID RADWASTE TREATMENT SYSTEM not in operation, prepare and submit to the Nuclear Regulatory Commission within 30 days a Special Report which includes the following information:
: a. Explanation of why liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems and the reason for inoperability, b. Action(s) taken to restore the inoperable equipment to OPERABLE status, and c. Summary description of action(s) taken to prevent a recurrence.
_-Version 23 2/13 HNP ODCM Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.2.1.4.3 Surveillance Requirements Doses due to liquid releases to UNRESTRICTED AREAS shall be projected at least once per 31 days, in accordance with Section 2.5, during periods in which the discharge of untreated liquid effluent containing radioactive materials occurs or is expected to occur.The installed LIQUID RADWASTE TREATMENT SYSTEM shall be demonstrated OPERABLE by meeting the controls of Sections 2.1.2 and 2.1.3.2.1.4.4 Basis The OPERABILITY of the LIQUID RADWASTE TREATMENT SYSTEM ensures that this system will be available for use whenever liquid effluents require treatment prior to release to the UNRESTRICTED AREAS. The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable." This control implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objective given in Section II.D of Appendix I to 10 CFR Part 50.The specified limits governing the use of appropriate portions of the LIQUID RADWASTE TREATMENT SYSTEM were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix 1, 10 CFR Part 50, for liquid effluents.
This control applies to the release of radioactive materials in liquid effluents from each unit at the site. For units with shared radwaste systems, the liquid effluents from the shared system are to be proportioned among the units sharing that system.2.1.5 MAJOR CHANGES TO LIQUID RADIOACTIVE WASTE TREATMENT SYSTEMS Licensee initiated MAJOR CHANGES TO LIQUID RADIOACTIVE WASTE TREATMENT SYSTEMS: a. Shall be reported to the Nuclear Regulatory Commission in the Radioactive Effluents Release Report for the period in which the change was implemented, in accordance with Section 7.2.2.7.b. Shall become effective upon review by the Plant Review Board and approval by the Vice President-Plant (VPP)..-Version 23 2/13 HNP ODCM 2.2 LIQUID RADWASTE TREATMENT SYSTEM The Edwin I. Hatch Nuclear Plant is located on the south bank of the Altamaha River, which supplies make-up water to the circulating water system and receives blowdown from the cooling tower. There are two boiling water reactors on the site. Each unit is served by a separate LIQUID RADWASTE TREATMENT SYSTEM.Schematics of the LIQUID RADWASTE TREATMENT SYSTEMS are presented in Figure 2-1 and Figure 2-2. The dotted lines indicate alternate pathways through which liquid radwaste may be routed.The two units release liquid radwaste to separate discharge lines. Dilution flow is furnished by the cooling tower blowdown and plant service water systems, if necessary.
Releases from plant service water systems are to the main condenser circulating flume, or to the cooling tower blowdown discharge line when needed for additional dilution.
Since each unit is served by a separate dilution stream, liquid releases may be made independently from each of the two units.Although no significant quantities of radioactivity are expected in the plant service water systems, these effluent pathways are monitored as a precautionary measure._-Version 23 2/13 HNP ODCM Figure 2-1 Unit 1 LIQUID RADWASTE TREATMENT SYSTEM 2- Version 23 2/13.-Version 23 2/13 HNP ODCM Off Standard Recycle-------------------------------
Figure 2-2 Unit 2 LIQUID RADWASTE TREATMENT SYSTEM_-Version 23 2/13 HNP ODCM F:I0 0etn Subsurface Outfall Y22NOORA\,,C&#xfd; Collection Tank & Auto Sampler s4-S Bldg.Fire Water Tanks TL C Service U Bldg.To Discharge Canal-----------C-a C C, C Water Subsurface Drainage Subsurface.System #2 Sbufc L---- ---------------
Outfall Y22N022A Subsurface Drainage System #1 4--L -------------------------- ----Figure 2-3 Site Subsurface Drainage Systems_-Version 23 2/13 HNPODCM 2.3 LIQUID EFFLUENT MONITOR SETPOINTS 2.3.1 General Provisions Regarding Setpoints Liquid monitor setpoints calculated in accordance with the methodology presented in this section will be regarded as upper bounds for the actual high alarm setpoints.
That is, a lower value for the high alarm setpoint may be established or retained on the monitor, if desired.Intermediate level setpoints should be established at an appropriate level to give sufficient warning prior to reaching the high alarm setpoint.
If no release is planned for a particular pathway, or if there is no detectable activity in the planned release, the monitor setpoint should be established as close to background as practical to prevent spurious alarms, and yet alarm should an inadvertent release occur.Two basic setpoint methodologies are presented below. For radwaste system discharge monitors, setpoints are determined to assure that the limits of Section 2.1.2 are not exceeded.For monitors on streams that are not expected to contain significant radioactivity, the purpose of the monitor setpoints is to cause an alarm on low levels of radioactivity, and to terminate the release where this is possible.
Section 2.1.1 establishes the requirements for liquid effluent monitoring instrumentation.
Table 2-4 lists the monitors for which each of the setpoint methodologies is applicable.
2- Versiori23 2/13_-Version 23 2/13 HNPODCM Table 2-4 Applicability of Liquid Monitor Setpoint Methodologies Liquid Radwaste Discharge Monitors Setpoint Method: Section 2.3.2 Release Type: BATCH Unit I or Unit 2 Liquid Radwaste System Effluent Monitor: ID II-N007 / 2D 11 -N007 Normally Low-Radioactivity Streams with Termination or Diversion upon Alarm Plant Hatch has no liquid effluent streams in this category.Normally Low-Radioactivity Streams with Alarm Only Setpoint Method: Section 2.3.3 Release Type: CONTINUOUS Unit I or Unit 2 Plant Service Water System Effluent Monitor: I D1 I-N008 / 2DI I-N008 Groundwater Outfall Stream Setpoint Method: Auto sampler and flow measurement, no radiation monitor Release Type: CONTINUOUS Plant Site Subsurface (Underdrain)
System #1 Effluent Outfall # Y22N008A 2- Version 23 2/13_-Version 23 2/13 HNP ODCM 2.3.2 Setpoints for Radwaste System Discharge Monitors 2.3.2.1 Overview of Method LIQUID RADWASTE TREATMENT SYSTEM effluent line radioactivity monitors are intended to provide alarm and automatic termination of release prior to exceeding the limits specified in Section 2.1.2 at the point of release of the diluted effluent into the UNRESTRICTED AREA.Therefore, their alarm/trip setpoints are established to ensure compliance with the following equation (equation adapted from Addendum to Reference 1): c"f <_ TF" CEc,.F+f (2.1)where: CECL = the Effluent Concentration Limit corresponding to the mix of radionuclides in the effluent being considered for discharge, in jtCi/mL.c = the setpoint, in &#xfd;tCi/mL, of the radioactivity monitor measuring the concentration of radioactivity in the effluent line prior to dilution and subsequent release. The setpoint represents a concentration which, if exceeded, could result in concentrations exceeding the limits of Section 2.1.2 in the UNRESTRICTED AREA.f = the effluent flowrate at the location of the radioactivity monitor, in gpm.F = the dilution stream flowrate which can be assured prior to the release point to the UNRESTRICTED AREA, in gpm. A predetermined dilution flowrate must be assured for use in the calculation of the radioactivity monitor setpoint.TF = the tolerance factor selected to allow flexibility in the establishment of a practical monitor setpoint which could accommodate effluent releases at concentrations higher than the ECL values stated in 10 CFR 20, Appendix B, Table 2, Column 2;the tolerance factor must not exceed a value of 10.While equation (2.1) shows the relationships of the critical parameters that determine the setpoint, it cannot be applied practically to a mixture of radionuclides with different Effluent Concentration Limits (ECLs). For a mixture of radionuclides, equation (2.1) is satisfied in a practicable manner based on the calculated ECL fraction of the radionuclide mixture and the dilution stream flowrate that can be assured for the duration of the release (Fd), by calculating the maximum permissible effluent flowrate (frm) and the radioactivity monitor setpoint (c).The setpoint method presented below is applicable to the release of only one tank of liquid radwaste per reactor unit at a given time. Liquid releases must be controlled administratively to ensure that this condition is met; otherwise, the setpoint method may not ensure that the limits of Section 2.1.2 are not exceeded.2- Version 23 2/13_-Version 23 2/13 HNP ODCM 2.3.2.2 Setpoint Calculation Steps Step 1: Determine the radionuclide concentrations in the liquid waste being considered for release in accordance with the sampling and analysis requirements of Section 2.1.2.All liquid radwastes are collected in tanks for sampling and analysis prior to release. To ensure that a representative sample can be taken from a tank, its contents will be recirculated for a minimum time period to allow adequate mixing of the contents.
Minimum recirculation times are as follows (Reference 22): Minimum Recirculation Time (minutes)Tank(s) Unit 1 Unit 2 Waste sample tanks 40 40 Floor drain sample tanks 70 65 Chemical waste sample tanks 65 65 Demineralizer feed tank 115 NA Laundry drain tanks 50 NA The total concentration of the liquid waste is determined by the results of all required analyses on the collected sample, as follows: Eci =C + EC, +Cf +C, + (2.2)i S g Ca the gross concentration of alpha emitters in the liquid waste, not less than that measured in the most recent applicable composite sample.Cs= the concentration of strontium radioisotope s (Sr-89 or Sr-90) in the liquid waste, not less than that measured in the most recent applicable composite sample.Cf = the concentration of Fe-55 in the liquid waste, not less than that measured in the most recent applicable composite sample.Ct= the concentration of H-3 in the liquid waste, not less than that measured in the most recent applicable composite sample.Cg the concentration of gamma emitter g in the liquid waste as measured by gamma ray spectroscopy performed on the sample for the release under consideration.
_-Version 23 2/13 HNP ODCM The Cg term will be included in the analysis of each waste sample; terms for gross concentrations of alpha emitters, Sr-89, Sr-90, Fe-55, and tritium will be included in accordance with the sampling and analysis program required for the waste stream (see Section 2.1.2). For each analysis, only radionuclides identified and detected above background for the given measurement should be included in the calculation.
When using the alternate setpoint methodology of step 5.b, the historical maximum values of Ca, Cs, Cf, and Ct shall be used.Step 2: Determine the required dilution factor for the mix of radionuclides detected in the waste.Measured radionuclide concentrations are used to calculate ECL fractions.
The ECL fractions are used along with a safety factor to calculate the required dilution factor; this is the minimum ratio of dilution flowrate to waste flowrate that must be maintained throughout the release to ensure that the limits of Section 2.1.2 are not exceeded at the point of discharge into the UNRESTRICTED AREA. The required dilution factor, RDF, is calculated as the sum of the dilution factors required for gamma emitters (RDFy) and for non-gamma-emitters (RDFY): RDF=I I[I CU + [(sFXTF)]L, ECL,= RDF, + RDF,,y (2.3)[Cg]ECU RDF; =(FT (2.4)(SFXTF)__ " C, Cf C'RDF,,,= L .ECL ECL.f EC (SF)(TF) (2.5)Ci = the measured concentration of radionuclide i as defined in step 1, in pCi/mL.The Ca, Cs, Cf, and Ct terms will be included in the calculation as appropriate.
ECLi = the ECL for radionuclide i from 10 CFR Part 20, Appendix B, Table 2, Column 2 (except for noble gases as discussed below). In the absence of information regarding the solubility classification of a given radionuclide in the waste stream, the solubility class with the lowest ECL shall be assumed. For dissolved or entrained noble gases, the concentration shall be limited to 1 x 10-4 1 iCi/mL. For gross alpha, the ECL shall be 2 x 10-9 [Ci/mL; if specific alpha-emitting radionuclides are measured, the ECL for the specific radionuclide(s) should be used._-Version 23 2/13 HNP ODCM SF the safety factor selected to compensate for statistical fluctuations and errors of measurement.
The value for the safety factor must be between 0 and 1. A value of 0.5 is reasonable for liquid releases; a more precise value may be developed if desired.TF = the tolerance factor (as defined in Section 2.3.2.1).Step 3: Determine the release-specific assured dilution stream flowrate.Determine the dilution stream flowrate that can be assured during the release period, designated Fd; this value is the setpoint for the dilution stream flowrate measurement device.If simultaneous radioactive releases are planned from the same reactor unit, the unit's dilution stream must be allocated among all the simultaneous releases, whether or not they are monitored during release. Normally, only the batch tank effluents need be considered, unless there is detectable radioactivity in one of the normally low-radioactivity streams (see Table 2-4). Allocation of the dilution stream to multiple release paths is accomplished as follows: Fd, = F, (AF, ) (2.6)Fdp = the dilution flowrate allocated to release pathway p, in gpm.AFp = the dilution allocation factor for release pathway p. AFp may be assigned any value between 0 and 1 for each active release pathway, under the condition that the sum of the AFp for all active release pathways for each unit does not exceed 1. [Note: Because the two units have separate dilution streams, the two units do not affect each other with respect to dilution allocation.]
Fd = the assured minimum dilution flow for the unit, in gpm. For Plant Hatch, Fd is normally established at 10,000 gpm.If more precise allocation factor values are desired, they may be determined based on the relative radiological impact of each active release pathway; this may be approximated by multiplying the RDF of each effluent stream by its respective planned release flowrate, and comparing these values. If only one release pathway for a given reactor unit contains detectable radioactivity, its AFp may be assigned the value of 1, making Fdp equal to Fd.For the case where RDF < 1, the planned release meets the limits of Section 2.1.2 without dilution, and may be released with any desired effluent flowrate and dilution flowrate.Step 4: Determine the maximum allowable waste discharge flowrate.For the case where RDF > 1, the maximum permissible effluent discharge flowrate for this release pathway, fmp (in gpm), is calculated as follows: Fdp (2.7)-(RDF)_-Version 23 2/13 HNP ODCM For the case RDF _< 1, equation (2.7) is not valid. However, as discussed above, when RDF < 1, the release may be made at full discharge pump capacity; the radioactivity monitor setpoint must still be calculated in accordance with Step 5 below.NOTE 1: Discharge flowrates are actually limited by the discharge pump capacity.
When the calculated maximum permissible release flowrate exceeds the pump capacity, the release may be made at full capacity.
Discharge flowrates less than the pump capacity must be achieved by throttling if this is available; if throttling is not available, the release may not be made as planned.NOTE 2: If, at the time of the planned release, there is detectable radioactivity due to plant operations in the dilution stream, the diluting capacity of the dilution stream is diminished. (In addition, sampling and analysis of the other radioactive effluents affecting the dilution stream must be sufficient to ensure that the liquid effluent dose limits specified in the controls of Section 2.1.3 are not exceeded.)
Under these conditions, equation (2.7) must be modified to account for the radioactivity present in the dilution stream prior to the introduction of the planned release: (RDF)L r[Fd iECLijJ Cir the measured concentration of radionuclide i in release pathway r that is contributing to radioactivity in the dilution stream.fr = the effluent discharge flowrate of release pathway r.If the entire dilution stream contains detectable activity due to plant operations, whether or not its source is identified, fr = Fd, and Cir is the concentration in the total dilution system. This note does not apply: a) if the RDF of the planned release is < 1; or b) if the release contributing radioactivity to the dilution stream has been accounted for by the assignment of an allocation factor.Step 5: Determine the maximum radioactivity monitor setpoint concentration.
Based on the values determined in previous steps, the radioactivity monitor setpoint for the planned release is calculated to ensure that the limits of Section 2.1.2 will not be exceeded.Because the radioactivity monitor responds primarily to gamma radiation, the monitor setpoint cp for release pathway p (in jiCi/mL) is based on the concentration of gamma emitters in the waste stream, as follows: Cp = Ap Cg (2.9)g_-Version 23 2/13 HNP ODCM where: Ap = an adjustment factor which will allow the setpoint to be established in a practical manner to prevent spurious alarms while allowing a margin between measured concentrations and the limits of Section 2.1.2.Step 5.a. If the concentration of gamma emitters in the effluent to be released is sufficient that the high alarm setpoint can be established at a level that will prevent spurious alarms, Ap should be calculated as follows: I I Fdp=A x ADF=-(p RDF RDF f(2p where: ADF = the assured dilution factor.fap = the anticipated actual discharge flowrate for the planned release (in gpm), a value less than fmp. The release must then be controlled so that the actual effluent discharge flowrate does not exceed fap at any time.Step 5.b. Alternatively, Ap may be calculated as follows: Ap -DF-PDFny (2.11)RDFy Step 5.c. Evaluate the computed value of AP as follows: If Ap 2! 1, calculate the monitor setpoint, cp. However, if cp is within about 10 percent of Cg, it may be impractical to use this value of cp. This situation indicates that measured concentrations are approaching values which would cause the limits of Section 2.1.2 to be exceeded.
Therefore, steps should be taken to reduce potential concentrations at the point of discharge; these steps may include decreasing the planned effluent discharge flowrate, increasing the dilution stream flowrate, postponing simultaneous releases, and/or decreasing the effluent concentrations by further processing the liquid planned for release. Alternatively, allocation factors for the active liquid release pathways may be reassigned.
When one or more of these actions has been taken, repeat Steps 1 -5 to calculate a new radioactivity monitor setpoint.If AP < 1, the release may not be made as planned. Consider the alternatives discussed in the paragraph above, and calculate a new setpoint based on the results of the actions taken._-Version 23 2/13 HNPODCM 2.3.2.3 Use of the Calculated Setpoint The setpoint calculated above is in the units giCi/mL. The monitor actually measures a count rate that includes background, so that the calculated setpoint must be converted accordingly:
C p = Cp* Ep + Bp (2.12)Cp the monitor setpoint as a count rate.Ep the monitor calibration factor, in count rate/(gCi/mL).
Monitor calibration data for conversion between count rate and concentration may include operational data obtained from determining the monitor response to stream concentrations measured by liquid sample analysis.Bp the monitor background count rate. In all cases, monitor background must be controlled so that the monitor is capable of responding to concentrations in the range of the setpoint value.The count rate units of Cp, 4, and Bp in equation (2.12) must be the same (cpm or cps).2.3.3 Setpoints for Monitors on Normally Low-Radioactivity Streams Radioactivity in these streams (listed in Table 2-4 above) is expected to be at very low levels, generally below detection limits. Accordingly, the purpose of these monitors is to alarm upon the occurrence of significant radioactivity in these streams, and to terminate or divert the release where this is possible.2.3.3.1 Normal Conditions When radioactivity in one of these streams is at its normal low level, its radioactivity monitor setpoint should be established as close to background as practical to prevent spurious alarms, and yet alarm should an inadvertent release occur.2.3.3.2 Conditions Requiring an Elevated Setpoint Under the following conditions, radionuclide concentrations must be determined and an elevated radioactivity monitor setpoint determined for these pathways: For streams that can be diverted or isolated, a new monitor setpoint must be established when it is desired to discharge the stream directly to the dilution water even though the radioactivity in the stream exceeds the level which would normally be diverted or isolated.2- Version 23 2/13_-Version 23 2/13 HNP ODCM For streams that cannot be diverted or isolated, a new monitor setpoint must be established whenever:
the radioactivity in the stream becomes detectable above the background levels of the applicable laboratory analyses; or the associated radioactivity monitor detects activity in the stream at levels above the established alarm setpoint.When an elevated monitor setpoint is required for any of these effluent streams, it should be determined in the same manner as described in Section 2.3.2. However, special consideration must be given to Step 3. An allocation factor must be assigned to the normally low-radioactivity release pathway under consideration, and allocation factors for other release pathways discharging simultaneously must be adjusted downward (if necessary) to ensure that the sum of the allocation factors does not exceed 1. Sampling and analysis of the normally low-radioactivity streams must be sufficient to ensure that the liquid effluent dose limits specified in the controls of Section 2.1.3 are not exceeded.2- Version 23 2/13_-Version 23 2/13 HNP ODCM 2.4 LIQUID EFFLUENT DOSE CALCULATIONS The following subsections present the methods required for liquid effluent dose calculations, in deepening levels of detail. Applicable site-specific pathways and parameter values for the calculation of D,, Aj, and CFi, are summarized in Table 2-5.2.4.1 Calculation of Dose The dose limits for a MEMBER OF THE PUBLIC specified in Section 2.1.3 are on a per-unit basis. Therefore, the doses calculated in accordance with this section must be determined and recorded on a per-unit basis, including apportionment of releases shared between the two units.For the purpose of implementing Section 2.1.3, the dose to the maximum exposed individual due to radionuclides identified in liquid effluents released from each unit to UNRESTRICTED AREAS will be calculated as follows (equation from Reference 1, page 15): Dr=, AT YAtC,,F,) 
(2.13)where: DT the cumulative dose commitment to the total body or to any organ T, in mrem, due to radioactivity in liquid effluents released during the total of the m time periods At,.Ai, the site-related adult ingestion dose commitment factor, for the total body or for any organ T, due to identified radionuclide i, in (mrem-mL)/(h
* jICi).Methods for the calculation of A 1 , are presented below in Section 2.4.2. The values of A 1 , to be used in dose calculations for releases from the plant site are listed in Table 2-8.At, the length of time period I, over which C,, and F, are averaged for liquid releases, in hours.C i l  the average concentration of radionuclide i in undiluted liquid effluent during time period I, in itCi/mL. Only radionuclides identified and detected above background in their respective samples should be included in the calculation.
F 1  the near-field average dilution factor in the receiving water of the UNRESTRICTED AREA: F 1 = (2.14)Ft xZ 2- Version 23 2/13_-Version 23 2/13 HNPODCM where: ft = the average undiluted liquid waste flowrate actually observed during the period of radioactivity release, in gpm.Ft the average dilution stream flowrate actually observed during the period of radioactivity release, in gpm.Z the applicable dilution factor for the receiving water body, in the near field of the discharge structure, during the period of radioactivity release, from Table 2-5.Note: In equation (2.14), the product (Ft x Z) is limited to 1000 cfs (= 448,000 gpm) or less.(Reference 1, Section 4.3.)2.4.2 Calculation of Am.The site-related adult ingestion dose commitment factor, Aj, is calculated as follows (equation adapted from Reference 1, page 16, by addition of the irrigated garden vegetation pathway): Ai =1 14xl05 IL- -I+ e- if+ UvCFiv iDFi (2.15), le ;tit Uf BFi ALt where: 1.14 x 105 a units conversion factor, determined by: 106 pCi/jiCi X 103 mL/L + 8760 h/y.Uw the adult drinking water consumption rate applicable to the plant site (L/y).Dw the dilution factor from the near field of the discharge structure for the plant site to the potable water intake location.Xi the decay constant for radionuclide i (h-i). Values of ki used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.tw the transit time from release to receptor for potable water consumption (h).Uf = the adult rate of fish consumption applicable to the plant site (kg/y).BFi = the bioaccumulation factor for radionuclide i applicable to freshwater fish in the receiving water body for the plant site, in (pCi/kg)/(pCi/L) 
= (L/kg). For specific values applicable to the plant site, see Table 2-6._-Version 23 2/13 HNP ODCM tf the transit time from release to receptor for fish consumption (h).Uv the adult consumption rate for irrigated garden vegetation applicable to the plant site (kg/y).CFiv the concentration factor for radionuclide i in irrigated garden vegetation, as applicable to the vicinity of the plant site, in (pCifkg)I(pCilL).
Methods for calculation of CFjv are presented below in Section 2.4.3.DFi, the dose conversion factor for radionuclide i for adults, in organ -r (mrem/pCi).
For specific values, see Table 2-7.2.4.3 Calculation of CFjy The concentration factor for radionuclide i in irrigated garden vegetation, CFi, in (L/kg), is calculated as follows: " For radionuclides other than tritium (equation adapted from Reference 3, equations A-8 and A-9): CF M I + f YA PA A, ., -At (2.16)L , I" For tritium (equation adapted from Reference 3, equations A-9 and A-1 0): CF,, = M. L, (2.17)where: M the additional river dilution factor from the near field of the discharge structure for the plant site to the point of irrigation water usage.I the average irrigation rate during the growing season (L)/(m 2.h).r the fraction of irrigation-deposited activity retained on the edible portions of leafy garden vegetation.
Yv the areal density (agricultural productivity) of leafy garden vegetation (kg/m 2).=j the fraction of the year that garden vegetation is irrigated.
2- Version 23 2/13_-Version 23 2/13 HNP ODCM Biv = the crop to soil concentration factor applicable to radionuclide i (pCi/kg garden vegetation)/(pCi/kg soil).P = the effective surface density of soil (kg/m2).= the decay constant for radionuclide i (h -). Values of Xi used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.w = the rate constant for removal of activity from plant leaves by weathering (hl).?,Ei = the effective removal rate for activity deposited on crop leaves (h)-calculated as: 2Ei = Xi + ,w.te the period of leafy garden vegetation exposure during the growing season (h).tb the period of long-term buildup of activity in soil (h).th the time between harvest of garden vegetation and human consumption (h).Lv the water content of leafy garden vegetation edible parts (L/kg).2- Version 23 2/13_-Version 23 2/13 HNP ODCM Table 2-5 Parameters for Calculation of Doses Due to Liquid Effluent Releases Dose Calculation Receptor Locations:
Fish: Drinking Water: Irrigated Garden Vegetation:
Numerical Parameters:*
Vicinity of plant discharge None++None'+Parameter z U, D, tw Uf tf Uv M I r Yv fi P kw te tb th Value 10 0 L/y 1.0 +12h 21 kg/y 24 h 0 kg/y i.0+&#xf7;No value **0.25 2.0 kg/m 2 1.0 +240 kg/m 2 0.0021 h-1 (i.e., half- life of 14 d)1440 h (= 60 d)1.31 x 105 h (= 15 y)24 h 0.92 L/kg Reference Ref. 9, Sec. 5.1; Ref. 6, Sec. B;Ref. 21 (Pathway not applicable)
Ref. 3, Sec. A.2 Ref. 3, Table E-5 Ref. 3, Sec. A.2 (Pathway not applicable)
Ref. 3, Table E-15 Ref. 3, Table E-15 Ref. 3, Table E-15 Ref. 3, Table E-15 Ref. 3, Table E-15 Ref. 3, Table E-15 Ref. 3, Table E-15 Based on Ref. 27, Table 5.16 (for lettuce, cabbage, etc.)-Because there is no known drinking water pathway or irrigated garden vegetation pathway downstream of the plant site, the parameters for these pathways are default values, and the usage factors are set to 0.+ -There is no established default value for this parameter.
The most conservative physically realistic value is 1.0.** There is no established default value for this parameter.
A value will be supplied if the pathway is ever observed.++ -Confirmed during the annual river water use survey..-Version 23 2/13 HNP ODCM Table 2-6 Element Transfer Factor Freshwater Fish Element BFi H 9.0 E-01 C 4.6 E+03 Na 6.6 E+01 P 2.5 E+04 Cr 1.5 E+02 Mn 8.9 E+01 Fe 6.0 E+00 Co 1.7 E+02 Ni 1.0 E+02 Cu 4.4 E+01 Zn 2.9 E+02 Br 4.2 E+02 Rb 2.0 E+03 Sr 3.8 E+00 Y 2.5 E+01 Zr 1.9 E+02 Nb 4.1 E+01 Mo 1.8 E+02 Tc 1.5 E+01 Ru 4.6 E+00 Rh 1.0 E+01 Ag 3.5 E+02 Sb 1.0 E+00 Te 4.0 E+02 1 4.3 E+01 Cs 5.8 E+02 Ba 5.0 E+00 La 2.5 E+01 Ce 8.4 E+01 Pr 2.5 E+01 Nd 4.6 E+01 W 1.2 E+03 Np 1.0 E+01*- Bioaccumulation Factors for freshwater fish, in (pCilkg)l(pCiIL).
They are obtained from Reference 9 (Appendix A, Table 2.3-1), except as follows: Reference 2 (Table A-8) for Sb.2- Version 23 2/13.-Version 23 2/13 HNP ODCM Table 2-7 Adult Ingestion Dose Factors Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 Na-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P-32 1.93E-04 1.20E-05 7.46E-06 No Data No Data No Data 2.17E-05 Cr-51 No Data No Data 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 Mn-54 No Data 4.57E-06 8.72E-07 No Data 1.36E-06 No Data 1.40E-05 Mn-56 No Data 1.15E-07 2.04E-08 No Data 1.46E-07 No Data 3.67E-06 Fe-55 2.75E-06 1.90E-06 4.43E-07 No Data No Data 1.06E-06 1.09E-06 Fe-59 4.34E-06 1.02E-05 3.91E-06 No Data No Data 2.85E-06 3.40E-05 Co-58 No Data 7.45E-07 1.67E-06 No Data No Data No Data 1.51 E-05 Co-60 No Data 2.14E-06 4.72E-06 No Data No Data No Data 4.02E-05 Ni-63 1.30E-04 9.01E-06 4.36E-06 No Data No Data No Data 1.88E-06 Ni-65 5.28E-07 6.86E-08 3.13E-08 No Data No Data No Data 1.74E-06 Cu-64 No Data 8.33E-08 3.91E-08 No Data 2.1OE-07 No Data 7.10E-06 Zn-65 4.84E-06 1.54E-05 6.96E-06 No Data i.03E-05 No Data 9.70E-06 Zn-69 1.03E-08 1.97E-08 1.37E-09 No Data 1.28E-08 No Data 2.96E-09 Br-83 No Data No Data 4.02E-08 No Data No Data No Data 5.79E-08 Br-84 No Data No Data 5.21 E-08 No Data No Data No Data 4.09E-13 Br-85 No Data No Data 2.14E-09 No Data No Data No Data No Data Rb-86 No Data 2.11 E-05 9.83E-06 No Data No Data No Data 4.16E-06 Rb-88 No Data 6.05E-08 3.21 E-08 No Data No Data No Data 8.36E-19 Rb-89 No Data 4.01 E-08 2.82E-08 No Data No Data No Data 2.33E-21 Sr-89 3.08E-04 No Data 8.84E-06 No Data No Data No Data 4.94E-05 Sr-90 7.58E-03 No Data 1.86E-03 No Data No Data No Data 2.19E-04 Sr-91 5.67E-06 No Data 2.29E-07 No Data No Data No Data 2.70E-05 Sr-92 2.15E-06 No Data 9.30E-08 No Data No Data No Data 4.26E-05 Y-90 9.62E-09 No Data 2.58E-10 No Data No Data No Data 1.02E-04 Y-91m 9.09E- I1 No Data 3.52E-12 No Data No Data No Data 2.67E-10 All values are in (mrem.p/Ci ingested).
They are obtained from Reference 3 (Table E-I 1), except as follows: Reference 2 (Table A-3) for Rh-105, Sb-124, and Sb-125.2-32ersion 23 2/13 HNPODCM Table 2-7 (contd) Adult Ingestion Dose Factors Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Y-91 1.41 E-07 No Data 3.77E-09 No Data No Data No Data 7.76E-05 Y-92 8.45E-10 No Data 2.47E-1 1 No Data No Data No Data 1.48E-05 Y-93 2.68E-09 No Data 7.40E-1 No Data No Data No Data 8.50E-05 Zr-95 3.04E-08 9.75E-09 6.60E-09 No Data 1.53E-08 No Data 3.09E-05 Zr-97 1.68E-09 3.39E-10 1.55E-10 No Data 5.12E-10 No Data 1.05E-04 Nb-95 6.22E-09 3.46E-09 1.86E-09 No Data 3.42E-09 No Data 2.10E-05 Mo-99 No Data 4.31 E-06 8.20E-07 No Data 9.76E-06 No Data 9.99E-06 Tc-99m 2.47E-10 6.98E-10 8.89E-09 No Data i.06E-08 3.42E-10 4.13E-07 Tc-101 2.54E-10 3.66E-10 3.59E-09 No Data 6.59E-09 1.87E-10 1.1OE-21 Ru-103 1.85E-07 No Data 7.97E-08 No Data 7.06E-07 No Data 2.16E-05 Ru-105 1.54E-08 No Data 6.08E-09 No Data 1.99E-07 No Data 9.42E-06 Ru-106 2.75E-06 No Data 3.48E-07 No Data 5.3 1E-06 No Data 1.78E-04 Rh-105 1.22E-07 8.86E-08 5.83E-08 No Data 3.76E-07 No Data 1.41E-05 Ag-i l0m 1.60E-07 1.48E-07 8.79E-08 No Data 2.91E-07 No Data 6.04E-05 Sb-124 2.8 1E-06 5.30E-08 1.1 IE-06 6.79E-09 No Data 2.18E-06 7.95E-05 Sb-125 2.23E-06 2.40E-08 4.48E-07 1.98E-09 No Data 2.33E-04 1.97E-05 Te-125m 2.68E-06 9.71 E-07 3.59E-07 8.06E-07 1.09E-05 No Data 1.07E-05 Te-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 No Data 2.27E-05 Te-127 1.1OE-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 No Data 8.68E-06 Te-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 No Data 5.79E-05 Te-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 No Data 2.37E-08 Te-131m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 No Data 8.40E-05 Te-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 No Data 2.79E-09 Te-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 No Data 7.71E-05 1-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 No Data 1.92E-06 1-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 No Data 1.57E-06 1-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 No Data 1.02E-07 1-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31 E-06 No Data 2.22E-06 All values are in (mrem.p/Ci ingested).
They are obtained from Reference 3 (Table E-1 1), except as follows: Reference 2 (Table A-3) for Rh-105, Sb-124, and Sb-125.2-33ersion 23 2/13 HNP ODCM Table 2-7 (contd) Adult Ingestion Dose Factors Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI 1-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 No Data 2.5 1E-10 1-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 No Data 1.31E-06 Cs-134 6.22E-05 1.48E-04 1.21 E-04 No Data 4.79E-05 1.59E-05 2.59E-06 Cs-136 6.51E-06 2.57E-05 1.85E-05 No Data 1.43E-05 1.96E-06 2.92E-06 Cs-137 7.97E-05 1.09E-04 7.14E-05 No Data 3.70E-05 1.23E-05 2.11 E-06 Cs-138 5.52E-08 1.09E-07 5.40E-08 No Data 8.01E-08 7.91E-09 4.65E-13 Ba-139 9.70E-08 6.91E- I1 2.84E-09 No Data 6.46E-1 I 3.92E-1 I 1.72E-07 Ba-140 2.03E-05 2.55E-08 1.33E-06 No Data 8.67E-09 1.46E-08 4.18E-05 Ba-141 4.71E-08 3.56E-I1 1.59E-09 No Data 3.31E-I1 2.02E-11 2.22E-17 Ba-142 2.13E-08 2.19E-11 I.34E-09 No Data 1.85E-11 1.24E-11 3.OOE-26 La-140 2.50E-09 1.26E-09 3.33E-10 No Data No Data No Data 9.25E-05 La-142 1.28E-10 5.82E-11 i.45E- II No Data No Data No Data 4.25E-07 Ce-141 9.36E-09 6.33E-09 7.18E-10 No Data 2.94E-09 No Data 2.42E-05 Ce-143 1.65E-09 1.22E-06 1.35E-10 No Data 5.37E-10 No Data 4.56E-05 Ce-144 4.88E-07 2.04E-07 2.62E-08 No Data 1.21 E-07 No Data 1.65E-04 Pr-143 9.20E-09 3.69E-09 4.56E-10 No Data 2.13E-09 No Data 4.03E-05 Pr-144 3.01E-1 1 1.25E-1 I 1.53E-12 No Data 7.05E-12 No Data 4.33E-18 Nd-147 6.29E-09 7.27E-09 4.35E-10 No Data 4.25E-09 No Data 3.49E-05 W-187 1.03E-07 8.61 E-08 3.01E-08 No Data No Data No Data 2.82E-05 Np-239 1.19E-09 1.17E-10 6.45E-I I No Data 3.65E-10 No Data 2.40E-05 All values are in (mrem.p/Ci ingested).
They are obtained from Reference 3 (Table E-I 1), except as follows: Reference 2 (Table A-3) for Rh-105, Sb-124, and Sb-125.2-34ersion 23 2/13 HNP ODCM Table 2-8 Site-Related Ingestion Dose Factors, Ai, Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 0.00 2.26E-0I 2.26E-01 2.26E-01 2.26E-01 2.26E-01 2.26E-0I C-14 3.13E+04 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 6.26E+03 Na-24 8.86E+01 8.86E+0I 8.86E+01 8.86E+01 8.86E+01 8.86E+01 8.86E+01 P-32 1.1OE+07 6.84E+05 4.25E+05 0.00 0.00 0.00 1.24E+06 Cr-51 0.00 0.00 9.32E-01 5.57E-01 2.05E-01 1.24E+00 2.34E+02 Mn-54 0.00 9.72E+02 1.85E+02 0.00 2.89E+02 0.00 2.98E+03 Mn-56 0.00 3.87E-02 6.86E-03 0.00 4.91E-02 0.00 1.23E+00 Fe-55 3.95E+01 2.73E+01 6.36E+00 0.00 0.00 1.52E+01 1.56E+01 Fe-59 6.14E+01 1.44E+02 5.53E+01 0.00 0.00 4.03E+01 4.81E+02 Co-58 0.00 3.OOE+02 6.73E+02 0.00 0.00 0.00 6.09E+03 Co-60 0.00 8.71E+02 1.92E+03 0.00 0.00 0.00 1.64E+04 Ni-63 3.11 E+04 2.16E+03 1.04E+03 0.00 0.00 0.00 4.50E+02 Ni-65 1.72E-01 2.23E-02 1.02E-02 0.00 0.00 0.00 5.66E-01 Cu-64 0.00 2.37E+00 1.1 IE+00 0.00 5.97E+00 0.00 2.02E+02 Zn-65 3.35E+03 1.07E+04 4.82E+03 0.00 7.13E+03 0.00 6.72E+03 Zn-69 1.14E-07 2.19E-07 1.52E-08 0.00 1.42E-07 0.00 3.28E-08 Br-83 0.00 0.00 3.83E-02 0.00 0.00 0.00 5.52E-02 Br-84 0.00 0.00 1.22E-12 0.00 0.00 0.00 9.61E-18 Br-85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Rb-86 0.00 9.73E+04 4.53E+04 0.00 0.00 0.00 1.92E+04 Rb-88 0.00 1.29E-22 6.82E-23 0.00 0.00 0.00 1.78E-33 Rb-89 0.00 1.61E-26 1.14E-26 0.00 0.00 0.00 0.00 Sr-89 2.76E+03 0.00 7.93E+01 0.00 0.00 0.00 4.43E+02 Sr-90 6.90E+04 0.00 1.69E+04 0.00 0.00 0.00 1.99E+03 Sr-91 8.95E+00 0.00 3.62E-01 0.00 0.00 0.00 4.26E+01 Sr-92 4.22E-02 0.00 1.83E-03 0.00 0.00 0.00 8.36E-01 Y-90 4.44E-01 0.00 1. 19E-02 0.00 0.00 0.00 4.71E+03 All values are in (mrem-mL)/(h.tCi).
They are calculated using equation (2.15), and data from Table 2-5, Table 2-6, and Table 2-7. When "No Data" is shown for a radionuclide-organ combination in Table 2-7, A 1 , factors in this table are presented as zero.2-35ersion 23 2/13 HNP ODCM Table 2-8 (contd)Site-Related Ingestion Dose Factors, Aj, I Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Y-91m 1.04E-I 1 0.00 4.01 E-13 0.00 0.00 0.00 3.04E-I 1 Y-91 8.34E+00 0.00 2.23E-01 0.00 0.00 0.00 4.59E+03 Y-92 4.60E-04 0.00 1.35E-05 0.00 0.00 0.00 8.06E+00 Y-93 3.09E-02 0.00 8.53E-04 0.00 0.00 0.00 9.80E+02 Zr-95 1.37E+01 4.39E+00 2.97E+00 0.00 6.88E+00 0.00 1.39E+04 Zr-97 2.86E-01 5.76E-02 2.63E-02 0.00 8.70E-02 0.00 1.78E+04 Nb-95 5.99E-01 3.33E-0I 1.79E-01 0.00 3.29E-01 0.00 2.02E+03 Mo-99 0.00 1.44E+03 2.75E+02 0.00 3.27E+03 0.00 3.35E+03 Tc-99m 5.59E-04 1.58E-03 2.01E-02 0.00 2.40E-02 7.75E-04 9.36E-01 Tc-101 2.71E-33 3.91E-33 3.83E-32 0.00 7.03E-32 2.OOE-33 0.00 Ru- 103 2.OOE+00 0.00 8.62E-01 0.00 7.64E+00 0.00 2.34E+02 Ru- 105 4.OOE-03 0.00 i.58E-03 0.00 5.17E-02 0.00 2.45E+00 Ru-106 3.02E+01 0.00 3.83E+00 0.00 5.84E+01 0.00 1.96E+03 Rh-105 1.83E+00 1.33E+00 8.72E-01 0.00 5.63E+00 0.00 2.11E+02 Ag-i l0m 1.34E+02 1.24E+02 7.34E+01 0.00 2.43E+02 0.00 5.05E+04 Sb-124 6.65E+00 1.25E-01 2.63E+00 1.61E-02 0.00 5.16E+00 1.88E+02 Sb-125 5.33E+00 5.74E-02 1.07E+00 4.74E-03 0.00 5.57E+02 4.71E+01 Te-125m 2.54E+03 9.19E+02 3.40E+02 7.63E+02 1.03E+04 0.00 1.O1E+04 Te-127m 6.44E+03 2.30E+03 7.85E+02 1.65E+03 2.62E+04 0.00 2.16E+04 Te-127 1.78E+01 6.38E+00 3.85E+00 1.32E+01 7.24E+01 0.00 1.40E+03 Te-129m 1.08E+04 4.02E+03 1.71E+03 3.71E+03 4.50E+04 0.00 5.43E+04 Te-129 1.78E-05 6.68E-06 4.33E-06 1.36E-05 7.47E-05 0.00 1.34E-05 Te-131m 9.51E+02 4.65E+02 3.88E+02 7.37E+02 4.71E+03 0.00 4.62E+04 Te-131 8.64E-17 3.61E-17 2.73E-17 7.10E-17 3.78E-16 0.00 1.22E-17 Te-132 1.95E+03 1.26E+03 1.18E+03 1.39E+03 1.22E+04 0.00 5.97E+04 1-130 1-131 2.03E+01 3.93E+02 5.98E+0lI 5.6213+02 2.36E+0 1 3.22E+02 5.06E+03 1.84E+05 9.32E+OlI 9.63E+02 0.00 0.00 5.14E+0 I 1.48E+02 All values are in (mrem-mL)/(h-tCi).
They are calculated using equation (2.15), and data from Table 2-5, Table 2-6, and Table 2-7. When "No Data" is shown for a radionuclide-organ combination in Table 2-7, A 1 , factors in this table are presented as zero.2-36ersion 23 2/13 HNP ODCM Table 2-8 (contd)Site-Related Ingestion Dose Factors, Aj, Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI 1-132 1.51E-02 4.04E-02 1.41E-02 1.41E+00 6.43E-02 0.00 7.59E-03 1-133 6.57E+01 1.14E+02 3.48E+01 1.68E+04 1.99E+02 0.00 1.03E+02 1-134 6.26E-08 1.70E-07 6.09E-08 2.95E-06 2.71E-07 0.00 1.48E-10 1-135 3.68E+00 9.64E+00 3.56E+00 6.36E+02 i.55E+01 0.00 1.09E+01 Cs-134 8.63E+04 2.05E+05 1.68E+05 0.00 6.64E+04 2.21E+04 3.59E+03 Cs-136 8.58E+03 3.39E+04 2.44E+04 0.00 1.88E+04 2.58E+03 3.85E+03 Cs-137 1.11E+05 1.51E+05 9.91E+04 0.00 5.14E+04 1.71E+04 2.93E+03 Cs-138 2.64E-12 5.22E-12 2.59E-12 0.00 3.84E-12 3.79E-13 2.23E-17 Ba-139 7.05E-06 5.03E-09 2.07E-07 0.00 4.70E-09 2.85E-09 1.25E-05 Ba-140 2.30E+02 2.89E-01 1.51E+01 0.00 9.83E-02 1.66E-01 4.74E+02 Ba-141 1.06E-24 8.OOE-28 3.57E-26 0.00 7.44E-28 4.54E-28 4.99E-34 Ba- 142 0.00 0.00 0.00 0.00 0.00 0.00 0.00 La-140 9.89E-02 4.99E-02 1.32E-02 0.00 0.00 0.00 3.66E+03 La-142 2.19E-07 9.96E-08 2.48E-08 0.00 0.00 0.00 7.27E-04 Ce-141 1.84E+00 i.25E+00 1.41E-01 0.00 5.79E-01 0.00 4.76E+03 Ce-143 2.OOE-01 1.48E+02 1.64E-02 0.00 6.52E-02 0.00 5.54E+03 Ce-144 9.79E+01 4.09E+01 5.26E+00 0.00 2.43E+01 0.00 3.31E+04 Pr-143 5.23E-01 2.1OE-01 2.59E-02 0.00 1.21E-01 0.00 2.29E+03 Pr-144 1.48E-28 6.14E-29 7.51E-30 0.00 3.46E-29 0.00 2.13E-35 Nd-147 6.50E-01 7.52E-01 4.50E-02 0.00 4.39E-01 0.00 3.61E+03 W-187 1.47E+02 1.23E+02 4.30E+01 0.00 0.00 0.00 4.03E+04 Np-239 2.12E-02 2.09E-03 1.15E-03 0.00 6.51E-03 0.00 4.28E+02 All values are in (mrem-mL)/(h.tCi).
They are calculated using equation (2.15), and data from Table 2-5, Table 2-6, and Table 2-7. When "No Data" is shown for a radionuclide-organ combination in Table 2-7, Aj, factors in this table are presented as zero.2-37ersion 23 2/13 HNP ODCM 2.5 LIQUID EFFLUENT DOSE PROJECTIONS 2.5.1 Thirty-One Day Dose Projections In order to meet the requirements for operation of the LIQUID RADWASTE TREATMENT SYSTEM (see Section 2.1.4), dose projections must be made at least once each 31 days; this applies during periods in which a discharge to UNRESTRICTED AREAS of liquid effluents containing radioactive materials occurs or is expected.Projected 31-day doses to individuals due to liquid effluents may be determined as follows:=(--,) x31+ Dra (2.18)where: D =p the projected dose to the total body or organ -t, for the next 31 days of liquid releases.Dec = the cumulative dose to the total body or organ -, for liquid releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration.
t = the number of whole or partial days elapsed into the current quarter, including the time to the end of the release under consideration (even if the release continues into the next quarter).Dta the anticipated dose contribution to the total body or any organ t, due to any planned activities during the next 31-day period, if those activities will result in liquid releases that are in addition to routine liquid effluents.
If only routine liquid effluents are anticipated, Dta may be set to zero.2.5.2 Dose Projections for Specific Releases Dose projections may be performed for a particular release by performing a pre-release dose calculation assuming that the planned release will proceed as anticipated.
For individual dose projections due to liquid releases, follow the methodology of Section 2.4, using sample analysis results for the source to be released, and parameter values expected to exist during the release period.2-38 Version 23 2/13 2-38 Version 23 2/13 HNP ODCM 2.6 DEFINITIONS OF LIQUID EFFLUENT TERMS The following symbolic terms are used in the presentation of liquid effluent calculations in the sub-sections above.Term Definition Ap = the adjustment factor used in calculating the effluent monitor setpoint for liquid release pathway p: the ratio of the assured dilution to the required dilution [unitless].
ADF = the assured dilution factor for a planned release [unitless].
AFp = the dilution allocation factor for liquid release pathway p [unitless].
Ai- = the site-related adult ingestion dose commitment factor, for the total body or for any organ T, due to identified radionuclide i[(mrem.mL)/(h.[iCi)].
The values of Ai, are listed in Table 2-8.Biv = the crop to soil concentration factor applicable to radionuclide i,[(pCi/kg garden vegetation)/(pCi/kg soil)].BFi the bioaccumulation factor for radionuclide i for freshwater fish[(pCi/kg)/(pCi/L)].
Values are listed in Table 2-6.c the setpoint of the radioactivity monitor measuring the concentration of radioactivity in the effluent line, prior to dilution and subsequent release [ Ci/mL].Cp = the calculated effluent radioactivity monitor setpoint for liquid release pathway p [jCi/mL].Ca = the gross concentration of alpha emitters in the liquid waste as measured in the applicable composite sample [[tCi/mL].
CECL = the Effluent Concentration Limit stated in 10 CFR 20, Appendix B, Table 2, Column 2 [liCi/mL].
Cf = the concentration of Fe-55 in the liquid waste as measured in the applicable composite sample [[.Ci/mL].
Cg = the concentration of gamma emitter g in the liquid waste as measured by gamma ray spectroscopy performed on the applicable pre-release waste sample [[tCi/mL].
Ci = the measured concentration of radionuclide i in a sample of liquid effluent [.tCi/mL].
Section of Initial Use 2.3.2.2 2.3.2.2 2.3.2.2 2.4.1 2.4.3 2.4.2 2.3.2.1 2.3.2.2 2.3.2.2 2.3.2.1 2.3.2.2 2.3.2.2 2.3.2.2 2-39 Version 23 2/13 2-39 Version 23 2/13 HNP ODCM Section of Term Definition Initial Use Cil the average concentration of radionuclide i in undiluted liquid effluent during time period I [pCi/mL].
2.4.1 Cir the measured concentration of radionuclide i in release pathway r that is contributing to radioactivity in the dilution stream [lCi/mL].
2.3.2.2 Cs = the concentration of strontium radioisotope s (Sr-89 or Sr-90) in the liquid waste as measured in the applicable composite sample[gtCi/mL].
2.3.2.2 Ct = the concentration of H-3 in the liquid waste as measured in the applicable composite sample [&#xfd;tCi/mL].
2.3.2.2 CFiv = the concentration factor for radionuclide i in irrigated garden vegetation 
[(pCi/kg)/(pCi/L)].
2.4.2 Dw = the dilution factor from the near field of the discharge structure to the potable water intake location [unitless].
2.4.2 D, = the cumulative dose commitment to the total body or to any organ c, due to radioactivity in liquid effluents released during a given time period [mrem]. 2.4.1 Dta = the anticipated dose contribution to the total body or any organ -C, due to any planned activities during the next 3 1-day period [mrem]. 2.5.1 DTC the cumulative dose to the total body or organ c, for liquid releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration 
[mrem]. 2.5.1 Dxp the projected dose to the total body or organ T, for the next 31 days of liquid releases [mrem]. 2.5.1 DFiT = the dose conversion factor for radionuclide i for adults, in organ t[mrem/pCi].
Values are listed in Table 2-7. 2.4.2 ECLi = the liquid Effluent Concentration Limit for radionuclide i from 10 CFR Part 20, Appendix B, Table 2, Column 2 [[iCi/mL].
2.3.2.2 f the effluent flowrate at the location of the radioactivity monitor[gpm]. 2.3.2.1 fap the anticipated actual discharge flowrate for a planned release from liquid release pathway p [gpm]. 2.3.2.2 2-40 Version 23 2/13 2-40 Version 23 2/13 HNP ODCM Section of Term Definition Initial Use fl = the fraction of the year that garden vegetation is irrigated 
[unitless].
2.4.3 fmp = the maximum permissible effluent discharge flowrate for release pathway p [gpm]. 2.3.2.2 fr = the effluent discharge flowrate of release pathway r [gpm]. 2.3.2.2 ft = the average undiluted liquid waste flowrate actually observed during the period of a liquid release [gpm]. 2.4.1 F = the dilution stream flowrate which can be assured prior to the release point to the UNRESTRICTED AREA [gpm]. 2.3.2.1 Fd = the entire assured dilution flowrate for the plant site during the release period [gpm]. 2.3.2.2 Fdp = the dilution flowrate allocated to release pathway p [gpm]. 2.3.2.2 Fi = the near-field average dilution factor in the receiving water of the UNRESTRICTED AREA [unitless].
2.4.1 Ft = the average dilution stream flowrate actually observed during the period of a liquid release [gpm]. 2.4.1 I the average irrigation rate during the growing season [L/(mr 2.h)]. 2.4.3 LV the water content of leafy garden vegetation edible parts [L/kg]. 2.4.3 M the additional river dilution factor from the near field of the discharge structure for the plant site to the point of irrigation water usage [unitless].
2.4.3 P = the effective surface density of soil [kg/mr 2]. 2.4.3 r the fraction of irrigation-deposited activity retained on the edible portions of leafy garden vegetation.
2.4.3 RDF = the required dilution factor: the minimum ratio by which liquid effluent must be diluted before reaching the UNRESTRICTED AREA, in order to ensure that the limits of Section 2.1.2 are not exceeded [unitless].
2.3.2.2 RDFY = the RDF for a liquid release due only to its concentration of gamma-emitting radionuclides 
[unitless].
2.3.2.2 2-41 Version 23 2/13 2-41 Version 23 2/13 HNP ODCM Section of Term Definition Initial Use RDFn7 = the RDF for a liquid release due only to its concentration of non-gamma-emitting radionuclides 
[unitless].
2.3.2.2 SF the safety factor selected to compensate for statistical fluctuations and errors of measurement 
[unitless].
2.3.2.2 t the number of whole or partial days elapsed into the current quarter, including the time to the end of the release under consideration.
2.5.1 tb = the period of long-term buildup of activity in soil [h]. 2.4.3 te = the period of leafy garden vegetation exposure during the growing season [h]. 2.4.3 tf = the transit time from release to receptor for fish consumption 
[h]. 2.4.2 th = the time between harvest of garden vegetation and human consumption 
[h]. 2.4.3 tw the transit time from release to receptor for potable water consumption 
[h]. 2.4.2 TF the tolerance factor selected to allow flexibility in the establishment of a practical monitor setpoint which could accommodate effluent releases at concentrations higher than the ECL values stated in 10 CFR 20, Appendix B, Table 2, Column 2 [unitless];
the tolerance factor must not exceed a value of 10. 2.3.2.1 Uf = the adult rate of fish consumption 
[kg/y]. 2.4.2 UV = the adult consumption rate for irrigated garden vegetation 
[kg/y]. 2.4.2 Uw the adult drinking water consumption rate applicable to the plant site [L/y]. 2.4.2 Yv the areal density (agricultural productivity) of leafy garden vegetation 
[kg/mr 2]. 2.4.3 Z the applicable dilution factor for the receiving water body, in the near field of the discharge structure, during the period of radioactivity release [unitless].
2.4.1 Atl the length of time period 1, over which Cil and F, are averaged for liquid releases [h]. 2.4.1 2-42 Version 23 2/13 HNP ODCM Term Definition-Ei = the effective removal rate for activity deposited on crop leaves[hK-., = the decay constant for radionuclide i [h-1].X = the rate constant for removal of activity from plant leaves by weathering 
[h-].Section of Initial Use 2.4.3 2.4.2 2.4.3 2-43 Version 23 2/13 HNPODCM CHAPTER 3 GASEOUS EFFLUENTS 3.1 LIMITS OF OPERATION The following Limits of Operation implement requirements established by Technical Specifications Section 5.0. Terms printed in all capital letters are defined in Chapter 10.3.1.1 Gaseous Effluent Monitoring Instrumentation Control In accordance with Technical Specification 5.5.4., the radioactive gaseous effluent monitoring instrumentation channels shown in Table 3-1 shall be OPERABLE with their alarm/trip setpoints set to ensure that the limits of Section 3.1.2.a are not exceeded.
The alarm/trip setpoints of these channels shall be determined in accordance with Section 3.3.3.1.1.1 Applicability These limits apply as shown in Table 3-1.3.1.1.2 Actions With a radioactive gaseous effluent monitoring instrumentation channel alarm/trip setpoint less conservative than required by the above control, immediately suspend the release of radioactive gaseous effluents monitored by the affected channel, declare the channel inoperable, or restore the setpoint to a value that will ensure that the limits of Section 3.1.2.a are met.With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table 3-1. NOTE: One instrument channel may be inoperable for up to 6 hours to perform required surveillances prior to entering other applicable ACTIONS. Otherwise, restore the inoperable instrumentation to OPERABLE status within 30 days and, if unsuccessful, explain in the next Radioactive Effluent Release Report, per Technical Specification 5.6.3, why this inoperability was not corrected in a timely manner.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.3.1.1.3 Surveillance Requirements Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION, and CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table 3-2.3-i Version 23 2/13 3-1 Version 23 2/13 HNP ODCM 3.1.1.4 Basis The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents.
The Alarm/Trip Setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in Section 3.3 to ensure that the alarm/trip will occur prior to exceeding the limits of Section 3.1.2.a. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.3-2 Version 23 2/13 3-2 Version 23 2/13 HNP ODCM Table 3-1 Radioactive Gaseous Effluent Monitoring Instrumentation Minimum Channels Instrument OPERABLE Applicability ACTION 1. Reactor Building Vent Stack Monitoring System (Each Unit)a. Noble Gas Activity Monitorc 1 (a) 105 b. Iodine Sampler Cartridge I (a) 107 c. Particulate Sampler Filter I (a) 107 d. Effluent System Flowrate Measurement 1 (a) 104 Device e. Sampler Flowrate Measurement Device I (a) 104 2. Recombiner Building Ventilation Monitoring System a. Noble Gas Activity Monitorc I (a) 105 b. Iodine Sampler Cartridge 1 (a) 107 c. Particulate Sampler Filter 1 (a) 107 d. Effluent System Flowrate Measurement I (a) 104 Device e. Sampler Flowrate Monitor I (a) 104 3. Main Stack Monitoring System a. Noble Gas Activity Monitorc I (a) 105 b. Iodine Sampler Cartridge I (a) 107 c. Particulate Sampler Filter I (a) 107 d. Effluent System Flowrate Measurement I (a) 104 Device e. Sampler Flowrate Measurement Device 1 (a) 104 4. Condenser Offgas Pretreatment Monitor (Each Unit)a. Noble Gas Activity Monitor I (b) 108 a. During radioactive releases via this pathway.b. During operation of the main condenser air ejector.c. Monitor must be capable of responding to a MINIMUM DETECTABLE CONCENTRATION of 1 x 104 &#xfd;.Ci/mL.3-3 Version 23 2/13 3-3 Version 23 2/13 HNP ODCM Table 3-1 (contd) Notation for Table 3-1.ACTION 104 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided the flowrate is estimated at least once per 4 hours. If the number of channels OPERABLE remains less than required by the minimum channels OPERABLE requirement for over 30 days, an explanation of the circumstances shall be included in the next Radioactive Effluent Release Report.ACTION 105 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided grab samples are taken daily and these samples are analyzed for gross activity within 24 hours. With the number of main stack monitoring system channels OPERABLE less than required by the minimum channels OPERABLE requirement, immediately suspend drywell purge. If the number of channels OPERABLE remains less than required by the minimum channels OPERABLE requirement for over 30 days, an explanation of the circumstances shall be included in the next Radioactive Effluent Release Report.ACTION 107 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue, provided samples are continuously collected with auxiliary equipment for periods on the order of 7 days and analyzed within 48 hours after the end of the sampling period. If the number of channels OPERABLE remains less than required by the minimum channels OPERABLE requirement for over 30 days, an explanation of the circumstances shall be included in the next Radioactive Effluent Release Report.ACTION 108 -With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue provided: a. The offgas treatment system is not bypassed; and b. The offgas post-treatment monitor (D1 1-K615) or the main stack monitor (D1 1-K600)is OPERABLE; and c. Perform Technical Specification SR 3.7.6.1 every 4 hours.Otherwise, enter Condition "A" of Technical Specification LCO 3.7.6.If the number of channels OPERABLE remains less than required by the minimum channels OPERABLE requirement for over 30 days, an explanation of the circumstances shall be included in the next Radioactive Effluent Release Report.3-4 Version 23 2/13 3-4 Version 23 2/13 HNP ODCM Table 3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements CHANNEL CHANNEL SOURCE CHANNEL FUNCTIONA INSTRUMENT CHECK CHECK CALIBRATION L TEST 1. Reactor Building Vent Stack Monitoring System (Each Unit)a. Noble Gas Activity Da M R QC Monitor b. Iodine Sampler Cartridge W ad NA NA NA c. Particulate Sampler Filter Wa'd NA NA NA d. Effluent System Flowrate Da NA R Q Measuring Device e. Sampler Flowrate Da NA R Q Measuring Device 2. Recombiner Building Ventilation Monitoring System a. Noble Gas Activity Da M R QC Monitor b. Iodine Sampler Cartridge Wa'd NA NA NA c. Particulate Sampler Filter Wa7d NA NA NA d. Effluent System Flowrate Da NA R Q Measuring Device e. Sampler Flowrate Da NA R Q Measuring Device 3. Main Stack Monitoring System a. Noble Gas Activity Da M R QC Monitor b. Iodine Sampler Cartridge Wad NA NA NA c. Particulate Sampler Filter Wa'd NA NA NA d. Effluent Flowrate Monitor Da NA R Q e. Sampler Flowrate Monitor Da NA R Q 4. Condenser Offgas Pretreatment Monitor (Each Unit)a. Noble Gas Activity Db M R Qc Monitor I a. Requirement applies during releases via this pathway.b. Requirement applies during operation of the main condenser air ejector.c. In addition to the basic functions of a CHANNEL FUNCTIONAL TEST (Section 10.2), the CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists: (1) Instrument indicates measured levels above the alarm/trip setpoint.(2) Circuit failure occurs.3-5 Version 23 2/13 HNP ODCM (3) Instrument indicates a downscale failure.d. The CHANNEL CHECK shall consist of verifying sampler flow and the presence of the collection device (i.e., particulate filter or charcoal cartridge, etc.) at the weekly changeout.
3.1.2 Gaseous Effluent Dose Rate Control In accordance with Technical Specifications 5.5.4.c and 5.5.4.g, the licensee shall conduct operations so that the dose rates due to radioactive materials released in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY (see Figure 10-1) are limited as follows: a. For noble gases: Less than or equal to a dose rate of 500 mrem/y to the total body and less than or equal to a dose rate of 3000 mrem/y to the skin, and b. For Iodine-131, Iodine-133, tritium, and for all radionuclides in particulate form with half-lives greater than 8 days: Less than or equal to a dose rate of 1500 mrem/y to any organ.3.1.2.1 Applicability This limit applies at all times.3.1.2.2 Actions With a dose rate due to radioactive material released in gaseous effluents exceeding the limit stated in Section 3.1.2, immediately decrease the release rate to within the stated limit.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.3.1.2.3 Surveillance Requirements The dose rates due to radioactive materials in areas at or beyond the SITE BOUNDARY due to releases of gaseous effluents shall be determined to be within the above limits, in accordance with the methods and procedures in Section 3.4.1, by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table 3-3.Basis This control is provided to ensure that gaseous effluent dose rates will be maintained within the limits that historically have provided reasonable assurance that radioactive material discharged in gaseous effluents will not result in a dose to a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, exceeding the limits specified in Appendix I of 10 CFR Part 50, while allowing operational flexibility for effluent releases.
For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of the MEMBER OF THE PUBLIC will be sufficiently low to compensate for any increase in the atmospheric diffusion factor above that for the SITE BOUNDARY.3-6 Version 23 2/13 HNP ODCM The dose rate limit for Iodine-1 31, Iodine-1 33, tritium, and radionuclides in particulate form with half-lives greater than 8 days specifically applies to dose rates to a child via the inhalation pathway.This control applies to the release of gaseous effluents from all reactors at the site.3-7 Version 23 2/13 3-7 Version 23 2/13 HNP ODCM Table 3-3 Radioactive Gaseous Waste Sampling and Analysis Program Sampling and Analysis Requirementsa M INIMUM DETECTABLE Minimum Type of CONCENTRATIO Gaseous Release Sampling Analysis Activity N (MDC)Type FREQUENCY FREQUENCY Analysis (&#xfd;tCi/mL)Mc Mc PRINCIPAL I E-4 Grab Sample GAMMA EMITTERS H-3 1 E-6 Environmental CONTINUOUS Wd Charcoal 1-131 1 E-12 e Release Points or Silver Zeolite 1-133 1 E-10 1. Main Stack Sample CONTINUOUS Wd PRINCIPAL I E-11 2. Reactor e Particulate GAMMA Building Vent Sample EMITTERS (Each Unit) CONTINUOUS M Gross Alpha I E-I 1 3. Recombiner e COMPOSITE Building Ventb Particulate Sample CONTINUOUS Q Sr-89, Sr-90 1 E-II e COMPOSITE Particulate Sample a. Terms printed in all capital letters are defined in Chapter 10. When unusual circumstances result in a MINIMUM DETECTABLE CONCENTRATION higher than required, the reasons shall be documented in the next Radioactive Effluent Release Report.b. The Recombiner Building Vent serves Unit 1. Sample analysis results and associated source terms must be assigned to Unit 1 for the purpose of release accountability and dose calculations.
: c. Sampling and analyses for PRINCIPAL GAMMA EMITTERS shall also be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a one-hour period. The more frequent sampling and analysis requirement applies only if analysis shows that the DOSE EQUIVALENT 1-131 concentration in the primary coolant and the Main Stack Noble Gas Activity Monitor reading have both increased by a factor of 3.3-8 Version 23 2/13 HNPODCM Table 3-3 (contd) Notation for Table 3-3 d. Sampling shall be performed weekly, and analyses completed within 48 hours of changing (or after removal from sampler).
Sampling shall also be performed once per 24 hours for 7 days following each shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a one-hour period, with analyses completed within 48 hours of changing.
When samples collected for 24 hours are analyzed, the corresponding MINIMUM DETECTABLE CONCENTRATIONs may be increased by a factor of 10. The more frequent sampling and analysis requirement applies only if analysis shows that the DOSE EQUIVALENT 1-131 concentration in the primary coolant and the Main Stack Noble Gas Activity Monitor reading have both increased by a factor of 3.e. The ratio of the sample flowrate to the sampled stream flowrate shall be known for the time period covered by each dose or dose rate calculation made in accordance with controls specified in Sections 3.1.2, 3.1.3, and 3.1.4.3-9 Version 23 2/13 HNPODCM 3.1.3 Gaseous Effluent Air Dose Control In accordance with Technical Specifications 5.5.4.e and 5.5.4.h, the air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and beyond the SITE BOUNDARY (see Figure 10-1) shall be limited to the following:
: a. During any calendar quarter: Less than or equal to 5 mrad for gamma radiation and less than or equal to 10 mrad for beta radiation, and b. During any calendar year: Less than or equal to 10 mrad for gamma radiation and less than or equal to 20 mrad for beta radiation.
3.1.3.1 Applicability This limit applies at all times.3.1.3.2 Actions With the calculated air dose from radioactive noble gases in gaseous effluents exceeding any of the above limits, prepare and submit to the Nuclear Regulatory Commission within 30 days a Special Report which identifies the cause(s) for exceeding the limit(s);
defines the corrective actions that have been taken to reduce the releases; and defines the proposed corrective actions to be taken to assure that subsequent releases of radioactive noble gases in gaseous effluents will be in compliance with the limits of Section 3.1.3.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.3.1.3.3 Surveillance Requirements Cumulative air dose contributions from noble gas radionuclides released in gaseous effluents from each unit to areas at and beyond the SITE BOUNDARY, for the current calendar quarter and current calendar year, shall be determined in accordance with Section 3.4.2 at least once per 31 days.3-10 Version 23 2/13 3-10 Version 23 2/13 HNP ODCM 3.1.3.4 Basis This control is provided to implement the requirements of Sections II.B, III.A and IV.A of Appendix 1, 10 CFR Part 50. Section 3.1.3 implements the guides set forth in Section II.B of Appendix I. The ACTION statements in Section 3.1.3.2 provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I, assuring that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The Surveillance requirements in Section 3.1.3.3 implement the requirements in Section IlI.A of Appendix I, which require that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.
The dose calculations established in Section 3.4.2 for calculating the doses due to the actual releases of noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109 (Reference 3), and Regulatory Guide 1.111 (Reference 5). The equations in Section 3.4.2 provided for determining the air doses at the SITE BOUNDARY are based upon the historical annual average atmospheric conditions.
3.1.4 Control on Gaseous Effluent Dose to a MEMBER OF THE PUBLIC In accordance with Technical Specifications 5.5.4.e and 5.5.4.i, the dose to a MEMBER OF THE PUBLIC from 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released, from each reactor unit, to areas at and beyond the SITE BOUNDARY (see Figure 10-1) shall be limited to the following:
: a. During any calendar quarter: < 7.5 mrem to any organ, and b. During any calendar year: < 15 mrem to any organ.3.1.4.1 Applicability This limit applies at all times.3.1.4.2 Actions With the calculated dose from the release of 1-131, 1-133, tritium, or radionuclides in particulate form with half-lives greater than 8 days, in gaseous effluents exceeding any of the above limits, prepare and submit to the Nuclear Regulatory Commission within 30 days a Special Report which identifies the cause(s) for exceeding the limit; defines the corrective actions that have been taken to reduce the releases of radioiodines and radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents; and defines proposed corrective actions to assure that subsequent releases will be in compliance with the limits stated in Section 3.1.4.Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.3-11 Version 23 2/13 HNP ODCM 3.1.4.3 Surveillance Requirements Cumulative organ dose contributions to a MEMBER OF THE PUBLIC from 1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days released in gaseous effluents from each unit to areas at and beyond the SITE BOUNDARY, for the current calendar quarter and current calendar year, shall be determined in accordance with Section 3.4.3 at least once per 31 days.3.1.4.4 Basis This control is provided to implement the requirements of Section II.C, III.A and IV.A of Appendix 1, 10 CFR Part 50. The limits stated in Section 3.1.4 are the guides set forth in Section II.C of Appendix I. The ACTION statements in Section 3.1.4.2 provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The calculational methods specified in the Surveillance Requirements of Section 3.1.4.3 implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.
The calculational methods in Section 3.4.3 for calculating the doses due to the actual releases of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109 (Reference 3), and Regulatory Guide 1.111 (Reference 5). These equations provide for determining the actual doses based upon the historical annual average atmospheric conditions.
The release specifications for radioiodines, radioactive materials in particulate form and radionuclides other than noble gases are dependent on the existing radionuclide pathways to man, in the areas at and beyond the SITE BOUNDARY.
The pathways which were examined in the development of these calculations were: 1) individual inhalation of airborne radionuclides, 2) deposition of radionuclides onto green leafy garden vegetation with subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.3.1.5 GASEOUS RADWASTE TREATMENT SYSTEM Control In accordance with Technical Specification 5.5.4.f., the GASEOUS RADWASTE TREATMENT SYSTEM as described in Section 3.2 shall be in operation.
3.1.5.1 Applicability Whenever the main condenser air ejector is in operation.
3.1.5.2 Actions With gaseous radwaste from the main condenser air ejector system being discharged without treatment for more than 7 days, prepare and submit to the Nuclear Regulatory Commission within 30 days a Special Report which includes the following information:
: a. Identification of the inoperable equipment or subsystem and the reason for inoperability, 3-12 Version 23 2/13 HNP ODCM b. Action(s) taken to restore the inoperable equipment to OPERABLE status, and c. Summary description of action(s) taken to prevent a recurrence.
Entry into an Operational Mode or other specified CONDITION shall be made if, as a minimum, the requirements of Technical Specifications LCO 3.0.4 are met.3.1.5.3 Surveillance Requirements The GASEOUS RADWASTE TREATMENT SYSTEM shall be demonstrated to be OPERABLE by administrative controls which ensure that the offgas treatment system is not bypassed.3.1.5.4 Basis The OPERABILITY of the GASEOUS RADWASTE TREATMENT SYSTEM ensures that the system will be available for use whenever gaseous effluents require treatment prior to release to the environment.
The requirement that the appropriate portions of this system be used, when specified, provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." This control implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the system were specified as a suitable fraction of the dose design objectives set forth in Section II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents.
This control applies to the release of radioactive materials in gaseous effluents from each unit at the site. For units with shared radwaste systems, the gaseous effluents from the shared system are proportioned among the units sharing that system.3.1.6 MAJOR CHANGES TO GASEOUS RADIOACTIVE WASTE TREATMENT SYSTEM Licensee initiated MAJOR CHANGES TO GASEOUS RADIOACTIVE WASTE TREATMENT SYSTEMS: a. Shall be reported to the Nuclear Regulatory Commission in the Radioactive Effluent Release Report for the period in which the change was implemented, in accordance with Section 7.2.2.7.b. Shall become effective upon review by the Plant Review Board and approval by the Vice President-Plant (VPP).3-13 Version 23 2/13 3-13 Version 23 2/13 HNPODCM 3.2 GASEOUS RADWASTE TREATMENT SYSTEM At Plant Hatch, there are four points where radioactivity normally is released to the atmosphere in gaseous discharges.
These four release pathways are: the Unit 1 and Unit 2 reactor building vent stacks; the Unit 1 recombiner building vent; and the main stack, which serves both units.In addition, releases may be made from any of the building exhaust augmented ventilation systems that have been included in Table 3-1, Table 3-2, and Table 3-3.The main stack serves as the discharge point from the following release sources from each unit:* Mechanical vacuum pumps;* Offgas treatment system (see Figure 3-1);" Gland seal exhaust; and" Standby gas treatment system (through which drywell purges are discharged).
In addition, the waste gas treatment building ventilation also discharges through the main stack.Each reactor building vent stack serves as the discharge point for the following release sources of its respective unit:* Reactor building;" Refueling floor ventilation;" Turbine building; and" Radwaste building.The Unit 1 recombiner building vent discharges directly to the atmosphere.
Releases from all of the above discharge points except the main stack are considered to be ground-level releases; releases from the main stack are considered to be elevated releases.Chapter 8 discusses the calculation of atmospheric dispersion parameters using the ground-level and elevated models. All release pathways are considered to be CONTINUOUS (as opposed to BATCH) in nature.3-14 Version 23 2/13 3-14 Version 23 2/13 HNP ODCM From Condenser f 1 It Stage Intercondenser L 2"d Stage Intercondenser El R Radiation Monitor A Ist Stage Ejector--] 2"' Stage Ejector 3 rd Stage Ejector Offgas Reheater Catalytic Recombiner Offgas Condenser Water Separator.ip Lter 7A Radiation Cooler Condenser From Standby Gas Treatment System From Gland Seal System Figure 3-1 Schematic Diagram of the Condenser Offgas Treatment System 3-15 Version 23 2/13 HNPODCM 3.3 GASEOUS EFFLUENT MONITOR SETPOINTS 3.3.1 General Provisions Regardinq Noble Gas Monitor Setpoints Noble gas radioactivity monitor setpoints calculated in accordance with the methodology presented in this section are intended to ensure that the limits of Section 3.1.2.a are not exceeded.
They will be regarded as upper bounds for the actual high alarm setpoints.
That is, a lower high alarm setpoint may be established or retained on the monitor, if desired.Intermediate level setpoints should be established at an appropriate level to give sufficient warning prior to reaching the high alarm setpoint.If no release is planned for a given pathway, or if there is no detectable activity in the gaseous stream being evaluated for release, the setpoint should be established as close to background as practical to prevent spurious alarms, and yet alarm should a significant inadvertent release occur.As established in Section 3.1.1, gaseous effluent monitor setpoints are required only for the noble gas monitors on the release streams listed above. However, Section 3.3.6 discusses setpoint methodologies for particulate and iodine monitors on an information-only basis.Note: Section 3.3.3 is included for section numbering compatibility with the ODCMs of the other Southern Company nuclear power plants. This section is not required by the existing release source and discharge point configuration of Plant Hatch.3-16 Version 23 2/13 HNP ODCM Table 3-4 Applicability of Gaseous Monitor Setpoint Methodologies Final Release Pathways with no Monitored Source Streams Setpoint Method: Section 3.3.2 Release Type: CONTINUOUS Main Stack Release Elevation:
Elevated Monitor: D1 1-K600 A and B Flowrate:
20,000 cfm (9.44 E+06 mL/s) [without SBGT in operation]
Maximum Flowrate:
36,000 cfm (1.70 E+07 mL/s) [with all four trains of SBGT operation at 4000 cfm per train]Unit 1 or Unit 2 Reactor Building Vent Release Elevation:
Ground-level Monitor: D11-K619 A and B / 2D11-K636 A and B Maximum Flowrate:
300,000 cfm (1.42 E+08 mL/s)Unit 1 Recombiner Building Vent Release Elevation:
Monitor: Maximum Flowrate: Ground-level D11-R763A and B 500 cfm (2.36 E+05 mL/s)Building Exhaust Augmented Ventilation The systems in this category are not currently vented to the atmosphere.
Final Release Pathways with One or More Monitored Source Streams Plant Hatch currently has no release pathways in this category.(X/Q)vb Values for Use in Setpoint Calculations Ground-Level Releases: Elevated Releases: 8.37 x 10-6 s/m 3 [ENE Sector]4.10 x 10-8 s/m 3[ENE Sector]3-17 Version 23 2/13 3-17 Version 23 2/13 HNPODCM 3.3.2 Setpoint for the Final Noble Gas Monitor on Each Release Pathway 3.3.2.1 Overview of Method Gaseous effluent radioactivity monitors are intended to alarm prior to exceeding the limits of Section 3.1.2.a. Therefore, their alarm setpoints are established to ensure compliance with the following equation: c=the lesser of AG-SF.X Rt (3.1)where: c = the setpoint, in [tCi/mL, of the radioactivity monitor measuring the concentration of radioactivity in the effluent line prior to release. The setpoint represents a concentration which, if exceeded, could result in dose rates exceeding the limits of Section 3.1.2.a at or beyond the SITE BOUNDARY.AG an administrative allocation factor applied to divide the release limit among all the gaseous release pathways at the site.SF the safety factor selected to compensate for statistical fluctuations and errors of measurement.
X = the noble gas concentration for the release under consideration.
Rt = the ratio of the dose rate limit for the total body, 500 mrem/y, to the dose rate to the total body for the conditions of the release under consideration.
Rk = the ratio of the dose rate limit for the skin, 3000 mrem/y, to the dose rate to the skin for the conditions of the release under consideration.
Equation (3.1) shows the relationships of the critical parameters that determine the setpoint.However, in order to apply the methodology presented in the equation to a mixture of noble gas radionuclides, radionuclide-specific concentrations and dose factors must be taken into account under conditions of maximum flowrate for the release point and annual average meteorology.
The basic setpoint method presented below is applicable to the radioactivity monitor nearest the point of release for the release pathway. For monitors measuring the radioactivity in source streams that merge with other streams prior to subsequent monitoring and release, the modifications presented in Section 3.3.3 must be applied.3-18 Version 23 2/13 HNP ODCM 3.3.2.2 Setpoint Calculation Steps Step 1: Determine the concentration, Xjv, of each noble gas radionuclide i in the gaseous stream v being considered for release, in accordance with the sampling and analysis requirements of Section 3.1.2. Then sum these concentrations to determine the total noble gas concentration, Xiv.Step 2: Determine Rt, the ratio of the dose rate limit for the total body, 500 mrem/y, to the total body dose rate due to noble gases detected in the release under consideration, as follows, a. for release pathways for which the release elevation is ground-level:
500 (3.2)Rt=(--Q)vb E[K,.Q'. .2 i Pt 500 (3.3)i b. for release pathways for which the release elevation is elevathed:
where: 500 = the dose rate limit for the total body, 500 mrem/y.(X/Q)vb = the highest annual average relative concentration at the SITE BOUNDARY for the discharge point of release pathway v. Table 3-4 includes an indication of what release elevation is applicable to each release pathway; release elevation determines the appropriate value of (X/Q)vb.Ki the total-body dose factor due to gamma emissions from noble gas radionuclide i, in (mrem/y)/(&#xfd;Ci/m 3), from Table 3-5.Q= the release rate of noble gas radionuclide i from the release pathway under consideration, in gCi/s, calculated as the product of Xiv and fav, where: X= the concentration of noble gas radionuclide i for the particular release, in &#xfd;tCi/mL.3-19 Version 23 2/13 HNP ODCM fav = the maximum anticipated flowrate for release pathway v during the period of the release under consideration, in mL/s.VI the elevated finite-plume total body dose factor due to gamma emissions from noble gas radionuclide i in effluents released from the main stack, in (mremly)l(p.Cils), from Table 3-6.Step 3: Determine Rk, the ratio of the dose rate limit for the skin, 3000 mrem/y, to the skin dose rate due to noble gases detected in the release under consideration, as follows: a. for release pathways for which the release elevation is ground-level:
3000 Rk = (3.4)(YI/O)vb 2[(Li + 1.l1Mi )'Ov]b. for release pathways for which the release elevation is elevated: 3000 Rk = x{[Li (/Q)vb+1.1 Bi ]Qi,} (3.5)i where: 3000 = the dose rate limit for the skin, 3000 mrem/y.Li = the skin dose factor due to beta emissions from noble gas radionuclide i, in (mremly)I(jiCilm 3), from Table 3-5.Mi = the air dose factor due to gamma emissions from noble gas radionuclide i, in (mradly)l(jCifm 3), from Table 3-5.1.1 = the factor to convert air dose in mrad to skin dose in mrem.Bi = the elevated finite-plume air dose factor due to gamma emissions from noble gas radionuclide i in effluents released from the main stack, in (mradly)/(jiCi/s), from Table 3-6.All other terms were defined previously.
Step 4: Determine the maximum noble gas radioactivity monitor setpoint concentration.
Based on the values determined in previous steps, the radioactivity monitor setpoint for the planned release is calculated to ensure that the limits of Section 3.1.2.a will not be exceeded.
Because the radioactivity monitor responds primarily to radiation from noble gas radionuclides, the monitor setpoint c,, (in &#xfd;tCi/mL) is based on the concentration of all noble gases in the waste stream, as follows: 3-20 Version 23 2/13 3-20 Version 23 2/13 HNP ODCM AG,
* SF .Xi, R, c,,, = the lesser of (3.6)LAGV .SF. Xi, Rk where: cnv calculated setpoint, in liCi/mL, for the noble gas monitor serving gaseous release pathway v.AGv the administrative allocation factor for gaseous release pathway v, applied to divide the release limit among all the gaseous release pathways at the site.The allocation factor may be assigned any value between 0 and 1, under the condition that the sum of the allocation factors for all simultaneously-active final release pathways at the entire plant site does not exceed 1. Alternative methods for determination of AGv are presented in Section 3.3.4.SF = the safety factor selected to compensate for statistical fluctuations and errors of measurement.
The value for the safety factor must be between 0 and 1. A value of 0.5 is reasonable for gaseous releases; a more precise value may be developed if desired.Xiv = the measured concentration of noble gas radionuclide i in gaseous stream v, as defined in Step 1, in jiCi/mL.The values of R{ and Rk to be used in the calculation are those which were determined in Steps 2 and 3 above.Step 5: Determine whether the release is permissible, as follows: If Cnv-> X iv , the release is permissible.
However, if Cnv is within about 10 percent of Zxiv, it may be impractical to use this value of Cnv. This situation indicates that measured concentrations are approaching values which would cause the limits of Section 3.1.2.a to be exceeded.
Therefore, steps should be taken to reduce contributing source terms of gaseous radioactive material, or to adjust the allocation of the limits among the active release points. The setpoint calculations (steps 1-4) must then be repeated with parameters that reflect the modified conditions.
If Cnv < Xx i , the release may not be made as planned. Consider the alternatives discussed in the paragraph above, and calculate a new setpoint based on the results of the actions taken.3.3.2.3 Use of the Calculated Setpoint The setpoint calculated above is in the units &#xfd;iCi/mL. The monitor actually measures a count rate that includes background, so that the calculated setpoint must be converted accordingly:
3-21 Version 23 2/13 HNP ODCM C* nv=(&#xa2;n.Ev)+Bv (3.7)where: C'n, = the monitor setpoint as a count rate.E = the monitor calibration factor, in count Monitor calibration data for conversion between count rate and concentration may include operational data obtained from determining the monitor response to effluent stream concentrations measured by sample analysis.B = the monitor background count rate. In all cases, monitor background must be controlled so that the monitor is capable of responding to concentrations in the range of the setpoint value. Contributions to the monitor background may include any or all of the following factors: ambient background radiation, plant-related radiation levels at the monitor location (which may change between shutdown and power conditions), and internal background due to contamination of the monitor's sample chamber.The count rate units for C,v , Ev, and B, in equation (3.7) must be the same, cpm or cps.3.3.3 Setpoints for Noble Gas Monitors on Effluent Source Streams The listing in Table 3-4 shows that Plant Hatch currently has no gaseous release pathways that meet the following criteria:
a setpoint is required for them under the effluent controls of this ODCM;and they are monitored prior to merging with other streams, and passing a final radioactivity monitor. This section, which presents a setpoint methodology for such monitors, is included in the Plant Hatch ODCM for compatibility with the ODCMs of the other Southern Company nuclear power plants.3.3.3.1 Setpoint of the Monitor on the Source Stream Step 1: Determine the concentration Xis of each noble gas radionuclide i in source stream s (in pCi/mL) according to the results of its required sample analyses[see Section 3.1.2].Step 2: Determine rt, the ratio of the dose rate limit for the total body, 500 mrem/y, to the total body dose rate due to noble gases detected in the source stream under consideration.
Use the Xis values and the maximum anticipated source stream flow rate f 2 s in equation (3.2) (or in equation (3.3) if the release is elevated) to determine the total body dose rate for the source stream, substituting rt for Rt.3-22 Version 23 2/13 3-22 Version 23 2/13 HNP ODCM The SITE BOUNDARY relative dispersion value used in Steps 2 and 3 for the source stream is the same as the (X/Q)vbthat applies to the respective merged stream. This is because the (X/Q) value is determined by the meteorology of the plant site and the physical attributes of the release point, and is unaffected by whether or not a given source stream is operating.
Step 3: Determine rk, the ratio of the dose rate limit for the skin, 3000 mrem/y, to the skin dose rate due to noble gases detected in the source stream under consideration.
Use the Xi, values and the maximum anticipated source stream flow rate fas in equation (3.4) (or in equation (3.5) if the release is elevated) to determine the skin dose rate for the source stream, substituting rk for Rk.Step 4: Determine the maximum noble gas radioactivity monitor setpoint concentration, as follows:[AGs "SF" Xs "r c, 1 5 = the lesser of (3.8)LAGs *SF. Xi, rk where: Cns the calculated setpoint (in &#xfd;iCi/mL) for the noble gas monitor serving gaseous source stream s.AGs = the administrative allocation factor applied to gaseous source stream s. For a given final release point v, the sum of all the AGs values for source streams contributing to the final release point must not exceed the release point's allocation factor AG,.X =s the measured concentration of noble gas radionuclide i in gaseous source stream s, as defined in Step 1, in &#xfd;tCi/mL.The values of rt and rk to be used in the calculation are those which were determined in Steps 2 and 3 above. The safety factor, SF, was defined previously.
Step 5: Determine whether the release is permissible, as follows: If Cn s > y_ Xis, the release is permissible.
However, if cns is within about 10 percent of Y.Xis' it I I may be impractical to use this value of c,,. This situation indicates that measured concentrations are approaching values which would cause the limits of Section 3.1.2.a to be exceeded.
Therefore, steps should be taken to reduce contributing source terms of gaseous radioactive material, or to adjust the allocation of the limits among the active release points. The setpoint calculations (steps 1-4) must then be repeated with parameters that reflect the modified conditions.
If Cns < : Xis, the release may not be made as planned. Consider the alternatives discussed I in the paragraph above, and calculate a new setpoint based on the results of the 3-23 Version 23 2/13 HNP ODCM actions taken.3.3.3.2 Effect on the Setpoint of the Monitor on the Merged Stream Before beginning a release from a monitored source stream, a setpoint must be determined for the source stream monitor as presented in Section 3.3.3.1. In addition, whether or not the source stream has its own effluent monitor, the previously-determined maximum allowable setpoint for the downstream final monitor on the merged stream must be redetermined.
This is accomplished by repeating the steps of Section 3.3.2, with the following modifications.
Modification 1: The new maximum anticipated flowrate of the merged stream is the sum of the old merged stream maximum flowrate, and the maximum flowrate of the source stream being considered for release.(f.y )neiv = (Jay )old + fa~s (3.9)Modification 2: The new concentration of noble gas radionuclide i in the merged stream includes both the contribution of the merged stream without the source stream, and the source stream being considered for release.(x,),?,t -(f. )Oldo' (x 1 ,. )old + f-1 + X 1" (fay)new (3.10)3.3.4 Determination of Allocation Factors, AG When simultaneous gaseous releases are conducted, an administrative allocation factor must be applied to divide the release limit among the active gaseous release pathways.
This is to assure that the dose rate limit for areas at and beyond the SITE BOUNDARY (see Section 3.1.2) will not be exceeded by simultaneous releases.
The allocation factor for any pathway may be assigned any value between 0 and 1, under the following two conditions:
: 1. The sum of the allocation factors for all simultaneously-active final release paths at the plant site may not exceed 1.2. The sum of the allocation factors for all simultaneously-active source streams merging into a given final release pathway may not exceed the allocation factor of that final release pathway.Any of the following three methods may be used to assign the allocation factors to the active gaseous release pathways: 1. For ease of implementation, AG, may be equal for all release pathways: 3-24 Version 23 2/13 HNP ODCM AGV (3.11)N where: N = the number of simultaneously active gaseous release pathways.2. AG, for a given release pathway may be selected based on an estimate of the portion of the total SITE BOUNDARY dose rate (from all simultaneous releases) that is contributed by the release pathway. During periods when a given building or release pathway is not subject to gaseous radioactive releases, it may be assigned an allocation factor of zero.3. AG, for a given release pathway may be selected based on a calculation of the portion of the total SITE BOUNDARY dose rate that is contributed by the release pathway, as follows, a. for ground-level release points: (xQ)b X:(KiQi,)AG =i (3.12)Z(VjQi) + X IQ) rb Z (KQir)r=lL i b. for the elevated release point (main stack): Z h iQis)AGV N 1 (3.13)Z(ViQis) + (f~rb (Ki)Qir i ~r=ILi where: (X70)vb = the annual average SITE BOUNDARY relative concentration applicable to the gaseous release pathway v for which the allocation factor is being determined, in s/m 3.Ki = the total-body dose factor due to gamma emissions from noble gas radionuclide i, in (mremly)l(&#xfd;1Cilm 3), from Table 3-5.Qv = the release rate of noble gas radionuclide i from release pathway v, in ACi/s, calculated as the product of Xiv and fay, where: 3-25 Version 23 2/13 HNP ODCM Xiv = the concentration of noble gas radionuclide i applicable to the gaseous release pathway v for which the allocation factor is being determined, in giCi/mL.fa. = the discharge flowrate applicable to gaseous release pathway v for which the allocation factor is being determined, in mL/s.Note: As applied in equations (3.12) and (3.13), Qjv is restricted to ground-level release pathways.VI = the elevated finite-plume total body dose factor due to gamma emissions from noble gas radionuclide i in effluents released from the main stack, in (mrem/y)I(j.Cils), from Table 3-6.Q, = the release rate of noble gas radionuclide i from the main stack, in &#xfd;LCi/s, calculated as the product of the Xiv and fav values specific to the main stack.(XiQ)r = the annual average SITE BOUNDARY relative concentration applicable to active gaseous release pathway r, in s/m 3.Qj = the value of Qjv applicable to active release pathway r, in gCi/s.N = the number of simultaneously active gaseous release pathways (including pathway v that is of interest).
Note: Although equations (3.11), (3.12), and (3.13) are written to illustrate the assignment of the allocation factors for final release pathways, they may also be used to assign allocation factors to the source streams that merge into a given final release pathway.3.3.5 Setpoints for Noble Gas Mointors with Special Requirements Unit 1 Condenser Offqas Pretreatment Mointor Monitor: 1D11-K601 and 1D11-K602 Unit 2 Condenser Offqas Pretreatment Mointor Monitor: 2D1 1-K601 and 2D1 1-K602 For the purpose of implementing Section 3.1.1, the alarm setpoint level for these noble gas monitors will be calculated as follows: Cnoc = (3.14)Eco "fco where: 2.40 x 105 the release rate limit for pretreatment condenser offgas as specified in Technical Specification 3.7.6 in gCi/s.3-26 Version 23 2/13 3-26 Version 23 2/13 HNP ODCM c-co the reading of the condenser offgas pretreatment monitor at the alarm setpoint, in mR/h.ECO the calibration factor for the condenser offgas pretreatment monitor, in (jiCi/s) per (cfm.mR/h).
fl= the condenser offgas flowrate, in cfm.3.3.6 Setpoints for Particulate and Iodine Monitors In accordance with Section 5.1.1 of NRC NUREG-0133 (Reference 1), the effluent controls of Section 3.1.1 do not require that the ODCM establish setpoint calculation methods for particulate and iodine monitors.3-27 Version 23 2/13 3-27 Version 23 2/13 HNP ODCM 3.4 GASEOUS EFFLUENT COMPLIANCE CALCULATIONS 3.4.1 Dose Rates at and Beyond the Site Boundary Because the dose rate limits for areas at and beyond the SITE specified in Section 3.1.2. are site limits applicable at any instant in time, the summations extend over all simultaneously active gaseous final release pathways at the plant site. Table 3-4 identifies the gaseous final release pathways at the plant site, and indicates the (X/Q)vb [or (X/Q)Sb] value for each.3.4.1.1 Dose Rates Due to Noble Gases For the purpose of implementing the controls of Section 3.1.2.a, the dose rates due to noble gas radionuclides in areas at or beyond the SITE BOUNDARY, due to releases of gaseous effluents, shall be calculated as follows: For total body dose rates: DRt =Z{XQv E[~~I + 1 V ~ (3.15)For skin dose rates: DRkzX=X/I v [(I+.,Mi)
QiV] +E[ox/S Li + 1.1JBiIQis (3.16)where: DRt = the total body dose rate at the time of the release, in mrem/y.DRk = the skin dose rate at the time of the release, in mrem/y.Qv = the release rate of noble gas radionuclide i, in &#xfd;iCi/s, equal to the product of ft, and Xv, where: ft the actual average flowrate for release pathway v during the period of the release, in mL/s.Note: For equations (3.15) and (3.16), the definition of Qiv, and the summations over v, are restricted to ground-level release pathways.Q =s the release rate of noble gas radionuclide i from the main stack, in [tCi/s, equal to the product of the ft, and Xj, values specific to the main stack. [This 3-28 Version 23 2/13 3-28 Version 23 2/13 HNP ODCM definition applies to both equations (3.15) and (3.16).](=YQLsb = the value of (X7Q)vb for the main stack; that is, the highest annual average relative concentration at the SITE BOUNDARY, for the main stack, in s/m 3.Table 3-4 includes the value of (XIQ)sb.All other terms were defined previously.
3.4.1.2 Dose Rates Due to lodine-131, lodine-133, Tritium, and Radionuclides in Particulate Form with Half-Lives Greater than 8 Days.For the purpose of implementing the controls of Section 3.1.2.b, the dose rates due to Iodine-131, Iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days, in areas at or beyond the SITE BOUNDARY, due to releases of gaseous effluents, shall be calculated as follows: DR 0 = _ $')vb [k QiJf ONXI+ Q)sb N [ov Q" (3.17)where: DR, = the dose rate to organ o at the time of the release, in mrem/y.Po = the site-specific dose factor for radionuclide i and organ o, in (mrem/y)/(g.Ci/m 3). Since the dose rate limits specified in Section 3.1.2.b apply only to the child age group exposed to the inhalation pathway, the values of Pi, may be obtained from Table 3-9, "Raipj for Inhalation Pathway, Child Age Group."'= the release rate of radionuclide i from gaseous release pathway v, in 1 iCi/s.Qi1 For the purpose of implementing the controls of Section 3.1.2.b, only 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days should be included in this calculation.
All other terms were defined previously.
3.4.2 Noble Gas Air Dose at or Beyond SITE BOUNDARY For the purpose of implementing the controls of Section 3.1.3, air doses in areas at or beyond the SITE BOUNDARY due to releases of noble gases from each unit shall be calculated as follows (adapted from Reference 1, page 28, by including only long-term releases):
8[V I i 3-LE Version 23 2/13-0i 3-29 Version 23 2/13 HNP ODCM Doy 3.17x 10 8 I5 (3.19)-0 + (4 (i where: 3.17 x 10-8 = a units conversion factor: 1 y/(3.15 x 107 s).D= the air dose due to beta emissions from noble gas radionuclides, in mrad.D= the air dose due to gamma emissions from noble gas radionuclides, in mrad.N 1  = the air dose factor due to beta emissions from noble gas radionuclide i, in (mradly)I(gCilm 3), from Table 3-5.(X7M)rb the value of (X7Q)vb for the main stack; that is, the highest annual average relative concentration at the SITE BOUNDARY, for the main stack, in s/m 3.Table 3-4 includes the value of (X-/)6b.= the air dose factor due to gamma emissions from noble gas radionuclide i, in (mradly)l( pCi/m 3), from Table 3-5.B, the elevated finite-plume air dose factor due to gamma emissions from noble gas radionuclide i in effluents released from the main stack, in (mrad/y)/(gCi/s), from Table 3-6.(iv the cumulative release of noble gas radionuclide i from non-elevated release pathway v, in IiCi, during the period of interest.= the value of (v for the main stack; that is, the cumulative release of noble gas radionuclide i from the main stack, in pCi, during the period of interest.and all other terms are as defined above.Because the air dose limit is on a per-reactor-unit basis, the summations extend over all gaseous final release pathways (other than the main stack, which has its own term) for a given unit. For a release pathway discharging materials originating in both reactor units, the activity discharged from the release point may be apportioned to the two units in any reasonable manner, provided that all activity released via the particular shared release pathway is apportioned to one or the other unit.The gaseous final release pathways at the plant site, and the (X/Q)Vb for each, are identified in Table 3-4.3-30 Version 23 2/13 3-30 Version 23 2/13 HNP ODCM Table 3-5 Dose Factors for Exposure to a Semi-Infinite Cloud of Noble Gases y -Body (K) 3 -Skin (L) y -Air (M) 3 -Air (N)Nuclide (mrem/y) per (mrem/y) per (mrad/y) per (mrad/y) per (pCi/m 3) (jiCi/m 3) (pci/r (pLCi/m)Kr-83m 7.56 E-02 0.00 E+00 1.93 E+01 2.88 E+02 Kr-85m 1.17 E+03 1.46 E+03 1.23 E+03 1.97 E+03 Kr-85 1.61 E+01 1.34 E+03 1.72 E+01 1.95 E+03 Kr-87 5.92 E+03 9.73 E+03 6.17 E+03 1.03 E+04 Kr-88 1.47 E+04 2.37 E+03 1.52 E+04 2.93 E+03 Kr-89 1.66 E+04 1.01 E+04 1.73 E+04 1.06 E+04 Kr-90 1.56 E+04 7.29 E+03 1.63 E+04 7.83 E+03 Xe-131m 9.15 E+01 4.76 E+02 1.56 E+02 1.11 E+03 Xe-133m 2.51 E+02 9.94 E+02 3.27 E+02 1.48 E+03 Xe-133 2.94 E+02 3.06 E+02 3.53 E+02 1.05 E+03 Xe-135m 3.12 E+03 7.11 E+02 3.36 E+03 7.39 E+02 Xe-135 1.81 E+03 1.86 E+03 1.92 E+03 2.46 E+03 Xe-137 1.42 E+03 1.22 E+04 1.51 E+03 1.27 E+04 Xe-138 8.83 E+03 4.13 E+03 9.21 E+03 4.75 E+03 Ar-41 8.84 E+03 2.69 E+03 9.30 E+03 3.28 E+03 All values in this table were obtained from Reference 3 (Table B-I), with units converted.
3-31 Version 23 2/13 3-31 Version 23 2/13 HNP ODCM Table 3-6 Dose Factors for Exposure to Direct Radiation from Noble Gases in an Elevated Finite Plume Nuclide 7 -Total Body (V) 7 -Air (B)(mrem/y) per (IiCi/s) (mrad/y) per (piCi/s)Kr-83m 0.00 E-00 0.00 E-00 Kr-85m 8.25 E-05 8.69 E-05 Kr-85 1.26 E-06 1.35 E-06 Kr-87 4.40 E-04 4.59 E-04 Kr-88 1.09 E-03 1.13 E-03 Kr-89 9.44 E-04 9.87 E-04 Kr-90 7.00 E-04 7.38 E-04 Xe-131m 1.68 E-06 1.76 E-06 Xe-133m 1.29 E-05 1.37 E-05 Xe-133 1.38 E-05 1.43 E-05 Xe-135m 2.42 E-04 2.59 E-04 Xe-135 1.33 E-04 1.42 E-04 Xe-137 9.55 E-05 1.02 E-04 Xe-1 38 6.16 E-04 6.44 E-04 Ar-41 7.34 E-04 7.72 E-04 Values are as reported in Reference 
: 24. They were calculated in accordance with Reference 1 (Section 5.2.1) and Reference 3 (Appendix F), using the meteorological joint frequency distributions presented in Reference 
: 14. All values in this table are for the Site Boundary (1545 m)in the ENE sector.3-32 Version 23 2/13 3-32 Version 23 2/13 HNP ODCM 3.4.3 Dose to a MEMBER OF THE PUBLIC at or BEYOND SITE BOUNDARY The dose received by an individual due to gaseous releases from each reactor unit, to areas at or beyond the SITE BOUNDARY, depends on the individual's location, age group, and exposure pathways.
The MEMBER OF THE PUBLIC expected to receive the highest dose in the plant vicinity is referred to as the controlling receptor.
The dosimetrically-significant attributes of the currently-defined controlling receptor are presented in Table 3-7.Doses to a MEMBER OF THE PUBLIC due to gaseous releases of 1-131,1-133, tritium, and all radionuclides in particulate form from each unit shall be calculated as follows (equation adapted from Reference 1, page 29, by considering only long-term releases):
Dja =3.17 x10-8  jZRaipj k[wvl .(3.20)where: Dia = the dose to organ j of an individual in age group a, due to gaseous releases of 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days, in mrem.3.17 x 108 = a units conversion factor: 1 y/(3.15 x 107 s).Raipj = the site-specific dose factor for age group a, radionuclide i, exposure pathway p, and organ j. For the purpose of implementing the controls of Section 3.1.4, the exposure pathways applicable to calculating the dose to the currently-defined controlling receptor are included in Table 3-7;values of Raipj for each exposure pathway and radionuclide applicable to calculations of dose to the controlling receptor are listed in Table 3-8 through Table 3-10.A detailed discussion of the methods and parameters used for calculating Raipj for the plant site is presented in Chapter 9. That information may be used for recalculating the Raipj values if the underlying parameters change, or for calculating Raipj values for special radionuclides and age groups when performing the assessments discussed in Section 3.4.4 below.Wjp the annual average relative dispersion or deposition at the location of the controlling receptor, for release pathway v, as appropriate to exposure pathway p and radionuclide i.For all tritium pathways, and for the inhalation of any radionuclide:
Wvp is (X/Q)vp, the annual average relative dispersion factor for release pathway v, at the location of the controlling receptor (s/mi 3). For the ground-plane exposure pathway, and for all ingestion-related pathways for radionuclides other than tritium: Wip is (D/Q)vp, the annual average relative deposition factor for release pathway v, at the location of the 3-33 Version 23 2/13 HNP ODCM controlling receptor (m-2). Values of (X/Q)vp and (D/Q)vp for use in calculating the dose to the currently-defined controlling receptor are included in Table 3-7.( =vthe cumulative release of radionuclide i from release pathway v, during the period of interest (&#xfd;tCi). For the purpose of implementing the controls of Section 3.1.4, only 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days should be included in this calculation.
In any dose assessment using the methods of this subsection, only radionuclides detectable above background in their respective samples should be included in the calculation.
Because the MEMBER OF THE PUBLIC dose limit is on a per-unit basis, the summations extend over all gaseous final release pathways for a given unit. For a release pathway discharging materials originating in both reactor units, the activity discharged from the release point may be apportioned between the two units in any reasonable manner, provided that all activity released from the plant site is apportioned to one or the other unit.The gaseous final release pathways at the plant site, and the release elevation for each, are identified in Table 3-4.3-34 Version 23 2/13 3-34 Version 23 2/13 HNP ODCM Table 3-7 Attributes of the Controlling Receptor The locations of MEMBERS OF THE PUBLIC in the vicinity of the plant site, and the exposure pathways associated with those locations, were determined in the Annual Land Use Census (Reference 12). Dispersion and deposition values were calculated based on site meteorological data collected for the period 1984 through 1986 (Reference 16).Based on an analysis of this information, the current controlling receptor for the HNP site is described as follows: Sector: Distance: Age Group: WSW 1.2 miles Child Exposure Pathways: Ground plane Inhalation Garden vegetation Dispersion Factors (X/Q),,: Ground-Level:
Elevated: 3.18 x 10' s/m 3 6.53 x 10.8 s/m 3 Deposition Factors (DfQ),,,: Ground-Level:
Elevated: 8.80 x 109 m-2 1.37 x 10-9 m-2 Elevated Plume Dose Factors:'Vi Radionuclide (mrem/y)/(p.Ci/s)
Kr-85m 6.92 E-05 Kr-85 9.95 E-07 Kr-87 3.36 E-04 Kr-88 8.23 E-04 Kr-89 7.20 E-04 Kr-90 5.39 E-04 Xe-131m 1.42 E-06 Vi Radionuclide (mrem/y)/(ACi/s)
Xe-1 33m 1.07 E-05 Xe-133 1.23 E-05 Xe-135m 1.90 E-04 Xe-135 1.09 E-04 Xe-137 7.54 E-05 Xe-138 4.71 E-04 Ar-41 5.59 E-04+ These values were calculated using the methods and data described in Reference 29.They are necessary when performing calculations for the purpose of demonstrating compliance with the limits of Section 5.1.3-35 Version 23 2/13 3-35 Version 23 2/13 HNP ODCM 3.4.4 Dose Calculations to Support Other Requirements Case 1: Under 10 CFR 50.73, a radiological impact assessment may be required to support evaluation of a reportable event.Dose calculations may be performed using the equations in Section 3.4.3, with the substitution of the dispersion and deposition parameters 
[(X/Q) and (D/Q)] for the period covered by the report, and using the appropriate pathway dose factors (Raipi) for the receptor of interest.
Methods for calculating (X/Q) and (D/Q) from meteorological data are presented in Chapter 8.The values of Raipj presented in Table 3-8 through Table 3-10 are applicable only to the currently-defined controlling receptor, so that when dose calculations must be performed for a different receptor, Raipj values applicable to that receptor must first be calculated.
Methods and parameters for calculating Raipj for radionuclides and age groups other than those required in Section 3.4.3 are presented in Chapter 9. When calculating Raipj for evaluation of an event, pathway and usage factors specific to the receptor involved in the event may be used in place of the values in Chapter 9, if the specific values are known.Case 2: A dose calculation is required to evaluate the results of the Land Use Census, under the provisions of Section 4.1.2.In the event that the Land Use Census reveals that exposure pathways have changed at previously-identified locations, or if new locations are identified, it may be necessary to calculate doses at two or more locations to determine which should be designated as the controlling receptor.
Such dose calculations may be performed using the equations in Section 3.4.3, with the substitution of the annual average dispersion and deposition values [(X/Q) and (D/Q)] for the locations of interest, and using the appropriate pathway dose factors (Rapj) for the receptors of interest.Methods for calculating (X/Q) and (D/Q) from meteorological data are presented in Chapter 8. The values of Raipj presented in Table 3-8 through Table 3-10 are applicable only to the currently-defined controlling receptor, so that when dose calculations must be performed for a different receptor, Raopj values applicable to that receptor must first be calculated.
Methods and parameters for calculating Raipj for radionuclides and age groups other than those required in Section 3.4.3 are presented in Chapter 9.Case 3: Under Section 5.2, a dose calculation is required to support determination of total dose to a receptor of age group other than that currently defined as the controlling receptor.Dose calculations shall be performed using the equations in Section 3.4.3, using the dispersion and deposition parameters defined in Table 3-7 for the controlling receptor, but substituting the appropriate pathway dose factors (Raipj) for the receptor age group of interest.3-36 Version 23 2/13 3-36 Version 23 2/13 HNP ODCM The values of Raipj presented in Table 3-8 through Table 3-10 are applicable only to the currently-defined controlling receptor, so that when dose calculations must be performed for a different receptor age group, Raipj values applicable to that receptor must first be calculated.
Methods and parameters for calculating Raipj for radionuclides and age groups other than those required in Section 3.4.3 are presented in Chapter 9.3-37 Version 23 2/13 3-37 Version 23 2/13 HNP ODCM Table 3-8 Raipj for Ground Plane Pathway, All Age Groups Nuclide T. Body Skin H-3 0.00 0.00 C-14 0.00 0.00 P-32 0.00 0.00 Cr-51 4.66E+06 5.51 E+06 Mn-54 1.39E+09 1.63E+09 Fe-55 0.00 0.00 Fe-59 2.73E+08 3.21E+08 Co-58 3.79E+08 4.44E+08 Co-60 2.15E+10 2.53E+10 Ni-63 0.00 0.00 Zn-65 7.47E+08 8.59E+08 Rb-86 8.99E+06 1.03E+07 Sr-89 2.16E+04 2.51E+04 Sr-90 0.00 0.00 Y-91 1.07E+06 1.21 E+06 Zr-95 2.45E+08 2.84E+08 Nb-95 1.37E+08 1.61E+08 Ru-103 1.08E+08 1.26E+08 Ru-106 4.22E+08 5.07E+08 Ag-110m 3.44E+09 4.01E+09 Sb-1 24 5.98E+08 6.90E+08 Sb-125 2.34E+09 2.64E+09 Te-125m 1.55E+06 2.13E+06 Te-127m 9.16E+04 1.08E+05 Te-129m 1.98E+07 2.31E+07 1-131 1.72E+07 2.09E+07 1-133 2.45E+06 2.98E+06 Cs-134 6.86E+09 8.OOE+09 Cs-136 1.51E+08 1.71E+08 Cs-137 1.03E+10 1.20E+10 Ba-140 2.05E+07 2.35E+07 Ce-141 1.37E+07 1.54E+07 Ce-144 6.95E+07 8.04E+07 Pr-143 0.00 0.00 Nd-147 8.39E+06 1.01E+07 1. Units are m 2.(mremlyr)I(jiCils).
: 2. The values in the Total Body column also apply to the Bone, Liver, Thyroid, Kidney, Lung, and GI-LLI organs.3. This table also supports the calculations of Section 6.2.3-38 Version 23 2/13 HNPODCM Table 3-9 Raipj for Inhalation Pathway, Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 0.OOV 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 1.12E+03 C-14 3.59E+04 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 6.73E+03 P-32 2.60E+06 1.14E+05 9.88E+04 0.00 0.00 0.00 4.22E+04 Cr-51 0.00 0.00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 1.08E+03 Mn-54 0.00 4.29E+04 9.51E+03 0.00 1.00E+04 1.58E+06 2.29E+04 Fe-55 4.74E+04 2.52E+04 7.77E+03 0.00 0.00 1.11E+05 2.87E+03 Fe-59 2.07E+04 3.34E+04 1.67E+04 0.00 0.00 1.27E+06 7.07E+04 Co-58 0.00 1.77E+03 3.16E+03 0.00 0.00 1.11E+06 3.44E+04 Co-60 0.00 1.31E+04 2.26E+04 0.00 0.00 7.07E+06 9.62E+04 Ni-63 8.21E+05 4.63E+04 2.80E+04 0.00 0.00 2.75E+05 6.33E+03 Zn-65 4.26E+04 1.13E+05 7.03E+04 0.00 7.14E+04 9.95E+05 1.63E+04 Rb-86 0.00 1.98E+05 1.14E+05 0.00 0.00 0.00 7.99E+03 Sr-89 5.99E+05 0.00 1.72E+04 0.00 0.00 2.16E+06 1.67E+05 Sr-90 1.01E+08 0.00 6.44E+06 0.00 0.00 1.48E+07 3.43E+05 Y-91 9.14E+05 0.00 2.44E+04 0.00 0.00 2.63E+06 1.84E+05 Zr-95 1.90E+05 4.18E+04 3.70E+04 0.00 5.96E+04 2.23E+06 6.11E+04 Nb-95 2.35E+04 9.18E+03 6.55E+03 0.00 8.62E+03 6.14E+05 3.70E+04 Ru-103 2.79E+03 0.00 1.07E+03 0.00 7.03E+03 6.62E+05 4.48E+04 Ru-106 1.36E+05 0.00 1.69E+04 0.00 1.84E+05 1.43E+07 4.29E+05 Ag-110m 1.69E+04 1.14E+04 9.14E+03 0.00 2.12E+04 5.48E+06 1.OOE+05 Sb-124 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sb-125 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Te-125m 6.73E+03 2.33E+03 9.14E+02 1.92E+03 0.00 4.77E+05 3.38E+04 Te-127m 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 Te-1 29m 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 1-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 0.00 2.84E+03 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 0.00 5.48E+03 Cs-134 6.51E+05 1.01E+06 2.25E+05 0.00 3.30E+05 1.21E+05 3.85E+03 Cs-136 6.51E+04 1.71E+05 1.16E+05 0.00 9.55E+04 1.45E+04 4.18E+03 Cs-137 9.07E+05 8.25E+05 1.28E+05 0.00 2.82E+05 1.04E+05 3.62E+03 Ba-140 7.40E+04 6.48E+01 4.33E+03 0.00 2.11E+01 1.74E+06 1.02E+05 Ce-141 3.92E+04 1.95E+04 2.90E+03 0.00 8.55E+03 5.44E+05 5.66E+04 Ce-144 6.77E+06 2.12E+06 3.61E+05 0.00 1.17E+06 1.20E+07 3.89E+05 Pr-143 1.85E+04 5.55E+03 9.14E+02 0.00 3.OOE+03 4.33E+05 9.73E+04 Nd-147 1.08E+04 8.73E+03 6.81E+02 0.00 4.81E+03 3.28E+05 8.21E+04 1. Units are (mremlyr)I(jiCilm3) for all radionuclides.
: 2. This table also supports the calculations of Section 6.2.3-39 Version 23 2/13 HNP ODCM Table 3-10 Raipi for Garden Vegetation Pathway, Child Age Group.Nuclide Bone Liver T.Body Thyroid Kidney Lung GI-LLI H-3 0.00 4.01E+03 4.01E+03 4.01E+03 4.01E+03 4.01E+03 4.01E+03 C-14 8.89E+08 1.78E+08 1.78E+08 1.78E+08 1.78E+08 1.78E+08 1.78E+08 P-32 3.37E+09 1.58E+08 1.30E+08 0.00 0.00 0.00 9.31E+07 Cr-51 0.00 0.00 1.17E+05 6.50E+04 1.78E+04 1.19E+05 6.21E+06 Mn-54 0.00 6.65E+08 1.77E+08 0.00 1.86E+08 0.00 5.58E+08 Fe-55 8.01E+08 4.25E+08 1.32E+08 0.00 0.00 2.40E+08 7.87E+07 Fe-59 3.98E+08 6.43E+08 3.20E+08 0.00 0.00 1.86E+08 6.70E+08 Co-58 0.00 6.44E+07 1.97E+08 0.00 0.00 0.00 3.76E+08 Co-60 0.00 3.78E+08 1.12E+09 0.00 0.00 0.00 2.1OE+09 Ni-63 3.95E+10 2.11E+09 1.34E+09 0.00 0.00 0.00 1.42E+08 Zn-65 8.13E+08 2.16E+09 1.35E+09 0.00 1.36E+09 0.00 3.80E+08 Rb-86 0.00 4.52E+08 2.78E+08 0.00 0.00 0.00 2.91E+07 Sr-89 3.60E+10 0.00 1.03E+09 0.00 0.00 0.00 1.39E+09 Sr-90 1.24E+12 0.00 3.15E+11 0.00 0.00 0.00 1.67E+10 Y-91 1.86E+07 0.00 4.99E+05 0.00 0.00 0.00 2.48E+09 Zr-95 3.86E+06 8.48E+05 7.55E+05 0.00 1.21E+06 0.00 8.85E+08 Nb-95 4.1OE+05 1.60E+05 1.14E+05 0.00 1.50E+05 0.00 2.96E+08 Ru-103 1.53E+07 0.00 5.90E+06 0.00 3.86E+07 0.00 3.97E+08 Ru-106 7.45E+08 0.00 9.30E+07 0.00 1.01E+09 0.00 1.16E+10 Ag-110m 3.21E+07 2.17E+07 1.73E+07 0.00 4.04E+07 0.00 2.58E+09 Sb-124 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sb-125 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Te-125m 3.51EE+08 9.50E+07 4.67E+07 9.84E+07 0.00 0.00 3.38E+08 Te-127m 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3.77E+09 0.00 1.07E+09 Te-129m 8.41E+08 2.35E+08 1.31E+08 2.71E+08 2.47E+09 0.00 1.03E+09 1-131 1.43E+08 1.44E+08 8.17E+07 4.75E+10 2.36E+08 0.00 1.28E+07 1-133 3.53E+06 4.37E+06 1.65E+06 8.11E+08 7.28E+06 0.00 1.76E+06 Cs-134 1.60E+10 2.63E+10 5.55E+09 0.00 8.15E+09 2.93E+09 1.42E+08 Cs-136 8.24E+07 2.27E+08 1.47E+08 0.00 1.21E+08 1.80E+07 7.96E+06 Cs-137 2.39E+10 2.29E+10 3.38E+09 0.00 7.46E+09 2.68E+09 1.43E+08 Ba-140 2.77E+08 2.42E+05 1.61E+07 0.00 7.89E+04 1.45E+05 1.40E+08 Ce-141 6.56E+05 3.27E+05 4.86E+04 0.00 1.43E+05 0.00 4.08E+08 Ce-144 1.27E+08 3.98E+07 6.78E+06 0.00 2.21E+07 0.00 1.04E+10 Pr-143 1.46E+05 4.37E+04 7.23E+03 0.00 2.37E+04 0.00 1.57E+08 Nd-147 7.15E+04 5.79E+04 4.48E+03 0.00 3.18E+04 0.00 9.17E+07 Units are (mremlyr)I(p.Cilm
: 3) for tritium, and m 2-(mrem/yr)/(jtCi/s) for all other radionuclides.
3-40 Version 23 2/13 3-40 Version 23 2/13 HNP ODCM 3.5 GASEOUS EFFLUENT DOSE PROJECTIONS 3.5.1 Thirty-One Day Dose Projections Because continuous operation of the gaseous radwaste treatment system is required (see Section 3.1.5), routine 31-day dose projections are not required for effluent control compliance at Plant Hatch. However, whenever it is desired to perform such projections, projected 31-day air doses and doses to individuals due to gaseous effluents may be determined as follows: For air doses: rD~c D x -j31+ D/3a (3.21)D Y Y tx 31+ Dya tt j For individual doses: D&p Do x 31+ DOa (3.22)where: D= the projected air dose due to beta emissions from noble gases, for the next 31 days of gaseous releases.D = the cumulative air dose due to beta emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration.
Doa = the anticipated air dose due to beta emissions from noble gas releases, contributed by any planned activities during the next 31-day period, if those activities will result in gaseous releases that are in addition to routine gaseous effluents.
If only routine gaseous effluents are anticipated, Dpa may be set to zero.Dyp the projected air dose due to gamma emissions from noble gases for the next 31 days of gaseous releases.Dyc the cumulative air dose due to gamma emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration.
3-41 Version 23 2/13 HNPODCM D = the anticipated air dose due to gamma emissions from noble gas releases, contributed by any planned activities during the next 31-day period, if those activities will result in gaseous releases that are in addition to routine gaseous effluents.
If only routine gaseous effluents are anticipated, D, may be set to zero.Dop = the projected dose to the total body or organ o, due to releases of 1-131, 1-133, tritium, and particulates for the next 31 days of gaseous releases.= the cumulative dose to the total body or organ o, due to releases of 1-131, 1-133, tritium, and particulates that have occurred in the elapsed portion of the current quarter, plus the release under consideration.
Doa = the anticipated dose to the total body or organ o, due to releases of 1-131, 1-133, tritium, and particulates, contributed by any planned activities during the next 31-day period, if those activities will result in gaseous releases that are in addition to routine gaseous effluents.
If only routine gaseous effluents are anticipated, Do, may be set to zero.t = the number of whole or partial days elapsed into the current quarter, including the time to the end of the release under consideration (even if the release continues into the next quarter).3.5.2 Dose Projections for Specific Releases Dose projections may be performed for a particular release by performing a pre-release dose calculation assuming that the planned release will proceed as anticipated.
For air dose and individual dose projections due to gaseous effluent releases, follow the methodology of Section 3.4, using sample analysis results for the gaseous stream to be released, and parameter values expected to exist during the release period.3-42 Version 23 2/13 3-42 Version 23 2/13 HNP ODCM 3.6 DEFINITIONS OF GASEOUS EFFLUENT TERMS Section of Term Definition Initial use AG the administrative allocation factor for gaseous streams, applied to divide the gaseous release limit among all the release pathways [unitless].
3.3.2.1 AGs = the administrative allocation factor for gaseous source stream s, applied to divide the gaseous release limit among all the release pathways [unitless].
3.3.3 AGv the administrative allocation factor for gaseous release pathway v, applied to divide the gaseous release limit among all the release pathways [unitless].
3.3.2.2 Bi the elevated finite plume air dose factor due to gamma emissions from noble gas radionuclide i in the effluents released from the main stack [(mradly)/(p.Ci/s)].
3.3.2.2 c = the setpoint of the radioactivity monitor measuring the concentration of radioactivity in the effluent line prior to release [[tCi/mL].
3.3.2.1=co the reading of the condenser offgas pretreatment monitor at the alarm setpoint [mR/h]. 3.3.5 Cns the calculated noble gas effluent monitor setpoint for gaseous source stream s [jiCi/mL].
3.3.3 Cnv the calculated noble gas effluent monitor setpoint for release pathway v [pCi/mL].
3.3.2.2 Dja the dose to organ j of an individual in age group a, due to gaseous releases of 1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days[mrem]. 3.4.3 Doa the anticipated dose to organ o due to releases of non-noble-gas radionuclides, contributed by any planned activities during the next 31-day period [mrem]. 3.5.1 Doc = the cumulative dose to organ o due releases of non-noble-gas radionuclides that have occurred in the elapsed portion of the current quarter, plus the release under consideration
[mrem]. 3.5.1 Dop the projected dose to organ o due the next 31 days of gaseous releases of non-noble-gas radionuclides 
[mrem]. 3.5.1 3-43 Version 23 2/13 HNP ODCM Section of Term Definition Initial use D = the air dose due to beta emissions from noble gas radionuclides 
[mrad]. 3.4.2 D ~a = the anticipated air dose due to beta emissions from noble gas releases, contributed by any planned activities during the next 31-day period [mrad]. 3.5.1 Do, the cumulative air dose due to beta emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration 
[mrad].3.5.1 D =p the projected air dose due to beta emissions from noble gases, for the next 31 days of gaseous releases [mrad]. 3.5.1 D = the air dose due to gamma emissions from noble gas radionuclides 
[mrad]. 3.4.2 Dya = the anticipated air dose due to gamma emissions from noble gas releases, contributed by any planned activities during the next 31-day period [mrad]. 3.5.1 D = the cumulative air dose due to gamma emissions from noble gas releases that have occurred in the elapsed portion of the current quarter, plus the release under consideration 
[mrad].3.5.1 D = the projected air dose due to gamma emissions from noble gases, for the next 31 days of gaseous releases [mrad].3.5.1 (D/Q)vp= the annual average relative deposition factor for release pathway v, at the location of the controlling receptor, from Table 3-7 [m-2]. 3.4.3 DRk = the skin dose rate at the time of the release [mrem/y].
3.4.1.1 DRo = the dose rate to organ o at the time of the release [mrem/y].3.4.1.2 DRt = the total body dose rate at the time of the release [mrem/y].3.4.1.1 E = the calibration factor for the condenser offgas pretreatment monitor [(&#xfd;tCi/s) per (cfm.mR/h)].
3.3.5 fav = the maximum anticipated actual discharge flowrate for release pathway v during the period of the planned release[mL/s]. 3.3.2.2 3-44 Version 23 2/13 3-44 Version 23 2/13 HNP ODCM Section of Term Definition Initial use f = the condenser offgas flowrate [cfm]. 3.3.5 fas = the maximum anticipated actual discharge flowrate for gaseous source stream s during the period of the planned release [mL/s]. 3.3.3 Ki the total body dose factor due to gamma emissions from noble gas radionuclide i, from Table 3-5 [(mremly)l(.ICilm 3)].3.3.2.2 Li the skin dose factor due to beta emissions from noble gas radionuclide i, from Table 3-5 [(mremly)I(ACilm 3)]. 3.3.2.2 M = the air dose factor due to gamma emissions from noble gas radionuclide i, from Table 3-5 [(mradly)I(ltCilm 3)]. 3.4.2 N the number of simultaneously active gaseous release pathways [unitless].
3.3.4 N = the air dose factor due to beta emissions from noble gas radionuclide i, from Table 3-5 [(mradly)l(jiCilm 3)]. 3.4.2 P 0.the site-specific dose factor for radionuclide i (1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days) and organ o. The values of Pi, are equal to the site-specific Raipj values presented in Table 3-9[(mremly)I(&#xfd;ICilm 3)]. 3.4.1.2 Q = the release rate of noble gas radionuclide i from release pathway v during the period of interest [l.Ci/s].
3.3.2.2 Q, = the release rate of radionuclide i (1-131, 1-133, tritium, and radionuclides in particulate form with half-lives greater than 8 days) from gaseous release pathway v during the period of interest [gCi/s]. 3.4.1.2 O = the cumulative release of noble gas radionuclide i from the main stack during the period of interest [[tCi]. 3.4.2 (v = the cumulative release of noble gas radionuclide i from release pathway v during the period of interest [&#xfd;tCi]. 3.4.2 41v = the cumulative release of non-noble-gas radionuclide i from release pathway v, during the period of interest [;iCi]. 3.4.3 3-45 Version 23 2/13 3-45 Version 23 2/13 HNP ODCM Section of Term Definition Initial use Raipj = the site-specific dose factor for age group a, radionuclide i, exposure pathway p, and organ j. Values and units of Raipj for each exposure pathway, age group, and radionuclide that may arise in calculations for implementing Section 3.1.4 are listed in Table 3-8 through Table 3-10. 3.4.3 Rk the ratio of the skin dose rate limit for noble gases, to the skin dose rate due to noble gases in the release under consideration 
[unitless].
3.3.2.1 Rt the ratio of the total body dose rate limit for noble gases, to the total body dose rate due to noble gases in the release under consideration 
[unitless].
3.3.2.1 rk the ratio of the skin dose rate limit for noble gases, to the skin dose rate due to noble gases in the source stream under consideration 
[unitless].
3.3.3.1 rt = the ratio of the total body dose rate limit for noble gases, to the total body dose rate due to noble gases in the source stream under consideration 
[unitless].
3.3.3.1 SF the safety factor used in gaseous setpoint calculations to compensate for statistical fluctuations and errors of measurement 
[unitless].
3.3.2.2 t = the number of whole or partial days elapsed in the current quarter, including the period of the release under consideration.
3.5.1 Vi the elevated finite plume total body dose factor due to gamma emissions from noble gas radionuclide i in the effluents released from the main stack [(mremly)I(&#xfd;.Cils)].
3.3.2.2 MP the annual average relative dispersion 
[(X/Q),p]
or deposition
[(D/Q)p] at the location of the controlling receptor, for release pathway v, as appropriate to exposure pathway p and radionuclide 
: i. 3.4.3 X the noble gas concentration for the release under consideration 
[liCi/mL].
3.3.2.1 Xir the concentration of radionuclide i applicable to active gaseous release pathway r [pCi/mL].
3.3.4 Xis = the measured concentration of radionuclide i in gaseous source stream s [gCi/mL].
3.3.3 3-46 Version 23 2/13 HNP ODCM Section of Term Definition Initial use X = the measured concentration of radionuclide i in gaseous stream v[VCi/mL].
3.3.2.2 (X/Q) = the highest relative concentration at any point at or beyond the SITE BOUNDARY [s/m 3]. 3.3.2.1 (X/Q)rb = the annual average SITE BOUNDARY relative concentration applicable to active gaseous release pathway r [s/m 3].3.3.4 (X/Q)sb = the highest annual average relative concentration at the SITE BOUNDARY for the main stack, from Table 3-4 [s/m 3].3.4.2 (X/Q)vb = the highest annual average relative concentration at the SITE BOUNDARY for the discharge point of release pathway v, from Table 3-4 [s/m 3]. 3.3.2.2 (X/Q)X = annual average relative dispersion factor for release pathway v, at the location of the controlling receptor, from Table 3-7 [s/m 3]. 3.4.3 3-47 Version 23 2/13 3-47 Version 23 2/13 HNP ODCM CHAPTER 4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 4.1 LIMITS OF OPERATION The following limits are the same for both units at the site. Thus, a single program including monitoring, land use survey, and quality assurance serves both units.4.1.1 Radiological Environmental Monitoring The Radiological Environmental Monitoring Program (REMP) shall be conducted as specified in Table 4-1.4.1.1.1 Applicability This control applies at all times.4.1.1.2 Actions 4.1.1.2.1 With the REMP not being conducted as specified in Table 4-1, submit to the Nuclear Regulatory Commission (NRC), in the Annual Radiological Environmental Operating Report, a description of the reasons for not conducting the program as required and the plans for preventing a recurrence.
Deviations from the required sampling schedule are permitted if specimens are unobtainable due to hazardous conditions, unavailability, inclement weather, equipment malfunction, or other just reasons. If deviations are due to equipment malfunction, efforts shall be made to complete corrective action prior to the end of the next sampling period.4.1.1.2.2 With the confirmed 1 measured level of radioactivity as a result of plant effluents in an environmental sampling medium specified in Table 4-1 exceeding the reporting levels of Table 4-2 when averaged over any calendar quarter, submit within 30 days a Special Report to the NRC. The Special Report shall identify the cause(s) for exceeding the limit(s) and define the corrective action(s) to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of Sections 2.1.3, 3.1.3, and 3.1.4. The methodology and parameters used to estimate the potential annual dose to a MEMBER OF THE PUBLIC shall be indicated in the Special Report.When more than one of the radionuclides in Table 4-2 are detected in the sampling medium, this report shall be submitted if: concentration (l) concentration (2) +  1.0 (4.1)reporting level (1) reporting level (2)Defined as confirmed by reanalysis of the original sample, or analysis of a duplicate or new sample, as appropriate.
The results of the confirmatory analysis shall be completed at the earliest time consistent with the analysis.4-1 Version 23 2/13 HNP ODCM When radionuclides other than those in Table 4-2 are detected and are the result of plant effluents, this Special Report shall be submitted if the potential annual dose to a MEMBER OF THE PUBLIC is equal to or greater than the calendar year limits stated in Sections 2.1.3, 3.1.3, and 3.1.4. This Special Report is not required if the measured level of radioactivity was not the result of plant effluents; however, in such an event, the condition shall be described in the Annual Radiological Environmental Operating Report. The levels of naturally-occurring radionuclides which are not included in the plant's effluent releases need not be reported.4.1.1.2.3 If adequate samples of milk, or during the growing season, grass or leafy vegetation, can no longer be obtained from one or more of the sample locations required by Table 4-1, or if the availability is frequently or persistently wanting, efforts shall be made: to identify specific locations for obtaining suitable replacement samples; and to add any replacement locations to the REMP given in the ODCM within 30 days. The specific locations from which samples became unavailable may be deleted from the REMP. Pursuant to Technical Specification 5.5.1, documentation shall be submitted in the next Radioactive Effluent Release Report for the change(s) in the ODCM, including revised figure(s) and table(s)reflecting the changes to the location(s), with supporting information identifying the cause of the unavailability of samples and justifying the selection of any new location(s).
When the ACTION statement or other requirements of this control cannot be met, steps need not be taken to change the Operational Mode of the unit. Entry into an Operational Mode or other specified CONDITION may be made if, as a minimum, the requirements of the ACTION statement are satisfied.
4.1.1.3 Surveillance Requirements The REMP samples shall be collected pursuant to Table 4-1 from the locations described in Section 4.2, and shall be analyzed pursuant to the requirements of Table 4-1 and Table 4-3.Required detection capabilities for thermoluminescent dosimeters used for environmental measurements shall be in accordance with the recommendations of Regulatory Guide 4.13.Program changes may be initiated based on operational experience.
Analyses shall be performed in such a manner that the stated MINIMUM DETECTABLE CONCENTRATIONS (MDCs) will be achieved under routine conditions.
Occasionally background fluctuations, unavoidable small sample sizes, the presence of interfering radionuclides, or other uncontrollable circumstances may render these MDCs unachievable.
In such cases, the contributing factors will be identified and described in the Annual Radiological Environmental Operating Report.4.1.1.4 Basis The REMP required by this control provides representative measurements of radiation and of radioactive materials in those exposure pathways, and for those radionuclides, which lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the plant operation.
The REMP implements Section IV.B.2, Appendix 1, 10 CFR 50, and thereby supplements the radiological effluent monitoring program by measuring concentrations of radioactive materials and levels of radiation, which may then be compared with those expected on the basis of the effluent measurements and modeling of the environmental exposure pathways.4-2 Version 23 2/13 HNP ODCM The detection capabilities required by Table 4-3 are within state-of-the-art for routine environmental measurements in industrial laboratories.
4-3 Version 23 2/13 4-3 Version 23 2/13 Exposure Pathway and/or Sample Approximate Number of Sample Locationsa Sampling and Collection FREQUENCY Radioiodines and 6 Continuous operation of Particulates sampler with sample collection weekly.DI'll Direct Radiation 37 Quarterly.
Type of Analysis and FREQUENCY Radioiodine canister.
1-131 weekly.Particulate sampler. Analyze for gross beta radioactivity not less than 24 hours following filter change and analyze for 1-131 weekly. Perform gamma isotopic analysis on affected sample when gross beta activity is 10 times the yearly mean of control samples.Composite (by location) for gamma isotopic analysis quarterly.
Gamma dose quarterly.-IL 0~1~ I Milk Bi-weeklv.
4 4" Fishc or Clams 2 Semi-annually.
Gamma isotopic and 1-131 analyses biweekly.Gamma isotopic analysis on edible portions semi-annually.Grass or Leafy Vegetation 3 Monthly during growing season.Gamma isotopic analysis monthly.0 Surface 2 Compositee sample collected monthly.Sediment 2 Semiannually Gamma isotopic analysis monthly. Composite (by location) for tritium analysis quarterly.
Gamma isotopic analysis yearly.2 CD 0 C.0 Exposure Approximate Number Sampling and Collection Pathway and/or of Sample Locationsa FREQUENCY Type of Analysis and FREQUENCY Sample Drinking Water( From each of the one River Water collected near the 1-131 analysis on each sample when bi-weekly to three nearest intake will be a composite collections are required.
Gross beta and water supplies which sample; the finished water will gamma isotopic analyses on each sample;could be affected by be a grab sample. These composite (by location) for tritium quarterly.
HNP discharge:
one samples will be collected sample of river water monthly unless the calculated near the intake and dose due to consumption of the one sample of water is greater than finished water. 1 mrem/year; then the collections will be bi-weekly.
The collection may revert to monthly should the calculated doses become less than 1 mrem/year.
Groundwaterh An adequate number Quarterly Tritium and gamma isotopic quarterly.
Other of onsite wells to analyses based on results of tritium and provide detection of gamma.radioactive liquid releases into the groundwater from tanks, underground piping, and other plant equipment.
At least one well at a control location.CD/0 t'j X z'a 0 a~
TABLE NOTATIONS 
" a. Sample locations are shown in Table 4-4 and Table 4-5 and in Figure 4-1 through Figure 4-7.b. Up to three sampling locations within 5 miles and in different sectors will be used as available.
In addition, one or more control locations beyond 10 miles will be used.CL c. Commercially or recreationally important fish may be sampled. Clams will be sampled if difficulties are encountered in obtaining sufficient fish samples.U&deg;d. If gamma isotopic analysis is not sensitive enough to meet the required MINIMUM DETECTABLE CONCENTRATION (MDC) for 1-131, a separate analysis for 1-131 may be performed.
: e. Composite samples shall be collected by collecting an aliquot at intervals not exceeding a few hours. 0 f. If it is found that river water downstream of HNP is used for drinking, water samples will be collected and analyzed as specified herein.0 g. A survey shall be conducted annually at least 50 river miles downstream of HNP to identify those who use the Altamaha River water for drinking.h. Table 4-5 contains typical groundwater monitoring locations.
Depending on the groundwater level in the wells, there may -0 be times when no sample is available or only enough sample to run a tritium analysis.0-I 0 0.oc Reporting Level Airborne Particulate or Water Gases Fish Milk Grass or Leafy Vegetation Analysis (pCi/L) (pCi/m 3) (pCi/kg, wet) (pCi/L) (pCi/kg, wet)H-3 2 E+4a Mn-54 1 E+3 3 E+4 Fe-59 4 E+2 I E+4 Co-58 1 E+3 3 E+4 Co-60 3 E+2 1 E+4 Zn-65 3 E+2 2 E+4 Zr-95 4 E+2 Nb-95 7 E+2 1-131 2 E+Ob 9 E-1 3 E+0 1 E+2 Cs-134 3 E+1 1 E+1 1 E+3 6 E+1 1 E+3 Cs-137 5 E+1 2 E+1 2 E+3 7 E+1 2 E+3 Ba-140 2 E+2 3 E+2 La-140 1 E+2 4 E+2 a. This is the 40 CFR 141 value for drinking water samples.used.If no drinking water pathway exists, a value of 3 E+04 pCi/L may be-I t'.J I'J b. If no drinking water pathway exists, a value of 20 pCi/L may be used.X z'U 0 0 C)
Minimum Detectable Concentration (MDC)a Airborne Grass or Leafy Water Particulate or Fish Milk Vegetation Sediment Analysis (pCi/L) Gases (pCi/m 3) (pCi/kg, wet) (pCi/L) (pCi/kg, wet) (pCi/kg, dry)Gross Beta 4 E+0 1 E-2 H-3 2 E+3b Mn-54 1.5 E+1 1.3 E+2 Fe-59 3 E+1 2.6 E+2 Co-58, Co-60 1.5 E+1 1.3 E+2 Zn-65 3 E+1 2.6 E+2 Zr-95 3 E+1 Nb-95 1.5 E+1 1-131 1 E+0c 7 E-2 1 E+0 6 E+1 Cs-134 1.5 E+1 5 E-2 1.3 E+2 1.5 E+1 6 E+1 1.5 E+2 Cs-137 1.8 E+1 6 E-2 1.5 E+2 1.8 E+1 8 E+1 1.8 E+2 Ba-140 6 E+1 6 E+1 La-140 1.5 E+1 1.5 E+1 a. See the definition of MINIMUM DETECTABLE CONCENTRATION in Section 10.1. Other peaks which are measurable and identifiable as plant effluents, together with the radionuclides in this table, shall be analyzed and reported in accordance with Section 7.1.b. If no drinking water pathway exists, a value of 3 E+3 pCi/L may be used.c. If no drinking water pathway exists, a value of 1.5 E+1 pCi/L may be used.00 CD~"I Z oU HNP ODCM 4.1.2 Land Use Census A land use census shall be conducted and shall identify the locations of the following:
the nearest MILK ANIMAL 1 and the nearest permanent residence in each of the 16 meteorological sectors within a distance of 5 miles; and all MILK ANIMALS within a distance of 3 miles.4.1.2.1 Applicability This control applies at all times.4.1.2.2 Actions 4.1.2.2.1 With a land use census identifying a location(s) which yields a calculated dose or dose commitment greater than values currently being calculated in accordance with Section 3.4.3, identify the new location(s) in the next Radioactive Effluent Release Report.4.1.2.2.2 With a land use census identifying a location(s) which yields a calculated dose or dose commitment (via the same exposure pathway) 20 percent greater than at a location from which samples are currently being obtained in accordance with Section 4.1.1, add the new location(s) to the REMP within 30 days if samples are available.
The sampling location, excluding control station location(s), having the lowest calculated dose or dose commitment (via the same exposure pathway) may be deleted from the REMP if new sampling locations are added. Pursuant to Technical Specification 5.5.1 submit in the next Radioactive Effluent Release Report any change(s) in the ODCM, including the revised figure(s) and table(s)reflecting any new location(s) and information supporting the change(s).
When the ACTION statement or other requirements of this control cannot be met, steps need not be taken to change the Operational Mode of the unit. Entry into an Operational Mode or other specified CONDITION may be made if, as a minimum, the requirements of the ACTION statement are satisfied.
4.1.2.3 Surveillance Requirements The land use census shall be conducted annually, using that information which will provide good results, such as a door-to-door census, a visual census from automobile or aircraft, consultation with local agriculture authorities, or some combination of these methods, as feasible.
Results of the land use census shall be included in the Annual Radiological Environmental Operating Report.4.1.2.4 Basis This control is provided to ensure that changes in the use of UNRESTRICTED AREAS are identified and that modifications to the REMP are made if required by the results of this census.This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50.1 Defined as a cow or goat that is producing milk for human consumption.
4-9 Version 23 2/13 HNP ODCM 4.1.3 Interlaboratory Comparision Program Analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which satisfies the requirements of Regulatory Guide 4.15, Revision 1, February, 1979.4.1.3.1 Applicability This control applies at all times.4.1.3.2 Actions With analyses not being performed as required by Section 4.1.3, report the corrective actions taken to prevent a recurrence in the Annual Radiological Environmental Operating Report.When the ACTION statement or other requirements of this control cannot be met, steps need not be taken to change the Operational Mode of the unit. Entry into an Operational Mode or other specified CONDITION may be made if, as a minimum, the requirements of the ACTION statement are satisfied.
4.1.3.3 Surveillance Requirements A summary of the results obtained as part of the required Interlaboratory Comparison Program shall be included in the Annual Radiological Environmental Operating Report.4.1.3.4 Basis The requirement for participation in an approved Interlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring, in order to demonstrate that the results are reasonably valid for the purposes of Section IV.B.2, Appendix 1, 10 CFR 50.4-10 Version 23 2/13 4-10 Version 23 2/13 HNP ODCM 4.2 RADIOLOGICAL ENVIRONMENTAL MONITORING LOCATIONS Table 4-4, and Figure 4-1 through Figure 4-5 specify the locations at which the measurements and samples are taken for the REMP required by Section 4.1.1.4-I I Version 23 2/13 4-11 Version 23 2/13 HNPODCM Table 4-4 Radiological Environmental Monitoring Locations Location Descriptive Distance Number Location Direction (miles) Sample Type*064 Roadside park WNW 0.8 D 101 Inner ring N 1.9 D 102 Inner ring NNE 2.5 D 103 Inner ring NE 1.8 AD 104 Inner ring ENE 1.6 D 105 Inner ring E 3.7 D 106 Inner ring ESE 1.1 DV 107 Inner ring SE 1.2 AD 108 Inner ring SSE 1.6 D 109 Inner ring S 0.9 D 110 Inner ring SSW 1.0 D 111 Inner ring SW 0.9 D 112 Inner ring WSW 1.0 ADV 113 Inner ring W 1.1 D 114 Inner ring WNW 1.2 D 115 Inner ring NW 1.1 D 116 Inner ring NNW 1.6 AD 170 Upriver WNW ** R 172 Downriver E ** R 201 Outer ring N 5.0 D 202 Outer ring NNE 4.9 D 203 Outer ring NE 5.0 D 204 Outer ring ENE 5.0 D 205 Outer ring E 7.2 D 206 Outer ring ESE 4.8 D 207 Outer ring SE 4.3 D 208 Outer ring SSE 4.8 D 209 Outer ring S 4.4 D 210 Outer ring SSW 4.3 D 4-12 Version 23 2/13 HNP ODCM Table 4-4 (contd)Radiological Environmental Monitoring Locations Location Descriptive Distance Sample Number Location Direction (miles) Type 211 Outer ring SW 4.7 D 212 Outer ring WSW 4.4 D 213 Outer ring W 4.3 D 214 Outer ring WNW 5.4 D 215 Outer ring NW 4.4 D 216 Outer ring NNW 4.8 D 301 Toombs Central School N 8.0 D 304 State Prison ENE 11.2 AD 304 State Prison ENE 10.3 M 309 Baxley substation S 10.0 AD 416 Emergency News Center NNW 21.0 DV* Sample Types: A -Airborne Radioactivity D -Direct radiation M -Milk R -River (fish or clams, shoreline sediment, and surface water)V -Vegetation Station 170 is located at approximately 0.6 river miles upstream of the intake structure for river water, 1.1 river miles for sediment and clams, and 1.5 river miles for fish.Station 172 is located at approximately 3.0 river miles downstream of the discharge structure for river water, sediment, and clams and 1.7 river miles for fish.The location from which river water and sediment may be taken can be rather precisely defined. Often, the sampling locations for clams have to be extended over a wide area to obtain a sufficient quantity.
High water adds to the difficulty in obtaining clam samples; high water might also make an otherwise suitable location for sediment sampling unavailable.
A stretch of the river on the order of a few miles or so is generally needed to obtain adequate fish samples. The mile locations given above represent approximations of the locations about which the catches are taken.4-13 Version 23 2/13 HNP ODCM Table 4-5 Groundwater Monitoring Locations WELL DEPTH (ft) MONITORING PURPOSE R1 82.9 Confined Aquifer Upgradient R2 82.7 Confined Aquifer Near Diesel Generator Bldg.R3 89.2 Confined Aquifer Near CST-1 R4 41 Dilution Line Near River Water Discharge Structure R5 33.6 Between Subsurface Drain Lines Downgradient R6 38.2 Between Subsurface Drain Lines Downgradient NW2A 27 Water Table Near CST-2 Inside of Subsurface Drain NW2B 27 Water Table Outside of Subsurface Drain NW3A 26.5 Water Table Inside of Subsurface Drain NW3B 25.3 Water Table Outside of Subsurface Drain NW4A 27 Water Table Upgradient Inside of Subsurface Drain NW5A 26.7 Water Table Upgradient Inside of Subsurface Drain NW5B 26.3 Water Table Upgradient Outside of Subsurface Drain NW6 27 Water Table Near Diesel Generator Bldg.NW8 23 Water Table Near Diesel Generator Bldg.NW9 26.1 Water Table Downgradient Inside of Subsurface Drain NW10 26.2 Water Table Near CST-2 T2 21.9 Water Table Near Recombiner Bldg.T3 18 Water Table Near Turbine Bldg.T7 21.4 Water Table Near Diesel Generator Bldg.T10 18.8 Water Table Near CST-1 T12 23.2 Water Table Near CST-1 T15 27.4 Water Table Near CST-1 P15A 74.5 Confined Aquifer Near Turbine Bldg.P15B 18 Water Table Near Turbine Bldg.P17A 77 Confined Aquifer Near Diesel Generator Bldg.P17B 14.8 Water Table Near Diesel Generator Bldg.Deep Well 1 680 Backup Supply for Potable Water (infrequently used)Deep Well 2 711 Plant Potable Water Supply Potable Water Supply -Rec. Center, Firing Range, and Deep Well 3 710Garage 4-14 Version 23 2/13 4-14 Version 23 2/13 HNP ODCM-4 ----.- ._-* ,'. .* *" tL 310-1 1.Fiue ,- Sampin Loaion Ma, Sie erphr&#xfd;'"w" *&deg;-ING 4M " .s': Figure 4-1 Sampling Location Map, Site Periphery 4-15 Version 23 2113 HNP ODCM Figure 4-2 Sampling Location Map Beyond Site Periphery, North and West of Site 4-16 Version 23 2113 4-16 Version 23 2113 HNP ODCM Figure 4-3 Sampling Location Map Beyond Site Periphery, South and West of Site 4-17 Version 23 2113 HNP ODCM Figure 4-4 Sampling Location Map Beyond Site Periphery, East of Site 4-18 Version 23 2113 HNP ODCM Figure 4-5 Location of Additional Control Station for TLDs and Vegetation 4-19 Version 23 2113 4-19 Version 23 2113 HNP ODCM 1&#xfd;Figure 4.6 Groundwater Monitoring Wells 4-20 Version 23 2113 4-20 Version 23 2113 HNP ODCM 1>INTAKE STRUCTURE PROTECTED AREA POTABLE POTABLE WATER --- Q4WATER CHLORINATION P TANK BLDG o00 DEEP WELL2 0 DEEP WELL 3 STRUCTURE Figure 4-7 Deep Wells 4 Version 23 2/13 4 Version 23 2/13 HNP ODCM CHAPTER 5 TOTAL DOSE DETERMINATIONS 5.1 LIMIT OF OPERATION In accordance with Technical Specification 5.5.4.j, the dose or dose commitment to any MEMBER OF THE PUBLIC over a calendar year, due to releases of radioactivity and to radiation from uranium fuel cycle sources, shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem.5.1.1 Applicability This limit applies at all times.5.1.2 Actions With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of Section 2.1.3, 3.1.3, or 3.1.4, calculations shall be made according to Section 5.2 methods to determine whether the limits of Section 5.1 have been exceeded.
If these limits have been exceeded, prepare and submit a Special Report to the Nuclear Regulatory Commission within 30 days, which defines the corrective actions to be taken to reduce subsequent releases to prevent recurrence of exceeding the limits of Section 5.1 and includes the schedule for achieving conformance with the limits of Section 5.1. This Special Report, as defined in 10 CFR 20.2203, shall also include an analysis which estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from uranium fuel cycle sources (including all effluent pathways and direct radiation) for the calendar year that includes the release(s) covered by this report. This Special Report shall also describe the levels of radiation and concentrations of radioactive material involved, and the cause of the exposure levels or concentrations.
If the estimated dose(s) exceeds the limits of Section 5.1, and if the release condition resulting in violation of the provisions of 40 CFR 190 has not already been corrected, the Special Report shall include a request for variance in accordance with the provisions of 40 CFR 190 and including the specified information of 40 CFR 190.11 (b). Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete.When the ACTION statement or other requirements of this control cannot be met, steps need not be taken to change the Operational Mode of the unit. Entry into an Operational Mode or other specified CONDITION may be made if, as a minimum, the requirements of the ACTION statement are satisfied.
5.1.3 Surveillance Requirements Cumulative dose contributions from liquid and gaseous effluents and from direct radiation shall be determined in accordance with Section 5.2. This requirement is applicable only under the conditions set forth above in Section 5.1.2.5-I Version 23 2/13 5-1 Version 23 2/13 HNP ODCM 5.1.4 Basis This control is provided to meet the dose limitations and reporting requirements of 40 CFR 190.The control requires the preparation and submittal of a Special Report whenever the calculated doses from plant radioactive effluents exceed the limits of Section 5.1. For sites containing up to 4 reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reactors remain within twice the dose design objectives of Appendix I and if direct radiation doses from the units, such as direct exposure from outside storage tanks, are kept small. The Special Report will describe a course of action which should result in the limitation of dose to a MEMBER OF THE PUBLIC for a calendar year to within the 40 CFR 190 limits. For the purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible with the exception that dose contributions from other uranium fuel cycle facilities at the same site or within a radius of 5 miles must be considered.
If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR 190, the Special Report with a request for variance (provided the release conditions resulting in violation of 40 CFR 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11 and 10 CFR 20.2203(a)(4), is considered to be a timely request and fulfills the requirements of 40 CFR 190 until NRC staff action is completed.
The variance only relates to the limits of 40 CFR 190 and does not apply in any way to the requirements for dose limitation addressed in other sections of this ODCM. An individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation which is part of the nuclear fuel cycle.5-2 Version 23 2/13 HNP ODCM 5.2 DEMONSTRATION OF COMPLIANCE There are no other uranium fuel cycle facilities within 5 miles of the plant site. Therefore, for the purpose of demonstrating compliance with the limits of Section 5.1, the total dose to a MEMBER OF THE PUBLIC in the vicinity of the plant site due to uranium fuel cycle sources shall be determined as follows: DTk = DL + DG + DD + DN (5.1)where: DTk = the total dose or dose commitment to the total body or organ k, in mrem.DL = the dose to the same organ due to radioactivity discharged from the plant site in liquid effluents, calculated in accordance with Section 2.4.1, in mrem.DG = the dose to the same organ due to non-noble-gas radionuclides discharged from the plant site in gaseous effluents, calculated for the controlling receptor in accordance with Section 3.4.3, in mrem.DD= the direct radiation dose to the whole body of an individual at the controlling receptor location, due to radioactive materials retained within the plant site, in mrem. Values of direct radiation dose may be determined by measurement, calculation, or a combination of the two.DN = the external whole body dose to an individual at the controlling receptor location, due to gamma ray emissions from noble gas radionuclides discharged from the plant site in gaseous effluents, in mrem. DN is calculated as follows (equation adapted from Reference 1, page 22, by recasting in cumulative dose form): DN = 3.17x 1041[ r~(X/Q)VI ZK~i} Z- Qsj (5.2)where: 3.17 x 10-8 = a units conversion factor: 1 y/(3.15 x 107 s).oiv = the cumulative release of noble gas radionuclide i from non-elevated release pathway v (jiCi), during the period of interest.Ois = the value of(Q, for the main stack; that is, the cumulative release of noble gas radionuclide i from the main stack (ptCi), during the period of interest.Ki the total-body dose factor due to gamma emissions from noble gas radionuclide i (mrem/y)/(piCi/m3), from Table 3-5.5-3 Version 23 2/13 HNPODCM VI the elevated finite-plume total-body dose factor at the controlling receptor location, due to gamma emissions from noble gas radionuclide i in effluents released from the main stack (mremly)(&#xfd;iCils), from Table 3-7.(X/Q)vp annual average relative dispersion factor for release pathway v, at the location of the controlling receptor, from Table 3-7 [s/m3].As defined above, DL and DG are for different age groups, while DD and DN are not age group specific.
When a more precise determination of DTk is desired, values of DL and DG may be calculated for all four age groups, and those values used in equation (5.1) to determine age group specific values of DTk; the largest value of DTk for any age group may then be compared to the limits of Section 5.1.5-4 Version 23 2/13 5-4 Version 23 2/13 HNP ODCM CHAPTER 6 POTENTIAL DOSES TO MEMBERS OF THE PUBLIC DUE TO THEIR ACTIVITIES INSIDE THE SITE BOUNDARY 6.1 REQUIREMENT FOR CALCULATION To support the reporting requirements of Section 7.2.2.3, an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figure 10-1) shall be performed as specified in Section 6.2, at least once per calendar year.6.2 CALCULATIONAL METHOD For the purpose of performing the calculations required in Section 6.1, the dose to a member of the public inside the SITE BOUNDARY shall be determined at the locations, and for the receptor age groups, defined in Table 6-1. The dose to such a receptor at any one of the defined locations shall be determined as follows: Dik = [DA + DS + Dp. Fo (6.1)where: Dik = the total dose to the total body or organ k, in mrem.DA = the dose to the same organ due to inhalation of non-noble-gas radionuclides discharged from the plant site in gaseous effluents, calculated in accordance with Section 3.4.3, in mrem. The (X-Q) value to be used is given for each receptor location in Table 6-1; depleted (X/Q) values may be used in calculations for non-noble-gas radionuclides.
Ds = the dose to the same organ due to _round plane deposition of non-noble-gas radionuclides discharged from the plant site in gaseous effluents, calculated in accordance with Section 3.4.3, in mrem. The (DIQ) value to be used is given for each receptor location in Table 6-1.Dp = the external whole body dose due to gamma ray emissions from noble gas radionuclides discharged from the plant site in gaseous effluents, calculated using equation (5.2), in mrem. The values of (X4Q) and Vi that are to be used are given for each receptor location in Table 6-1.Fo = the occupancy factor for the given location, which is the fraction of the year that one individual MEMBER OF THE PUBLIC is assumed to be present at the receptor location [unitless].
Values of F, for each receptor location are included in Table 6-1.6-I Version 23 2/13 6-1 Version 23 2/13 HNP ODCM Table 6-1 Attributes Of MEMBER OF THE PUBLIC Receptor Locations Inside The SITE BOUNDARY Location:
Roadside Park, WNW at 1182 meters A.qe Group: Child Occupancy Factor: 2.28x 1 0-4 (based on 2 hours per year)Dispersion and Deposition Parameters:
Parameter Ground-Level Elevated Undepleted (X-/), s/m 3  7.83 E-6 2.42 E-8 Depleted (X/Q), s/m 3  7.00 E-6 2.37 E-8 (D/Q), m-2 2.01 E-8 1.29 E-9 Elevated Plume Dose Factors:+Vi Radionuclide (mrem/y)/(gCi/s)
Kr-85m 8.39 E-05 Kr-85 1.31 E-06 Kr-87 4.60 E-04 Kr-88 1. 14 E-03 Kr-89 9.89 E-04 Kr-90 7.32 E-04 Xe-131m 1.70 E- 06 Vi Radionuclide (mrem/y)/(pCi/s)
Xe-1 33m 1.32 E-05 Xe-133 1.37 E-05 Xe-135m 2.51 E-04 Xe-135 1.37 E-04 Xe-137 9.91 E-05 Xe-138 6.45 E-04 Ar-41 7.69 E-04-I Values from Reference 16.See footnotes to Table 3-6.6-2 Version 23 2/13 6-2 Version 23 2/13 HNPODCM Table 6-1 (contd)Attributes of MEMBER OF THE PUBLIC Receptor Locations Inside the SITE BOUNDARY Location:
Camping Area, WNW at 1274 meters Age Group: Child Occupancy Factor: 5.48 x 10-3 (based on 48 hours per year)Dispersion and Deposition Parameters:*
Parameter Ground-Level Elevated Undepleted (7--), s/m 3  7.03 E-6 2.38 E-8 Depleted (X/Q), s/m 3  6.27 E-6 2.33 E-8 (D/Q), m 2 1.80 E-8 1.21 E-9 Elevated Plume Dose Factors:'Vi Radionuclide (mremly)I(.iCils)
Kr-85m 7.84 E-05 Kr-85 1.22 E-06 Kr-87 4.28 E-04 Kr-88 1.06 E-03 Kr-89 9.19 E-04 Kr-90 6.80 E-04 Xe-131m 1.59 E-06* Values from Reference 16.+ See footnotes to Table 3-6.Vi Radionuclide (mrem/y)/(g.Ci/s)
Xe-133m 1.24 E-05 Xe-133 1.28 E-05 Xe-135m 2.34 E-04 Xe-135 1.27 E-04 Xe-137 9.23 E-05 Xe-138 5.99 E-04 Ar-41 7.14 E-04 6-3 Version 23 2/13 6-3 Version 23 2/13 HNP ODCM Table 6-1 (contd)Attributes of MEMBER OF THE PUBLIC Receptor Locations Inside the SITE BOUNDARY Location:
Recreation Area, SSE at 1030 meters Age Group: Child Occupancy Factor: 2.37 Dispersion and Deposition Parameters:*
< 10-2 (based on 208 hours per year)Parameter Ground-Level Elevated Undepleted (X7Q), s/m 3  6.42 E-6 3.30 E-8 Depleted (X/Q), s/m 3  5.73 E-6 3.21 E-8 (D/Q), m 2 2.36 E-8 1.56 E-9 Elevated Plume Dose Factors:+Vi Radionuclide (mrem/y)/(jiCi/s)
Kr-85m 7.21 E-05 Kr-85 1.13 E-06 Kr-87 3.99 E-04 Kr-88 9.90 E-04 Kr-89 8.57 E-04 Kr-90 6.34 E-04 Xe-131m 1.46 E-06 Vi Radionuclide (mrem/y)/(giCi/s)
Xe-133m 1.14 E-05 Xe-133 1.17 E-05 Xe-1 35m 2.17 E-04 Xe-135 1.18 E-04 Xe-137 8.57 E-05 Xe-138 5.58 E-04 Ar-41 6.66 E-04* Values from Reference 16.+ See footnote to Table 3-6.6-4 Version 23 2/13 HNP ODCM Table 6-1 (contd)Attributes of MEMBER OF THE PUBLIC Receptor Locations Inside the SITE BOUNDARY Location:
Visitors Center, WSW at 694 meters Age Group: Child Occupancy Factor: 4.57 x 10-4 (based on 4 hours per year)Dispersion and Deposition Parameters:*
Parameter Ground-Level Elevated Undepleted (X/Q), s/m 3  1.87 E-5 5.00 E-8 Depleted (X/Q), s/im 3  1.72 E-5 4.97 E-8 (D/Q), m 2 5.47 E-8 2.26 E-9 Elevated Plume Dose Factors:+Vi Radionuclide (mrem/y)(&#xfd;.iCi/s)
Kr-85m 1.47 E-04 Kr-85 2.34 E-06 Kr-87 8.27 E-04 Kr-88 2.06 E-03 Kr-89 1.78 E-03 Kr-90 1.31 E-03 Xe-I 31m 2.98 E-06 Vi Radionuclide (mremly)I(I.Cils)
Xe-133m 2.34 E-05 Xe-133 2.36 E-05 Xe-1 35m 4.49 E-04 Xe-135 2.42 E-04 Xe-137 1.77 E-04 Xe-138 1.16 E-03 Ar-41 1.38 E-03* Values from Reference 16.+ See footnotes to Table 3-6.6-5 Version 23 2/13 6-5 Version 23 2/13 HNP ODCM CHAPTER 7 REPORTS 7.1 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT 7.1.1 Requirement for Report In accordance with Technical Specification 5.6.2, the Annual Radiological Environmental Operating Report covering the REMP activities during the previous calendar year shall be submitted by May 15 of each year. (A single report fulfills the requirements for both units.) The material provided shall be consistent with the objectives outlined in Section 4.1 and Section 7.1.2 of the ODCM, and in Sections IV.B.2, IV.B.3, and IV.C of Appendix I to 10 CFR Part 50.7.1.2 Report Contents The materials specified in the following subsections shall be included in each Annual Radiological Environmental Operating Report: 7.1.2.1 Data The report shall include summarized and tabulated results of all REMP samples required by Table 4-1 taken during the report period, in a format similar to that contained in Table 3 of the Radiological Assessment Branch Technical Position (Reference 18); the results for any additional samples shall also be reported.
In the event that some results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results; the missing data shall be submitted as soon as possible in a supplementary report. The results for naturally-occurring radionuclides not included in plant effluents need not be reported.7.1.2.2 Evaluations Interpretations and analyses of trends of the results shall be included in the report, including the following: (as appropriate) comparisons with pre-operational studies, operational controls, and previous environmental surveillance reports; and an assessment of any observed impacts of the plant operation on the environment.
If the measured level of radioactivity in an environmental sampling medium exceeding the reporting levels of Table 4-2 is not the result of plant effluents, the condition shall be described as required by Section 4.1.1.2.2.
7.1.2.3 Programmatic Information Also to be included in each report are the following:
a summary description of the REMP; a map(s) of all sampling locations keyed to a table giving distances and directions from the main stack; the results of land use censuses required by Section 4.1.2; and the results of licensee participation in the Interlaboratory Comparison Program required by Section 4.1.3.7-1 Version 23 2/13 HNP ODCM 7.1.2.4 Descriptions of Program Deviations Discussions of deviations from the established program must be included in each report, as follows: 7.1.2.4.1 If the REMP is not conducted as required in Table 4-1, a description of the reasons for not conducting the program as required, and the plans for preventing a recurrence, must be included in the report.7.1.2.4.2 If the MDCs required by Table 4-3 are not achieved, the contributing factors must be identified and described in the report.7.1.2.4.3 If Interlaboratory Comparison Program analyses are not performed as required by Section 4.1.3, the corrective actions taken to prevent a recurrence must be included in the report.7-2 Version 23 2/13 HNP ODCM 7.2 RADIOACTIVE EFFLUENT RELEASE REPORT 7.2.1 Requirement for Report In accordance with Technical Specification 5.6.3, the Radioactive Effluent Release Report covering the operation of the units during the previous calendar year of operation shall be submitted in accordance with 10 CFR 50.36.a. (A single submittal may be made for Units 1 and 2. However, the submittal shall specify the releases of radioactive material in liquid and gaseous effluents from each unit and solid radioactive waste from the site.) The report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the units. The material provided shall be consistent with the objectives outlined throughout this ODCM and the Process Control Program (PCP) and in conformance with 10 CFR Part 50.36a and Section IV.B.1 of Appendix I to 10 CFR Part 50.7.2.2 Report Contents The materials specified in the following subsections shall be included in each Radioactive Effluent Release Report: 7.2.2.1 Quantities of Radioactive Materials Released The report shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the units as outlined in NRC Regulatory Guide 1.21, "Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with liquid and gaseous effluent data summarized on a quarterly basis and solid radioactive waste data summarized on a semiannual basis following the format of Appendix B thereof. The report shall include documentation of quantities of radioactive materials in unplanned releases of gaseous and liquid effluents from the site to UNRESTRICTED AREAS, tabulated either by quarter or by event. For gamma emitters released in liquid and gaseous effluents, in addition to the principal gamma emitters for which MDCs are specifically established in Table 2-3 and Table 3-3, other peaks which are measurable and identifiable also shall be identified and reported.7.2.2.2 Meteorological Data The report shall include an annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of an hour-by-hour listing of wind speed, wind direction, and atmospheric stability, and precipitation (if measured) on magnetic tape; or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability.
In lieu of submission with the Radioactive Effluent Release Report, the licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request.7-3 Version 23 2/13 7-3 Version 23 2/13 HNPODCM 7.2.2.3 Dose Assessments The report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from each unit during the previous calendar year. Historical annual average meteorology or the meteorological conditions concurrent with the time of release of radioactive materials in gaseous effluents (as determined by sampling frequency and measurement) shall be used for determining the gaseous pathway dose. This assessment of radiation doses shall be performed in accordance with Sections 2.1.3, 2.4, 3.1.3, 3.1.4, 3.4.2, 3.4.3, 5.1, and 5.2.If a determination is required by Section 5.1.2, the report shall also include an assessment of radiation doses to the likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR 190, Environmental Radiation Protection Standards for Nuclear Power Operation; this dose assessment must be performed in accordance with Chapter 5. The report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figure 10-1) during the report period; this assessment must be performed in accordance with Chapter 6.7.2.2.4 Solid Radwaste Data For each type of solid waste shipped offsite during the report period, the following information shall be included: a. Container volume, b. Total curie quantity (specify whether determined by measurement or estimate), c. Principal radionuclides (specify whether determined by measurement or estimate), d. Type of waste (e.g., spent resin, compacted dry waste, evaporator bottoms), e. Type of container (e.g., LSA, Type A, Type B, Large Quantity), and f. Solidification agent (e.g., cement, urea formaldehyde).
7.2.2.5 Licensee Initiated Document Changes Licensee initiated changes shall be submitted to the Nuclear Regulatory Commission as a part of or concurrent with the Radioactive Effluent Release Report for the period in which any changes were made. Such changes to the ODCM shall be submitted pursuant to Technical Specification 5.5.1. This requirement includes: 7.2.2.5.1 Any changes to the sampling locations in the radiological environmental monitoring program, including any changes made pursuant to Section 4.1.1.2.3.
Documentation of changes made pursuant to Section 4.1.1.2.3 shall include supporting information identifying the cause of the unavailability of samples.7.2.2.5.2 Any changes to dose calculation locations or pathways, including any changes made pursuant to Section 4.1.2.2.2.
7-4 Version 23 2/13 HNP ODCM 7.2.2.6 Descriptions of Program Deviations Discussions of deviations from the established program shall be included in each report, as follows: 7.2.2.6.1 The report shall include deviations from MINIMUM DETECTABLE CONCENTRATION (MDC) requirements included in Table 3-3.7.2.2.6.2 The report shall include deviations from the liquid and gaseous effluent monitoring instrumentation OPERABILITY requirements included in Sections 2.1.1 and 3.1.1, respectively.
The report shall include an explanation as to why the inoperability of the liquid or gaseous effluent monitoring instrumentation was not corrected within the specified time requirement. (This requirement does not include the Service Water System to Closed Cooling Water System Differential Pressure channel.)7.2.2.6.3 The report shall include notification if the contents within any outside temporary tank exceed the limits of Technical Specification 5.5.8.b.7.2.2.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS As required by Sections 2.1.5 and 3.1.6, licensee initiated MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS (liquid and gaseous) shall be reported to the Nuclear Regulatory Commission in the Radioactive Effluents Release Report covering the period in which the change was reviewed and accepted for implementation.1 The discussion of each change shall contain: a. A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR Part 50.59;b. Sufficient detailed information to totally support the reason for the change without benefit of additional or supplemental information;
: c. A detailed description of the equipment, components, and processes involved and the interfaces with other plant systems;d. An evaluation of the change, which shows the predicted releases of radioactive materials in liquid and gaseous effluents that differ from those previously predicted in the license application and amendments thereto;e. An evaluation of the change, which shows the expected maximum exposures to a MEMBER OF THE PUBLIC in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the license application and amendments thereto;In lieu of inclusion in the Radioactive Effluents Release Report, this same information may be submitted as part of the annual FSAR update.7-5 Version 23 2/13 HNP ODCM f. A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents, to the actual releases for the period prior to when the changes are to be made;g. An estimate of the exposure to plant operating personnel as a result of the change; and h. Documentation of the fact that the change was reviewed and found acceptable by the Plant Review Board.7.3 MONTHLY OPERATING REPORT This ODCM establishes no requirements pertaining to the Monthly Operating Report.7.4 SPECIAL REPORTS Special reports shall be submitted to the Nuclear Regulatory Commission as required by Sections 2.1.3.2, 2.1.4.2, 3.1.3.2, 3.1.4.2, 3.1.5.2, 4.1.1.2.2, and 5.1.2.7-6 Version 23 2/13 7-6 Version 23 2/13 HNP ODCM CHAPTER 8 METEOROLOGICAL MODELS The models presented in this chapter are those which were used to compute the specific values of meteorology-related parameters that are referenced throughout this ODCM. These models should also be used whenever it is necessary to calculate values of these parameters for new locations of interest.Note 1: When calculating values of annual average parameters for new locations, use the joint frequency meteorological data presented in Reference 
: 28. Those are the data which were used to compute the specific values of meteorology-related parameters that are referenced throughout this ODCM.Note 2: Although Plant Hatch has no mixed-mode releases, the sections on mixed mode calculations (8.1.3 and 8.2.3) are included to preserve section number compatibility with the ODCMs of the other Southern Company nuclear power plants.8.1 ATMOSPHERIC DISPERSION Atmospheric dispersion may be calculated using the appropriate form of the sector-averaged Gaussian model. Gaseous release elevations may be considered to be either at ground-level, elevated, or mixed mode. Facility release elevations for each gaseous release point are as indicated in Table 3-4.8.1.1 Ground-Level Releases Relative concentration calculations for ground-level releases, or for the ground-level portion of mixed-mode releases, shall be made as follows: 2.0322 K F njk 1" (XQ)I I (8.1)Nr JAUJZ:k I where: (X/Q)G = the ground-level sector-averaged relative concentration for a given wind direction (sector) and distance (s/m3).2.032 = (2/c)1 1 2 divided by the width in radians of a 22.50 sector, which is 0.3927 radians.5 = the plume depletion factor for all radionuclides other than noble gases at a distance r shown in Figure 8-3. For noble gases, the depletion factor is unity.If an undepleted relative concentration is desired, the depletion factor is unity.Only depletion by deposition is considered since depletion by radioactive decay would be of little significance at the distances considered.
8-1 Version 23 2/13 HNP ODCM Kr = the terrain recirculation factor corresponding to a distance r, taken from Figure 8-2.njk = the number of hours that wind of wind speed class j is directed into the given sector during the time atmospheric stability category k existed.N = the total hours of valid meteorological data recorded throughout the period of interest for all sectors, wind speed classes, and stability categories.
uj = the wind speed (mid-point of wind speed class j) at ground level (m/s).r = the distance from release point to location of interest (m).Xzk = the vertical standard deviation of the plume concentration distribution considering the initial dispersion within the building wake, calculated as follows: U 2 + 1/2 zk+ 27r=the lesser of OR (8.2)azk = the vertical standard deviation of the plume concentration distribution (m)for a given distance and stability category k as shown in Figure 8-1. The stability category is determined by the vertical temperature gradient AT/Az (&deg;C/100 m).iT = 3.1416.b = the maximum height of adjacent plant structure (47 m).8.1.2 Elevated Releases Relative dispersion calculations for elevated releases, or for the elevated portion of mixed-mode releases, shall be made as follows:.(knjkexp 
=h2 (XQ)E= N r U1 IU (8.3)J 8-2 Version 23 2/13 8-2 Version 23 2/13 HNP ODCM where: (XIQ)E = the elevated release sector-averaged relative concentration for a given wind direction (sector) and distance (s/m 3).5k = the plume depletion factor for all radionuclides other than noble gases at a distance r for elevated releases, as shown in Figure 8-4, Figure 8-5, and Figure 8-6. For an elevated release, this factor is stability dependent.
For noble gases, the depletion factor is unity. If an undepleted relative concentration is desired, the depletion factor is unity. Only depletion by deposition is considered since depletion by radioactive decay would be of little significance at the distances considered.
nik = the number of hours that wind of wind speed class j is directed into the given sector during the time atmospheric stability category k existed.uj = the wind speed (mid-point of wind speed class j) at the effective release height h (m/s).h = the effective height of the release (m), which is calculated as follows: 1 h = hv -h7t (8.4)hv the height of the release point (m), which is the height of the main stack, 120 m.ht the maximum terrain height between the release point and the point of interest (m), from Figure 2.3-12 of Reference 8.All other symbols are as previously defined in Section 8.1 .1.8.1.3 Mixed-Mode Releases Relative dispersion calculations for mixed-mode releases shall be made as follows: (XIQ).,f = (I -E).- (.YIQ)E + E .(X/Qa (8.5)where: (X/Q)M = the mixed mode release sector-averaged relative concentration for a given wind direction (sector) and distance (s/m 3).Effective release height may be further adjusted for plume rise in accordance with Paragraph 2.3.5.2.2 of Reference 8.8-3 Version 23 2/13 HNP ODCM E = the fraction of hours during which releases are considered as ground-level releases, calculated as follows: 1.0 o3-0.0o6.{w}
0 for 1 < 1.0 Uj for 1.O<  <1.5 Ui forl.5< W  <5.0 Ui forW&deg; >5.0 Uj (8.6)All other symbols are as previously defined.8-4 Version 23 2/13 8-4 Version 23 2/13 HNP ODCM 8.2 RELATIVE DEPOSITION Plume depletion may be calculated using the appropriate form of the sector-averaged Gaussian model. Gaseous release elevations may be considered to be either at ground-level, elevated, or mixed-mode.
Facility release elevations for each gaseous release points are as indicated in Table 3-4.8.2.1 Ground-Level Releases Relative deposition calculations for ground-level releases, or for the ground-level portion of mixed-mode releases, shall be made as follows: 2.55Dg Kr (D/Q)G N r Ink (8.7)k where: (D/Q)G = the ground-level sector-averaged relative deposition for a given wind direction (sector) and distance (m-2).2.55 = the inverse of the number of radians in a 22.50 sector [= (2 -r16)-1].Dg = the deposition rate at distance r, taken from Figure 8-7 for ground-level releases (m-1).nk = the number of hours in which the wind is directed into the sector of interest, and during which stability category k exists.All other symbols are as defined previously in Section 8.1.8.2.2 Elevated Releases Relative deposition calculations for elevated releases, or for the elevated portion of mixed-mode releases, shall be made as follows: (D/Q)E = 2.55Kr I.(nk Dek (8.8)N r k where: (D/Q)E = the elevated-plume sector-averaged relative deposition for a given wind direction (sector) and distance (m-2).Dek = the elevated plume deposition rate at distance r, taken from Figure 8-8, Figure 8-9, or Figure 8-10, as appropriate to the plume effective release height h defined in Section 8.1.2, for stability class k (m-1).8-5 Version 23 2/13 HNP ODCM All other symbols are as defined previously.
8.2.3 Mixed-Mode Releases Relative deposition calculations for mixed-mode releases shall be made as follows: (D/Q)M = (I -E) .(D/Q)E + E .(D/Q)G (8.9)where: (D/Q)M = the mixed-mode release sector-averaged relative deposition for a given wind direction (sector) and distance (m-2).E = the fraction of hours during which releases are considered as ground-level releases, defined in Section 8.1.3.All other symbols are as previously defined.8-6 Version 23 2/13 8-6 Version 23 2/13 HNP ODCM 8.3 ELEVATED PLUME DOSE FACTORS Certain gaseous effluent dose calculations require the use of the elevated-plume noble gas dose parameters B, or Vi, which are first defined in Section 3.4. These parameters are calculated as follows: K F Fnjk -Aia E6. I k_(r)B i = r c (8.10)=.K n e -(l-TE .d) (8.11)rN j,k.8L ujI where: K = a numerical constant representing the aggregated numerical constants and unit conversions, 2.1 X 104.A = the number of photons in energy group E emitted per transformation of radionuclide i (number/decay).
ita, = the air energy absorption coefficient for photons in energy group s (m-').E,= the photon energy assigned to energy group F (MeV).Ik,(r) = the (dimensionless) result of integrating the emission and attenuation of photons of energy group F, over the entire spatial activity distribution of a plume that has spread under atmospheric stability classification k, for a dose receptor at downwind distance r (see below for calculational method).1.1 = the average ratio of the photon energy absorption coefficient for tissue to that of air over the energy range of interest.
This ratio converts air dose (rad) to dose equivalent (rem).= the tissue energy absorption coefficient for photons in energy group 6 (cm 2/g).d = the tissue density thickness taken to represent the depth at which total body dose is received (5.0 g/cm 2).All other symbols are as previously defined.For a sector-averaged plume model like that described in Section 8.1, the dose integral Ik,(r) is calculated as follows: 8-7 Version 23 2/13 HNP ODCM 1 0000 c0 7 23/ o B ( ,p R)xG(zkr)xA(p,,R)xLdLdz (8.12)where: L = the upwind or downwind distance from the differential volume element of the plume to the dose receptor point.z = the vertical distance from the differential volume element of the plume to the dose receptor point.R = the total distance from the differential volume element of the plume to the dose receptor point: R =L2 + z2 Bg = the air dose buildup factor through a thickness R of air: Bg =1 +(u.e -IPa, )', ]xR&#xfd;Lc = the total photon attenuation coefficient in air, for energy group & (m-').G = the function describing the vertical distribution of activity in a plume that has travelled downwind a distance r from the point of emission, at an effective height h, under stability classification k: G = exp I 2-/ +- exp 2 3[12u 2 2o2-: LLz zk A = the attenuation and geometric loss factor for photons in energy group F, for the distance R from the differential plume volume element to the dose receptor point: A exp[- y 8 R]R2 27r L dL dz = the volume of the differential plume element. (When the 27r is factored out into the constants in equations (8.10), (8.11), and (8.12), only L dL dz is left.)All other symbols are as previously defined.8-8 Version 23 2/13 HNP ODCM A derivation of the model describing the gamma dose rate from an elevated finite plume is found in Chapter 7 of Reference 
: 19. Numerical methods for evaluating the dose integral are found in Appendix F of Reference 
: 3. Details of the numerical methods used there may be found in Reference 20.8-9 Version 23 2/13 8-9 Version 23 2/13 HNPODCM Table 8-1 Terrain Elevation Above Plant Site Grade This table intentionally left blank.8-10 Version 23 2/13 8-10 Version 23 2/13 HNP ODCM 1000 I'/I I.-, w U, 1 4 .0" 1 11. 1 -l- --- I I.I / I! "" loo .Ap 100 F Itif ~..'P A 'l I_ 0.1 1.0 10 100 PLUME TRAVEL DISTANCE (KILOMETERS)
Range of Vertical Temperature Range of Vertical Temperature Category Gradient (&deg;C/100 m) Gradient (&deg;F/100 ft)A AT/AZ < -1.9 AT/AZ < -1.0 B -1.9< AT/AZ < -1.7 -1.0< AT/AZ < -0.9 C -1.7 AT/AZ < -1.5 -0.9 AT/AZ < -0.8 D -1.5 _ AT/AZ < -0.5 -0.8 <_ AT/AZ < -0.3 E -0.5_< AT/AZ < 1.5 -0.3 AT/AZ < 0.8 F 1.5 _AT/AZ < 4.0 0.8 AT/AZ < 2.2 G 4.0 <AT/AZ 2.2 _< AT/AZ This graph is reproduced from Reference 5 (Figure 1).Figure 8-1 Vertical Standard Deviation of Material in a Plume (cz)8-1 1 Version 23 2/13 8-11 Version 23 2/13 Si 0 0 S I I I I lit'4 I I lilt&#xb6;.0 0.1 1.0 S0 DISTANCE 11KSLOMIETINV This graph is reproduced from Reference 4.Figure 8-2 Terrain Recirculation Factor (Kr)8-12 version L~ LI IJ 8-12 version /13 /-/li-1w IJJ cc 06 1.0 0.9 0.9 0.7 0.8 0.5 0.4 0.2 0.1 0.1 I.S 10.0 PLUME TRAVEL DISTANCE (KILOMETERSl 100.0 200.0 This graph is reproduced from Reference 5 (Figure 2).Figure 8-3 Plume Depletion Effect for Ground-Level Releases 8-13 Version 23 2/13 1.0 0.9 0.8-J z i 0.7 I0.5 CA 0.2 0.1 1.0 10.0 PLUME TRAVEL DISTANCE {KILOMETERS}
100.01 V0 This graph is reproduced from Reference 5 (Figure 3).Figure 8-4 Plume Depletion Effect for 30-Meter Releases 8-14 Version 23 2/13 8-14 Version 23 2/13 o.g ,, 0.8 0.5 O.6 hi.3 0.1-0.1 1.0 10,0 PLUME TRAVEL DISTANCE (KILOMETERS)
This graph is reproduced from Reference 5 (Figure 4).10.o00=Figure 8-5 Plume Depletion Effect for 60-Meter Releases 8-15 Version 23 2113 8-15 Version 23 2/13 1.0 02 uw 0.6 0.7 C ,6 2oA SOS 2 SOA 0.3 0.2 0.1-NEUTRAL (0)STABLE (E,F.G)NO DEPLETION (FRACTION REMAINING 1.01.0 10i.PLUME TRAVEL DISTANCE lKILOMETERS) 100.0 200.0 This graph is reproduced from Reference 5 (Figure 5).Figure 8-6 Plume Depletion Effect for 100-Meter Releases 8-16 Version 23 2/13 I I I 1I I I I IIII 1O-4 LU LU CL LU z 0 0 Uj a LU 10-6 I r SL r I I 10-0.1 1.0 10.0 100.0 200.0 PLUME TRAVEL DISTANCE (KILOMETERS)
This graph is reproduced for Reference 5 (Figure 6).Figure 8-7 Relative Deposition for Ground-Level Releases 8-17 Version 23 2/13 8-17 Version 23 2/13 w--w S LU w 0 4L c.0 us 10-6 UNTBEIAIii I STBE I 11 7 UNSTALE LEII ; I I.il!V i l l ll lfill 10-7 0.1 1.0 100 100.0 200.0 PLUME TRAVEL DISTANCE lKILOMETERS)
This graph is reproduced from Reference 5 (Figure 7).Figure 8-8 Relative Deposition for 30-Meter Releases 8-18 Version 23 2/13 8-18 Version 23 2/13 I
I; A ACI'La I-Q U't.cc NEUTRAL (D)\ " NSTABLEI/ NEUTRAL IS/sSTABLE (E,FG)I f 0.1 1.0 10.0.100.0 200.0 PLUME TRAVEL DISTANCE (KILOMETERS)
This graph is reproduced from Reference 5 (Figure 8).Figure 8-9 Relative Deposition for 60-Meter Releases 8-19 Version 23 2/13 8-19 Version 23 2/13 I I I II I I I I1 I-?-, UNSTABLE (A.B.(ua.~ 0 W 0 w-101 10-; ~~NEUTRAL ID)- "'-STABLE (E.F.G)NO DEPLETION 0.1 1.0 10.0 100.0 200.0 PLUME TRAVEL DISTANCE (KILOMETERS)
This graph is reproduced from Reference 5 (Figure 9).Figure 8-10 Relative Deposition for 100-Meter (or Greater) Releases 8-20 Version 23 2/13 8-20 Version 23 2/13 CHAPTER 9 METHODS AND PARAMETERS FOR CALCULATION OF GASEOUS EFFLUENT PATHWAY DOSE FACTORS. Ra 9.1 INHALATION PATHWAY FACTOR For the inhalation pathway, Raipj in (mrem/y) per (gCi/m 3) is calculated as follows (Reference 1, Section 5.3.1.1): Raip] = Ki .(BR)a .(DFA)aij (9.1)where: K 1  = the units conversion factor: 106 pCi/ltCi.(BR)a = the breathing rate of receptor age group a, in m 3/y, from Table 9-5.(DFA)aij = the inhalation dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-7 through Table 9-10.9-1 Version 23 2/13 9-1 Version 23 2/13 9.2 GROUND PLANE PATHWAY FACTOR For the ground plane external exposure pathway, Raipj in (m 2.mrem/y) per (jtCi/s) is calculated as follows (Reference 1, Section 5.3.1.2): Raipj = K,. K 2.(SHF). (DFG)i 1 e- (9.2)2iA )where: K, = the units conversion factor: 106 pCi/ljCi.K 2  = the units conversion factor: 8760 h/y.(SHF) = the shielding factor due to structure (dimensionless).
The value used for (SHF) is 0.7, from (Reference 3, Table E-15).(DFG)ij = the ground plane dose factor for radionuclide i and organ j, in (mrem/h) per (pCi /m 2), from Table 9-15. Dose factors are the same for all age groups, and those for the total body also apply to all organs other than skin.ki = the radioactive decay constant for radionuclide i, in s-'. Values of XI used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.t = the exposure time, in s. The value used for t is 4.73 x 108 s (= 15 y), from (Reference 1, Section 5.3.1.2).9.3 GARDEN VEGETATION PATHWAY FACTOR For radionuclides other than tritium in the garden vegetation consumption pathway, Raipj in (m 2.mrem/y) per (pLCi/s) is calculated as follows (Reference 1, Section 5.3.1.5): Ripj= K, .T, (DFL),J (Ua.,.fe-"" + U,sfge-&#xfd;t'') 
(9.3)Al +where: K, = the units conversion factor: 106 pCi/pCi.r = the fraction of deposited activity retained on the edible parts of garden vegetation (dimensionless).
The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1).Y = the areal density (agricultural productivity) of growing leafy garden vegetation, in kg/M 2 , from Table 9-1.9-2 Version 23 2/13 x = the radioactive decay constant for radionuclide i, in s-1.Values of Xi used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.S = the rate constant for removal of activity on leaf and plant surfaces by weathering, in s-1, from Table 9-1.(DFL)aij = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14.UaL the consumption rate of fresh leafy garden vegetation by a receptor in age group a, in kgly, from Table 9-5.Uas the consumption rate of stored garden vegetation by a receptor in age group a, in kg/y, from Table 9-5.fL the fraction of the annual intake of fresh leafy garden vegetation that is grown locally (dimensionless), from Table 9-1.f9 the fraction of the annual intake of stored garden vegetation that is grown locally (dimensionless), from Table 9-1.tL the average time between harvest of fresh leafy garden vegetation and its consumption, in s, from Table 9-1.thv the average time between harvest of stored garden vegetation and its consumption, in s, from Table 9-1.For tritium in the garden vegetation consumption pathway, Raipj in (mrem/y) per (g Ci/m 3) is calculated as follows (Reference 1, Section 5.3.1.5), based on the concentration in air rather than deposition onto the ground: Raipj = KI K 3 "(DFL)aii 
"(UaLfL +UaSfg )O. 75. 1'-9,4 where: K 3  = the units conversion factor: 10 3 g/kg.H = the absolute humidity of atmospheric air, in g/m 3 , from Table 9-1.0.75 = the fraction of the mass of total garden vegetation that is water (dimensionless).
0.5 = the ratio of the specific activity of tritium in garden vegetation water to that in atmospheric water (dimensionless).
and other parameters are as defined above.9-3 Version 23 2/13 Table 9-1 Miscellaneous Parameters for the Garden Vegetation Pathway The following parameter values are for use in calculating Raipj for the garden vegetation pathway only. The terms themselves are defined in Section 9.3.Parameter Value Reference Yv 2.0 kg/m 2  Ref. 3, Table E-15 kW 5.73 x 10-7 S1 Ref. 1, page 33 (14-day half-life) fL 1.0 Ref. 1, page 36 fg 0.76 Ref. 1, page 33 tL 8.6 x 104S Ref. 3, Table E-15 (1 day)thv 5.18 x 106 s Ref. 3, Table E-15 (60 days)H 8 g/m 3 Ref. 3 9-4 Version 23 2/13 9-4 Version 23 2/13 9.4 GRASS-COW-MILK PATHWAY FACTOR For radionuclides other than tritium in the grass-cow-milk pathway, Raipj in (m 2.mrem/y) per (gCi/s) is calculated as follows (Reference 1, Section 5.3.1.3): r f f,,Ji + (I fpfi) RP K, +Tr,) Qr Up Fm, "(DFL)i .[L + (I- J e-' (9.5)where: K, the units conversion factor: 106 pCi/iCi.r = the fraction of deposited activity retained on the edible parts of vegetation (dimensionless).
The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1).ki = the radioactive decay constant for radionuclide i, in s-1. Values of Xi used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.k. the rate constant for removal of activity on leaf and plant surfaces by weathering, in s-1, from Table 9-2.QF = the cow's consumption rate of feed, in kg/d, from Table 9-2.Uap = the consumption rate of cow milk by a receptor in age group a, in Uy, from Table 9-5.Fmi = the stable element transfer coefficient applicable to radionuclide i, for cow's milk, in d/L, from Table 9-6.(DFL)aij = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14.fp the fraction of the year that the cow is on pasture (dimensionless), from Table 9-2.f = the fraction of the cow's feed that is pasture grass while the cow is on pasture (dimensionless), from Table 9-2.Yp the areal density (agricultural productivity) of growing pasture feed grass, in kglm 2 , from Table 9-2.Y = the areal density (agricultural productivity) of growing stored feed, in kg/M 2 , from Table 9-2.th= = the transport time from harvest of stored feed to its consumption by the cow, in s, from Table 9-2.9-5 Version 23 2/13 9-5 Version 23 2/13 
= the transport time from consumption of feed by the cow, to consumption of milk by the receptor, in s, from Table 9-2.For tritium in the grass-cow-milk pathway, Raipj in (mrem/y) per  3) is calculated as follows (Reference 1, Section 5.3.1.5), based on the concentration in air rather than deposition onto the ground: (05")Raipj = KI " K3 " QF "Uap " Fmi "(DFL)aij "0. 75- '1(9.6)where: K 3  = the units conversion factor: 103 g/kg.H = the absolute humidity of atmospheric air, in g/m3, from Table 9-2.0.75 = the fraction of the mass of total vegetation that is water (dimensionless).
0.5 = the ratio of the specific activity of tritium in vegetation water to that in atmospheric water (dimensionless).
and other parameters are as defined above.9-6 Version 23 2/13 Table 9-2 Miscellaneous Parameters for the Grass-Cow-Milk Pathway The following parameter values are for use in calculating only. The terms themselves are defined in Section 9.4.Raipj for the grass-cow-milk pathway Parameter Value Reference 5.73 x 10-7 s-1 Ref. 1, page 33 (14-day half-life)
QF 50 kg/d Ref. 3, Table E-3 fp 1.0 Ref. 1, page 33 f 1.0 Ref. 1, page 33 Yp 0.7 kg/m 2  Ref. 3, Table E-15 Y 2.0 kg/M 2  Ref. 3, Table E-15 thin 7.78 x 106S Ref. 3, Table E-15 (90 days)tf 1.73 x 105 s Ref. 3, Table E-15 (2 days)H 8 g/m 3 Ref. 3 9-7 Version 23 2/13 9-7 Version 23 2/13 9.5 GRASS-GOAT-MILK PATHWAY FACTOR For radionuclides other than tritium in the grass-goat-milk pathway, Raipj in (m 2.mrem/y) per ([.Ci/s) is calculated as follows (Reference 1, Section 5.3.1.3): Raip K1(F + (1-fpfs)e-itIhm Rar K" U (DFL)a if f, + e-Aitf (9.7)where: K 1  = the units conversion factor: 106 pCi/liCi.r = the fraction of deposited activity retained on the edible parts of vegetation (dimensionless).
The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1).Xi = the radioactive decay constant for radionuclide i, in s-1. Values of Xi used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26..= the rate constant for removal of activity on leaf and plant surfaces by weathering, in s-1, from Table 9-3.QF = the goat's consumption rate of feed, in kg/d, from Table 9-3.Uap = the consumption rate of goat milk by a receptor in age group a, in L/y, from Table 9-5.Fmi = the stable element transfer coefficient applicable to radionuclide i, for goat's milk, in d/L, from Table 9-6.(DFL)aj = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14.fp = the fraction of the year that the goat is on pasture (dimensionless), from Table 9-3.f. =the fraction of the goat's feed that is pasture grass while the goat is on pasture (dimensionless), from Table 9-3.Yp = the areal density (agricultural productivity) of growing pasture feed grass, in kg/m 2 , from Table 9-3.Y = the areal density (agricultural productivity) of growing stored feed, in kg/M 2 , from Table 9-3.thrn = the transport time from harvest of stored feed to its consumption by the goat, in s, from Table 9-3.9-8 Version 23 2/13 tf =the transport time from consumption of feed by the goat, to consumption of milk by the receptor, in s, from Table 9-3.For tritium in the grass-goat-milk pathway, Raipj in (mrem/y) per (&#xfd;iCi/m 3) is calculated as follows (Reference 1, Section 5.3.1.5), based on the concentration in air rather than deposition onto the ground: R,ipj= K ' KK Qj. .U .F *(DFL),j .0. 75. (05) (9.8)a 1p3 ap Min Hi where: K 3  = the units conversion factor: 10 3 g/kg.H = the absolute humidity of atmospheric air, in g/m 3 , from Table 9-3.0.75 = the fraction of the mass of total vegetation that is water (dimensionless).
0.5 = the ratio of the specific activity of tritium in vegetation water to that in atmospheric water (dimensionless).
and other parameters are as defined above.9-9 Version 23 2/13 9-9 Version 23 2/13 Table 9-3 Miscellaneous Parameters for the Grass-Goat-Milk Pathway The following parameter values are for use in calculating Raipj for the grass-goat-milk pathway only. The terms themselves are defined in Section 9.5.Parameter Value Reference 5.73 x 10-7 S 1  Ref. 1, page 33 (14-day half-life)
QF 6 kg/d Ref. 3, Table E-3 fp 1.0 Ref. 1, page 33 f, 1.0 Ref. 1, page 33 Yp 0.7 kg/m 2  Ref. 3, Table E-15 Y" 2.0 kg/m 2  Ref. 3, Table E-15 thin 7.78 x 106 s Ref. 3, Table E-15 (90 days)tf 1.73 x 105 s Ref. 3, Table E-15 (2 days)H 8 g/m3 Ref. 3 9-10 Version 23 2/13 9.6 GRASS-COW-MEAT PATHWAY FACTOR For radionuclides other than tritium in the grass-cow-meat pathway, Raipj in (m 2-mrem/y) per (&#xfd;tCi/s) is calculated as follows (Reference 1, Section 5.3.1.4): Raip =K r QF Uap -Ff(DFL)a ifpfs + ( fpfs)e-2 ithm eitf (9.9)Raip = (9.9) A) a ypY where: K 1  = the units conversion factor: 106 pCi/lpCi.r = the fraction of deposited activity retained on the edible parts of vegetation (dimensionless).
The value used for r is 1.0 for radioiodines and 0.2 for particulates, from (Reference 3, Table E-1).?, = the radioactive decay constant for radionuclide i, in s-1.Values of Xi used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.x = the rate constant for removal of activity on leaf and plant surfaces by weathering, in s-', from Table 9-4.QF = the cow's consumption rate of feed, in kg/d, from Table 9-4.Uap = the consumption rate of meat by a receptor in age group a, in kg/y, from Table 9-5.F 6  = the stable element transfer coefficient applicable to radionuclide i, for meat, in d/kg, from Table 9-6.(DFL)aij = the ingestion dose factor for receptor age group a, radionuclide i, and organ j, in mrem/pCi, from Table 9-11 through Table 9-14.fp = the fraction of the year that the cow is on pasture (dimensionless), from Table 9-4.fs = the fraction of the cow's feed that is pasture grass while the cow is on pasture (dimensionless), from Table 9-4.Yp the areal density (agricultural productivity) of growing pasture feed grass, in kg/M 2 , from Table 9-4.Y = the areal density (agricultural productivity) of growing stored feed, in kg/M 2 , from Table 9-4.thin = the transport time from harvest of stored feed to its consumption by the cow, in s, from Table 9-4.9-11 Version 23 2/13 
= the transport time from consumption of feed by the cow, to consumption of meat by the receptor, in s, from Table 9-4.For tritium in the grass-cow-meat pathway, Rjpj in (mrem/y) per (jiCi/m 3) is calculated as follows (Reference 1, Section 5.3.1.4), based on the concentration in air rather than deposition onto the ground: Raipj = KI " K3 "QF "U ap,) f! .(DFL)aj .0. 75. (05(9.10)where: K 3  = the units conversion factor: 10 3 g/kg.H = the absolute humidity of atmospheric air, in g/m 3 , from Table 9-4.0.75 = the fraction of the mass of total vegetation that is water (dimensionless).
0.5 = the ratio of the specific activity of tritium in vegetation water to that in atmospheric water (dimensionless).
and other parameters are as defined above.9-12 Version 23 2/13 9-12 Version 23 2/13 Table 9-4 Miscellaneous Parameters for the Grass-Cow-Meat Pathway The following parameter values are for use in calculating only. The terms themselves are defined in Section 9.6.Raipj for the grass-cow-meat pathway Parameter Value Reference xW 5.73 x 10 7 s-1 Ref. 1, page 33 (14-day half-life)
QF 50 kg/d Ref. 3, Table E-3 fp 1.0 Ref. 1, page 33% 1.0 Ref. 1, page 33 Yp 0.7 kg/m 2  Ref. 3, Table E-15 Ys 2.0 kg/m 2  Ref. 3, Table E-15 thin 7.78 x 106 S Ref. 3, Table E-15 (90 days)tf 1.73 x 10 6 s Ref. 3, Table E-15 (20 days)H 8 g/m 3 Ref. 3 9-13 Version 23 2/13 9-13 Version 23 2/13 Table 9-5 Individual Usage Factors-Usage Factor Receptor Age Group Infant Child Teenager Adult Milk Consumption Rate, Uap 330 330 400 310 (L/y)Meat Consumption Rate, Uap 0 41 65 110 (kg/y)Fresh Leafy Garden Vegetation 0 26 42 64 Consumption Rate, UaL(kg/y)Stored Garden Vegetation 0 520 630 520 Consumption Rate, Uas (kg/y)Breathing Rate, (BR)a 1400 3700 8000 8000 (m 3/y) 1 1 All values are from Reference 3, Table E-5.9-14 Version 23 2/13 9-14 Version 23 2/13 Table 9-6 Stable Element Transfer Data Cow Milk Goat Milk Meat Element Fm (d/L)* Fm (d/L)&#xf7; Ff (d/kg)*H 1.0 E-02 1.7 E-01 1.2 E-02 C 1.2 E-02 1.0 E-01 3.1 E-02 Na 4.0 E-02 4.0 E-02 3.0 E-02 P 2.5 E-02 2.5 E-01 4.6 E-02 Cr 2.2 E-03 2.2 E-03 2.4 E-03 Mn 2.5 E-04 2.5 E-04 8.0 E-04 Fe 1.2 E-03 1.3 E-04 4.0 E-02 Co 1.0 E-03 1.0 E-03 1.3 E-02 Ni 6.7 E-03 6.7 E-03 5.3 E-02 Cu 1.4 E-02 1.3 E-02 8.0 E-03 Zn 3.9 E-02 3.9 E-02 3.0 E-02 Br 5.0 E-02 5.0 E-02 2.6 E-02 Rb 3.0 E-02 3.0 E-02 3.1 E-02 Sr 8.0 E-04 1.4 E-02 6.0 E-04 Y 1.0 E-05 1.0 E-05 4.6 E-03 Zr 5.0 E-06 5.0 E-06 3.4 E-02 Nb 2.5 E-03 2.5 E-03 2.8 E-01 Mo 7.5 E-03 7.5 E-03 8.0 E-03 Tc 2.5 E-02 2.5 E-02 4.0 E-01 Ru 1.0 E-06 1.0 E-06 4.0 E-01 Rh 1.0 E-02 1.0 E-02 1.5 E-03 Ag 5.0 E-02 5.0 E-02 1.7 E-02 Sb 1.5 E-03 1.5 E-03 4.0 E-03 Te 1.0 E-03 1.0 E-03 7.7 E-02 1 6.0 E-03 6.0 E-02 2.9 E-03 Cs 1.2 E-02 3.0 E-01 4.0 E-03 Ba 4.0 E-04 4.0 E-04 3.2 E-03 La 5.0 E-06 5.0 E-06 2.0 E-04 Ce 1.0 E-04 1.0 E-04 1.2 E-03 Pr 5.0 E-06 5.0 E-06 4.7 E-03 Nd 5.0 E-06 5.0 E-06 3.3 E-03 W 5.0 E-04 5.0 E-04 1.3 E-03 Np 5.0 E-06 5.0 E-06 2.0 E-04 Values from Reference 3 and Sb.(Table E-1) except as follows: Reference 2 (Table C-5) for Br+ Values from Reference 3, Table E-2 for H, C, P, Fe, Cu, Sr, I, and Cs in goat milk, and Table E-1 for all other elements in cow milk, except as follows: Reference 2 (Table C-5)for Br and Sb in cow milk.9-15 Version 23 2/13 Table 9-7 Inhalation Dose Factors for the Infant Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 C-14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 Na-24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P-32 1.45E-03 8.03E-05 5.53E-05 No Data No Data No Data 1.1 5E-05 Cr-51 No Data No Data 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07 Mn-54 No Data 1.81E-05 3.56E-06 No Data 3.56E-06 7.14E-04 5.04E-06 Mn-56 No Data 1.1OE-09 1.58E-10 No Data 7.86E-10 8.95E-06 5.12E-05 Fe-55 1.41E-05 8.39E-06 2.38E-06 No Data No Data 6.21 E-05 7.82E-07 Fe-59 9.69E-06 1.68E-05 6.77E-06 No Data No Data 7.25E-04 1.77E-05 Co-58 No Data 8.71E-07 1.30E-06 No Data No Data 5.55E-04 7.95E-06 Co-60 No Data 5.73E-06 8.41E-06 No Data No Data 3.22E-03 2.28E-05 Ni-63 2.42E-04 1.46E-05 8.29E-06 No Data No Data 1.49E-04 1.73E-06 Ni-65 1.71E-09 2.03E-10 8.79E-11 No Data No Data 5.80E-06 3.58E-05 Cu-64 No Data 1.34E-09 5.53E-10 No Data 2.84E-09 6.64E-06 1.07E-05 Zn-65 1.38E-05 4.47E-05 2.22E-05 No Data 2.32E-05 4.62E-04 3.67E-05 Zn-69 3.85E-11 6.91E-11 5.13E-12 No Data 2.87E-11 1.05E-06 9.44E-06 Br-83 No Data No Data 2.72E-07 No Data No Data No Data No Data Br-84 No Data No Data 2.86E-07 No Data No Data No Data No Data Br-85 No Data No Data 1.46E-08 No Data No Data No Data No Data Rb-86 No Data 1.36E-04 6.30E-05 No Data No Data No Data 2.17E-06 Rb-88 No Data 3.98E-07 2.05E-07 No Data No Data No Data 2.42E-07 Rb-89 No Data 2.29E-07 1.47E-07 No Data No Data No Data 4.87E-08 Sr-89 2.84E-04 No Data 8.15E-06 No Data No Data 1.45E-03 4.57E-05 Sr-90 2.92E-02 No Data 1.85E-03 No Data No Data 8.03E-03 9.36E-05 Sr-91 6.83E-08 No Data 2.47E-09 No Data No Data 3.76E-05 5.24E-05 All values are in (mrem/pCi inhaled).
They are obtained from Reference 3 (Table E-10).Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-125.9-16 Version 23 2/13 Table 9-7 (contd)Inhalation Dose Factors for the Infant Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 7.50E-09 No Data 2.79E-10 No Data No Data 1.70E-05 1.OOE-04 Y-90 2.35E-06 No Data 6.30E-08 No Data No Data 1.92E-04 7.43E-05 Y-91m 2.91E-10 No Data 9.90E-12 No Data No Data 1.99E-06 1.68E-06 Y-91 4.20E-04 No Data 1.12E-05 No Data No Data 1.75E-03 5.02E-05 Y-92 1.17E-08 No Data 3.29E-10 No Data No Data 1.75E-05 9.04E-05 Y-93 1.07E-07 No Data 2.91 E-09 No Data No Data 5.46E-05 1.19E-04 Zr-95 8.24E-05 1.99E-05 1.45E-05 No Data 2.22E-05 1.25E-03 1.55E-05 Zr-97 1.07E-07 1.83E-08 8.36E-09 No Data 1.85E-08 7.88E-05 1.OOE-04 Nb-95 1.12E-05 4.59E-06 2.70E-06 No Data 3.37E-06 3.42E-04 9.05E-06 Mo-99 No Data 1.1 8E-07 2.31 E-08 No Data 1.89E-07 9.63E-05 3.48E-05 Tc-99m 9.98E-13 2.06E-12 2.66E-11 No Data 2.22E-11 5.79E-07 1.45E-06 Tc-101 4.65E-14 5.88E-14 5.80E-13 No Data 6.99E-13 4.17E-07 6.03E-07 Ru-103 1.44E-06 No Data 4.85E-07 No Data 3.03E-06 3.94E-04 1.15E-05 Ru-105 8.74E-10 No Data 2.93E-10 No Data 6.42E-10 1.12E-05 3.46E-05 Ru-106 6.20E-05 No Data 7.77E-06 No Data 7.61E-05 8.26E-03 1.17E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-110m 7.13E-06 5.16E-06 3.57E-06 No Data 7.80E-06 2.62E-03 2.36E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-1 25 No Data No Data No Data No Data No Data No Data No Data Te-125m 3.40E-06 1.42E-06 4.70E-07 1.16E-06 No Data 3.19E-04 9.22E-06 Te-127m 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 Te-127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 Te-129m 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 Te-129 5.63E-11 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 Te-131m 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05 Te-131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 9-17 Version 23 2/13 9-17 Version 23 2/13 Table 9-7 (contd)Inhalation Dose Factors for the Infant Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E-05 1-130 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 No Data 1.42E-06 1-131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 No Data 7.56E-07 1-132 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 No Data 1.36E-06 1-133 9.46E-06 1.37E-05 4.OOE-06 2.54E-03 1.60E-05 No Data 1.54E-06 1-134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 No Data 9.21E-07 1-135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 No Data 1.31 E-06 Cs-134 2.83E-04 5.02E-04 5.32E-05 No Data 1.36E-04 5.69E-05 9.53E-07 Cs-1 36 3.45E-05 9.61E-05 3.78E-05 No Data 4.03E-05 8.40E-06 1.02E-06 Cs-1 37 3.92E-04 4.37E-04 3.25E-05 No Data 1.23E-04 5.09E-05 9.53E-07 Cs-1 38 3.61E-07 5.58E-07 2.84E-07 No Data 2.93E-07 4.67E-08 6.26E-07 Ba-139 1.06E-09 7.03E-13 3.07E-11 No Data 4.23E-13 4.25E-06 3.64E-05 Ba-140 4.OOE-05 4.OOE-08 2.07E-06 No Data 9.59E-09 1.14E-03 2.74E-05 Ba-141 1.12E-10 7.70E-14 3.55E-12 No Data 4.64E-14 2.12E-06 3.39E-06 Ba-142 2.84E-11 2.36E-14 1.40E-12 No Data 1.36E-14 1.11E-06 4.95E-07 La-140 3.61E-07 1.43E-07 3.68E-08 No Data No Data 1.20E-04 6.06E-05 La-142 7.36E-10 2.69E-10 6.46E-11 No Data No Data 5.87E-06 4.25E-05 Ce-141 1.98E-05 1.19E-05 1.42E-06 No Data 3.75E-06 3.69E-04 1.54E-05 Ce-143 2.09E-07 1.38E-07 1.58E-08 No Data 4.03E-08 8.30E-05 3.55E-05 Ce-144 2.28E-03 8.65E-04 1.26E-04 No Data 3.84E-04 7.03E-03 1.06E-04 Pr-143 1.OOE-05 3.74E-06 4.99E-07 No Data 1.41E-06 3.09E-04 2.66E-05 Pr-144 3.42E-11 1.32E-11 1.72E-12 No Data 4.80E-12 1.15E-06 3.06E-06 Nd-147 5.67E-06 5.81E-06 3.57E-07 No Data 2.25E-06 2.30E-04 2.23E-05 W-187 9.26E-09 6.44E-09 2.23E-09 No Data No Data 2.83E-05 2.54E-05 Np-239 2.65E-07 2.37E-08 1.34E-08 No Data 4.73E-08 4.25E-05 1.78E-05 9-18 Version 23 2/13 9-18 Version 23 2/13 Table 9-8 Inhalation Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C-14 9.70E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 Na-24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 P-32 7.04E-04 3.09E-05 2.67E-05 No Data No Data No Data 1.14E-05 Cr-51 No Data No Data 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 Mn-54 No Data 1.16E-05 2.57E-06 No Data 2.71E-06 4.26E-04 6.19E-06 Mn-56 No Data 4.48E-10 8.43E-11 No Data 4.52E-10 3.55E-06 3.33E-05 Fe-55 1.28E-05 6.80E-06 2.1OE-06 No Data No Data 3.OOE-05 7.75E-07 Fe-59 5.59E-06 9.04E-06 4.51E-06 No Data No Data 3.43E-04 1.91E-05 Co-58 No Data 4.79E-07 8.55E-07 No Data No Data 2.99E-04 9.29E-06 Co-60 No Data 3.55E-06 6.12E-06 No Data No Data 1.91E-03 2.60E-05 Ni-63 2.22E-04 1.25E-05 7.56E-06 No Data No Data 7.43E-05 1.71E-06 Ni-65 8.08E-10 7.99E-11 4.44E-11 No Data No Data 2.21E-06 2.27E-05 Cu-64 No Data 5.39E-10 2.90E-10 No Data 1.63E-09 2.59E-06 9.92E-06 Zn-65 1.15E-05 3.06E-05 1.90E-05 No Data 1.93E-05 2.69E-04 4.41E-06 Zn-69 1.81E-11 2.61E-11 2.41E-12 No Data 1.58E-11 3.84E-07 2.75E-06 Br-83 No Data No Data 1.28E-07 No Data No Data No Data No Data Br-84 No Data No Data 1.48E-07 No Data No Data No Data No Data Br-85 No Data No Data 6.84E-09 No Data No Data No Data No Data Rb-86 No Data 5.36E-05 3.09E-05 No Data No Data No Data 2.16E-06 Rb-88 No Data 1.52E-07 9.90E-08 No Data No Data No Data 4.66E-09 Rb-89 No Data 9.33E-08 7.83E-08 No Data No Data No Data 5.11 E-10 Sr-89 1.62E-04 No Data 4.66E-06 No Data No Data 5.83E-04 4.52E-05 Sr-90 2.73E-02 No Data 1.74E-03 No Data No Data 3.99E-03 9.28E-05 Sr-91 3.28E-08 No Data 1.24E-09 No Data No Data 1.44E-05 4.70E-05 All values are in (mrem/pCi inhaled).
They are obtained from Reference 3 (Table Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-125.E-9). Neither 9-19 Version 23 2/13 9-19 Version 23 2/13 Table 9-8 (contd)Inhalation Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 3.54E-09 No Data 1.42E-10 No Data No Data 6.49E-06 6.55E-05 Y-90 1.11 E-06 No Data 2.99E-08 No Data No Data 7.07E-05 7.24E-05 Y-91m 1.37E-10 No Data 4.98E-12 No Data No Data 7.60E-07 4.64E-07 Y-91 2.47E-04 No Data 6.59E-06 No Data No Data 7.1OE-04 4.97E-05 Y-92 5.50E-09 No Data 1.57E-10 No Data No Data 6.46E-06 6.46E-05 Y-93 5.04E-08 No Data 1.38E-09 No Data No Data 2.01E-05 1.05E-04 Zr-95 5.13E-05 1.13E-05 1.OOE-05 No Data 1.61E-05 6.03E-04 1.65E-05 Zr-97 5.07E-08 7.34E-09 4.32E-09 No Data 1.05E-08 3.06E-05 9.49E-05 Nb-95 6.35E-06 2.48E-06 1.77E-06 No Data 2.33E-06 1.66E-04 1.OOE-05 Mo-99 No Data 4.66E-08 1.15E-08 No Data 1.06E-07 3.66E-05 3.42E-05 Tc-99m 4.81E-13 9.41E-13 1.56E-11 No Data 1.37E-11 2.57E-07 1.30E-06 Tc-101 2.19E-14 2.30E-14 2.91E-13 No Data 3.92E-13 1.58E-07 4.41E-09 Ru-103 7.55E-07 No Data 2.90E-07 No Data 1.90E-06 1.79E-04 1.21E-05 Ru-105 4.13E-10 No Data 1.50E-10 No Data 3.63E-10 4.30E-06 2.69E-05 Ru-106 3.68E-05 No Data 4.57E-06 No Data 4.97E-05 3.87E-03 1.16E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-110m 4.56E-06 3.08E-06 2.47E-06 No Data 5.74E-06 1.48E-03 2.71E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 1.82E-06 6.29E-07 2.47E-07 5.20E-07 No Data 1.29E-04 9.13E-06 Te-127m 6.72E-06 2.31E-06 8.16E-07 1.64E-06 1.72E-05 4.OOE-04 1.93E-05 Te-127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E-05 Te-129m 5.19E-06 1.85E-06 8.22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05 Te-129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E-06 Te-131m 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8.32E-05 Te-131 5.87E-12 2.28E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07 9-20 Version 23 2/13 9-20 Version 23 2/13 Table 9-8 (contd)Inhalation Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05 1-130 2.21 E-06 4.43E-06 2.28E-06 4.99E-04 6.61 E-06 No Data 1.38E-06 1-131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 No Data 7.68E-07 1-132 5.72E-07 1.1OE-06 5.07E-07 5.23E-05 1.69E-06 No Data 8.65E-07 1-133 4.48E-06 5.49E-06 2.08E-06 1.04E-03 9.13E-06 No Data 1.48E-06 1-134 3.17E-07 5.84E-07 2.69E-07 1.37E-05 8.92E-07 No Data 2.58E-07 1-135 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 No Data 1.20E-06 Cs-134 1.76E-04 2.74E-04 6.07E-05 No Data 8.93E-05 3.27E-05 1.04E-06 Cs-136 1.76E-05 4.62E-05 3.14E-05 No Data 2.58E-05 3.93E-06 1.13E-06 Cs-137 2.45E-04 2.23E-04 3.47E-05 No Data 7.63E-05 2.81 E-05 9.78E-07 Cs-138 1.71E-07 2.27E-07 1.50E-07 No Data 1.68E-07 1.84E-08 7.29E-08 Ba-139 4.98E-10 2.66E-13 1.45E-11 No Data 2.33E-13 1.56E-06 1.56E-05 Ba-140 2.OOE-05 1.75E-08 1.17E-06 No Data 5.71 E-09 4.71E-04 2.75E-05 Ba-141 5.29E-11 2.95E-14 1.72E-12 No Data 2.56E-14 7.89E-07 7.44E-08 Ba-142 1.35E-11 9.73E-15 7.54E-13 No Data 7.87E-15 4.44E-07 7.41E-10 La-140 1.74E-07 6.08E-08 2.04E-08 No Data No Data 4.94E-05 6.1OE-05 La-142 3.50E-10 1.11E-10 3.49E-11 No Data No Data 2.35E-06 2.05E-05 Ce-141 1.06E-05 5.28E-06 7.83E-07 No Data 2.31 E-06 1.47E-04 1.53E-05 Ce-143 9.89E-08 5.37E-08 7.77E-09 No Data 2.26E-08 3.12E-05 3.44E-05 Ce-144 1.83E-03 5.72E-04 9.77E-05 No Data 3.17E-04 3.23E-03 1.05E-04 Pr-143 4.99E-06 1.50E-06 2.47E-07 No Data 8.11E-07 1.17E-04 2.63E-05 Pr-144 1.61E-11 4.99E-12 8.10E-13 No Data 2.64E-12 4.23E-07 5.32E-08 Nd-147 2.92E-06 2.36E-06 1.84E-07 No Data 1.30E-06 8.87E-05 2.22E-05 W-187 4.41E-09 2.61E-09 1.17E-09 No Data No Data 1.11E-05 2.46E-05 Np-239 1.26E-07 9.04E-09 6.35E-09 No Data 2.63E-08 1.57E-05 1.73E-05 9-21 Version 23 2/13 9-21 Version 23 2/13 Table 9-9 Inhalation Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C-14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 Na-24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 P-32 2.36E-04 1.37E-08 8.95E-06 No Data No Data No Data 1.16E-05 Cr-51 No Data No Data 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 Mn-54 No Data 6.39E-06 1.05E-06 No Data 1.59E-06 2.48E-04 8.35E-06 Mn-56 No Data 2.12E-10 3.15E-11 No Data 2.24E-10 1.90E-06 7.18E-06 Fe-55 4.18E-06 2.98E-06 6.93E-07 No Data No Data 1.55E-05 7.99E-07 Fe-59 1.99E-06 4.62E-06 1.79E-06 No Data No Data 1.91 E-04 2.23E-05 Co-58 No Data 2.59E-07 3.47E-07 No Data No Data 1.68E-04 1.19E-05 Co-60 No Data 1.89E-06 2.48E-06 No Data No Data 1.09E-03 3.24E-05 Ni-63 7.25E-05 5.43E-06 2.47E-06 No Data No Data 3.84E-05 1.77E-06 Ni-65 2.73E-10 3.66E-11 1.59E-11 No Data No Data 1.17E-06 4.59E-06 Cu-64 No Data 2.54E-10 1.06E-10 No Data 8.01E-10 1.39E-06 7.68E-06 Zn-65 4.82E-06 1.67E-05 7.80E-06 No Data 1.08E-05 1.55E-04 5.83E-06 Zn-69 6.04E-12 1.15E-11 8.07E-13 No Data 7.53E-12 1.98E-07 3.56E-08 Br-83 No Data No Data 4.30E-08 No Data No Data No Data No Data Br-84 No Data No Data 5.41 E-08 No Data No Data No Data No Data Br-85 No Data No Data 2.29E-09 No Data No Data No Data No Data Rb-86 No Data 2.38E-05 1.05E-05 No Data No Data No Data 2.21E-06 Rb-88 No Data 6.82E-08 3.40E-08 No Data No Data No Data 3.65E-15 Rb-89 No Data 4.40E-08 2.91E-08 No Data No Data No Data 4.22E-17 Sr-89 5.43E-05 No Data 1.56E-06 No Data No Data 3.02E-04 4.64E-05 Sr-90 1.35E-02 No Data 8.35E-04 No Data No Data 2.06E-03 9.56E-05 Sr-91 1.1OE-08 No Data 4.39E-10 No Data No Data 7.59E-06 3.24E-05 All values are in (mrem/pCi inhaled).
They are obtained from Reference 3 (Table E-8). Neither Reference 2 nor Reference 3 contains data for Rh-1 05, Sb-124, or Sb-125.9-22 Version 23 2/13 Table 9-9 (contd)Inhalation Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 1.1 9E-09 No Data 5.08E-1 1 No Data No Data 3.43E-06 1.49E-05 Y-90 3.73E-07 No Data 1.00E-08 No Data No Data 3.66E-05 6.99E-05 Y-91m 4.63E-11 No Data 1.77E-12 No Data No Data 4.OOE-07 3.77E-09 Y-91 8.26E-05 No Data 2.21 E-06 No Data No Data 3.67E-04 5.11E-05 Y-92 1.84E-09 No Data 5.36E-11 No Data No Data 3.35E-06 2.06E-05 Y-93 1.69E-08 No Data 4.65E-10 No Data No Data 1.04E-05 7.24E-05 Zr-95 1.82E-05 5.73E-06 3.94E-06 No Data 8.42E-06 3.36E-04 1.86E-05 Zr-97 1.72E-08 3.40E-09 1.57E-09 No Data 5.15E-09 1.62E-05 7.88E-05 Nb-95 2.32E-06 1.29E-06 7.08E-07 No Data 1.25E-06 9.39E-05 1.21 E-05 Mo-99 No Data 2.11E-08 4.03E-09 No Data 5.14E-08 1.92E-05 3.36E-05 Tc-99m 1.73E-13 4.83E-13 6.24E-12 No Data 7.20E-12 1.44E-07 7.66E-07 Tc-101 7.40E-15 1.05E-14 1.03E-13 No Data 1.90E-13 8.34E-08 1.09E-16 Ru-103 2.63E-07 No Data 1.12E-07 No Data 9.29E-07 9.79E-05 1.36E-05 Ru-105 1.40E-10 No Data 5.42E-11 No Data 1.76E-10 2.27E-06 1.13E-05 Ru-106 1.23E-05 No Data 1.55E-06 No Data 2.38E-05 2.01E-03 1.20E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-110m 1.73E-06 1.64E-06 9.99E-07 No Data 3.13E-06 8.44E-04 3.41 E-05 Sb-1 24 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 6.1OE-07 2.80E-07 8.34E-08 1.75E-07 No Data 6.70E-05 9.38E-06 Te-127m 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 Te-127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05 Te-129m 1.74E-06 8.23E-07 2.81E-07 5.72E-07 6.49E-06 2.47E-04 5.06E-05 Te-129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-11 4.12E-07 2.02E-07 Te-131m 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05 Te-131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 9-23 Version 23 2/13 9-23 Version 23 2/13 Table 9-9 (contd)Inhalation Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05 1-130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 No Data 1.14E-06 1-131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 No Data 8.11E-07 1-132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 No Data 1.59E-07 1-133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 No Data 1.29E-06 1-134 1.11E-07 2.90E-07 1.05E-07 4.94E-06 4.58E-07 No Data 2.55E-09 1-135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 No Data 8.69E-07 Cs-134 6.28E-05 1.41E-04 6.86E-05 No Data 4.69E-05 1.83E-05 1.22E-06 Cs-136 6.44E-06 2.42E-05 1.71E-05 No Data 1.38E-05 2.22E-06 1.36E-06 Cs-137 8.38E-05 1.06E-04 3.89E-05 No Data 3.80E-05 1.51E-05 1.06E-06 Cs-138 5.82E-08 1.07E-07 5.58E-08 No Data 8.28E-08 9.84E-09 3.38E-11 Ba-139 1.67E-10 1.18E-13 4.87E-12 No Data 1.11E-13 8.08E-07 8.06E-07 Ba-140 6.84E-06 8.38E-09 4.40E-07 No Data 2.85E-09 2.54E-04 2.86E-05 Ba-141 1.78E-11 1.32E-14 5.93E-13 No Data 1.23E-14 4.11E-07 9.33E-14 Ba-142 4.62E-12 4.63E-15 2.84E-13 No Data 3.92E-15 2.39E-07 5.99E-20 La-140 5.99E-08 2.95E-08 7.82E-09 No Data No Data 2.68E-05 6.09E-05 La-142 1.20E-10 5.31E-11 1.32E-11 No Data No Data 1.27E-06 1.50E-06 Ce-141 3.55E-06 2.37E-06 2.71E-07 No Data 1.11E-06 7.67E-05 1.58E-05 Ce-143 3.32E-08 2.42E-08 2.70E-09 No Data 1.08E-08 1.63E-05 3.19E-05 Ce-144 6.11E-04 2.53E-04 3.28E-05 No Data 1.51E-04 1.67E-03 1.08E-04 Pr-143 1.67E-06 6.64E-07 8.28E-08 No Data 3.86E-07 6.04E-05 2.67E-05 Pr-144 5.37E-12 2.20E-12 2.72E-13 No Data 1.26E-12 2.19E-07 2.94E-14 Nd-147 9.83E-07 1.07E-06 6.41E-08 No Data 6.28E-07 4.65E-05 2.28E-05 W-187 1.50E-09 1.22E-09 4.29E-10 No Data No Data 5.92E-06 2.21E-05 Np-239 4.23E-08 3.99E-09 2.21E-09 No Data 1.25E-08 8.11E-06 1.65E-05 9-24 Version 23 2/13 9-24 Version 23 2/13 Table 9-10 Inhalation Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C-14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 Na-24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 P-32 1.65E-04 9.64E-06 6.26E-06 No Data No Data No Data 1.08E-05 Cr-51 No Data No Data 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 Mn-54 No Data 4.95E-06 7.87E-07 No Data 1.23E-06 1.75E-04 9.67E-06 Mn-56 No Data 1.55E-10 2.29E-11 No Data 1.63E-10 1.18E-06 2.53E-06 Fe-55 3.07E-06 2.12E-06 4.93E-07 No Data No Data 9.01E-06 7.54E-07 Fe-59 1.47E-06 3.47E-06 1.32E-06 No Data No Data 1.27E-04 2.35E-05 Co-58 No Data 1.98E-07 2.59E-07 No Data No Data 1.16E-04 1.33E-05 Co-60 No Data 1.44E-06 1.85E-06 No Data No Data 7.46E-04 3.56E-05 Ni-63 5.40E-05 3.93E-06 1.81E-06 No Data No Data 2.23E-05 1.67E-06 Ni-65 1.92E-10 2.62E-11 1.14E-11 No Data No Data 7.OOE-07 1.54E-06 Cu-64 No Data 1.83E-10 7.69E-11 No Data 5.78E-10 8.48E-07 6.12E-06 Zn-65 4.05E-06 1.29E-05 5.82E-06 No Data 8.62E-06 1.08E-04 6.68E-06 Zn-69 4.23E-12 8.14E-12 5.65E-13 No Data 5.27E-12 1.15E-07 2.04E-09 Br-83 No Data No Data 3.01E-08 No Data No Data No Data 2.90E-08 Br-84 No Data No Data 3.91E-08 No Data No Data No Data 2.05E-13 Br-85 No Data No Data 1.60E-09 No Data No Data No Data No Data Rb-86 No Data 1.69E-05 7.37E-06 No Data No Data No Data 2.08E-06 Rb-88 No Data 4.84E-08 2.41E-08 No Data No Data No Data 4.18E-19 Rb-89 No Data 3.20E-08 2.12E-08 No Data No Data No Data 1.16E-21 Sr-89 3.80E-05 No Data 1.09E-06 No Data No Data 1.75E-04 4.37E-05 Sr-90 1.24E-02 No Data 7.62E-04 No Data No Data 1.20E-03 9.02E-05 Sr-91 7.74E-09 No Data 3.13E-10 No Data No Data 4.56E-06 2.39E-05 All values are in (mrem/pCi inhaled).
They are obtained from Reference 3 (Table E-7), except as follows: Reference 2 (Table C-1) for Rh-105, Sb-124, and Sb-125.9-25 Version 23 2/13 Table 9-10 (contd) Inhalation Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 8.43E-10 No Data 3.64E-11 No Data No Data 2.06E-06 5.38E-06 Y-90 2.61E-07 No Data 7.01E-09 No Data No Data 2.12E-05 6.32E-05 Y-91m 3.26E-11 No Data 1.27E-12 No Data No Data 2.40E-07 1.66E-10 Y-91 5.78E-05 No Data 1.55E-06 No Data No Data 2.13E-04 4.81E-05 Y-92 1.29E-09 No Data 3.77E-1 1 No Data No Data 1.96E-06 9.19E-06 Y-93 1.18E-08 No Data 3.26E-10 No Data No Data 6.06E-06 5.27E-05 Zr-95 1.34E-05 4.30E-06 2.91 E-06 No Data 6.77E-06 2.21E-04 1.88E-05 Zr-97 1.21E-08 2.45E-09 1.13E-09 No Data 3.71E-09 9.84E-06 6.54E-05 Nb-95 1.76E-06 9.77E-07 5.26E-07 No Data 9.67E-07 6.31E-05 1.30E-05 Mo-99 No Data 1.51E-08 2.87E-09 No Data 3.64E-08 1.14E-05 3.10E-05 Tc-99m 1.29E-13 3.64E-13 4.63E-12 No Data 5.52E-12 9.55E-08 5.20E-07 Tc-101 5.22E-15 7.52E-15 7.38E-14 No Data 1.35E-13 4.99E-08 1.36E-21 Ru-103 1.91E-07 No Data 8.23E-08 No Data 7.29E-07 6.31E-05 1.38E-05 Ru-105 9.88E-11 No Data 3.89E-11 No Data 1.27E-10 1.37E-06 6.02E-06 Ru-106 8.64E-06 No Data 1.09E-06 No Data 1.67E-05 1.17E-03 1.14E-04 Rh-105 9.24E-10 6.73E-10 4.43E-10 No Data 2.86E-09 2.41E-06 1.09E-05 Ag-110m 1.35E-06 1.25E-06 7.43E-07 No Data 2.46E-06 5.79E-04 3.78E-05 Sb-124 3.90E-06 7.36E-08 1.55E-06 9.44E-09 No Data 3.1OE-04 5.08E-05 Sb-125 8.26E-06 8.91E-08 1.66E-06 7.34E-09 No Data 2.75E-04 1.26E-05 Te-125m 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 Te-127m 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05 Te-127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 Te-129m 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 Te-129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 Te-131m 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05 Te-131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 9-26 Version 23 2/13 9-26 Version 23 2/13 Table 9-10 (contd) Inhalation Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 3.25E-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 1-130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 No Data 9.61 E-07 1-131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 No Data 7.85E-07 1-132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 No Data 5.08E-08 1-133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 No Data 1.11E-06 1-134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 No Data 1.26E-10 1-135 3.35E-07 8.73E-07 3.21E-07 5.60E-05 1.39E-06 No Data 6.56E-07 Cs-134 4.66E-05 1.06E-04 9.1OE-05 No Data 3.59E-05 1.22E-05 1.30E-06 Cs-136 4.88E-06 1.83E-05 1.38E-05 No Data 1.07E-05 1.50E-06 1.46E-06 Cs-137 5.98E-05 7.76E-05 5.35E-05 No Data 2.78E-05 9.40E-06 1.05E-06 Cs-138 4.14E-08 7.76E-08 4.05E-08 No Data 6.OOE-08 6.07E-09 2.33E-13 Ba-139 1.17E-10 8.32E-14 3.42E-12 No Data 7.78E-14 4.70E-07 1.12E-07 Ba-140 4.88E-06 6.13E-09 3.21E-07 No Data 2.09E-09 1.59E-04 2.73E-05 Ba-141 1.25E-11 9.41E-15 4.20E-13 No Data 8.75E-15 2.42E-07 1.45E-17 Ba-142 3.29E-12 3.38E-15 2.07E-13 No Data 2.86E-15 1.49E-07 1.96E-26 La-140 4.30E-08 2.17E-08 5.73E-09 No Data No Data 1.70E-05 5.73E-05 La-142 8.54E-11 3.88E-11 9.65E-12 No Data No Data 7.91E-07 2.64E-07 Ce-141 2.49E-06 1.69E-06 1.91E-07 No Data 7.83E-07 4.52E-05 1.50E-05 Ce-143 2.33E-08 1.72E-08 1.91E-09 No Data 7.60E-09 9.97E-06 2.83E-05 Ce-144 4.29E-04 1.79E-04 2.30E-05 No Data 1.06E-04 9.72E-04 1.02E-04 Pr-143 1.17E-06 4.69E-07 5.80E-08 No Data 2.70E-07 3.51E-05 2.50E-05 Pr-144 3.76E-12 1.56E-12 1.91E-13 No Data 8.81E-13 1.27E-07 2.69E-18 Nd-147 6.59E-07 7.62E-07 4.56E-08 No Data 4.45E-07 2.76E-05 2.16E-05 W-187 1.06E-09 8.85E-10 3.10E-10 No Data No Data 3.63E-06 1.94E-05 Np-239 2.87E-08 2.82E-09 1.55E-09 No Data 8.75E-09 4.70E-06 1.49E-05 9-27 Version 23 2/13 9-27 Version 23 2/13 Table 9-11 Ingestion Dose Factors for the Infant Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C-14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 Na-24 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 P-32 1.70E-03 1.OOE-04 6.59E-05 No Data No Data No Data 2.30E-05 Cr-51 No Data No Data 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 Mn-54 No Data 1.99E-05 4.51E-06 No Data 4.41E-06 No Data 7.31E-06 Mn-56 No Data 8.18E-07 1.41 E-07 No Data 7.03E-07 No Data 7.43E-05 Fe-55 1.39E-05 8.98E-06 2.40E-06 No Data No Data 4.39E-06 1.14E-06 Fe-59 3.08E-05 5.38E-05 2.12E-05 No Data No Data 1.59E-05 2.57E-05 Co-58 No Data 3.60E-06 8.98E-06 No Data No Data No Data 8.97E-06 Co-60 No Data 1.08E-05 2.55E-05 No Data No Data No Data 2.57E-05 Ni-63 6.34E-04 3.92E-05 2.20E-05 No Data No Data No Data 1.95E-06 Ni-65 4.70E-06 5.32E-07 2.42E-07 No Data No Data No Data 4.05E-05 Cu-64 No Data 6.09E-07 2.82E-07 No Data 1.03E-06 No Data 1.25E-05 Zn-65 1.84E-05 6.31E-05 2.91E-05 No Data 3.06E-05 No Data 5.33E-05 Zn-69 9.33E-08 1.68E-07 1.25E-08 No Data 6.98E-08 No Data 1.37E-05 Br-83 No Data No Data 3.63E-07 No Data No Data No Data No Data Br-84 No Data No Data 3.82E-07 No Data No Data No Data No Data Br-85 No Data No Data 1.94E-08 No Data No Data No Data No Data Rb-86 No Data 1.70E-04 8.40E-05 No Data No Data No Data 4.35E-06 Rb-88 No Data 4.98E-07 2.73E-07 No Data No Data No Data 4.85E-07 Rb-89 No Data 2.86E-07 1.97E-07 No Data No Data No Data 9.74E-08 Sr-89 2.51E-03 No Data 7.20E-05 No Data No Data No Data 5.16E-05 Sr-90 1.85E-02 No Data 4.71E-03 No Data No Data No Data 2.31E-04 Sr-91 5.00E-05 No Data 1.81E-06 No Data No Data No Data 5.92E-05 All values are in (mrem/pCi ingested).
They are obtained from Reference 3 (Table E-14).Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-125.9-28 Version 23 2/13 9-28 Version 23 2/13 Table 9-11 (contd) Ingestion Dose Factors for the Infant Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 1.92E-05 No Data 7.13E-07 No Data No Data No Data 2.07E-04 Y-90 8.69E-08 No Data 2.33E-09 No Data No Data No Data 1.20E-04 Y-91m 8.10E-10 No Data 2.76E-11 No Data No Data No Data 2.70E-06 Y-91 1.13E-06 No Data 3.01E-08 No Data No Data No Data 8.10E-05 Y-92 7.65E-09 No Data 2.15E-10 No Data No Data No Data 1.46E-04 Y-93 2.43E-08 No Data 6.62E-10 No Data No Data No Data 1.92E-04 Zr-95 2.06E-07 5.02E-08 3.56E-08 No Data 5.41 E-08 No Data 2.50E-05 Zr-97 1.48E-08 2.54E-09 1.16E-09 No Data 2.56E-09 No Data 1.62E-04 Nb-95 4.20E-08 1.73E-08 1.OOE-08 No Data 1.24E-08 No Data 1.46E-05 Mo-99 No Data 3.40E-05 6.63E-06 No Data 5.08E-05 No Data 1.12E-05 Tc-99m 1.92E-09 3.96E-09 5.1OE-08 No Data 4.26E-08 2.07E-09 1.15E-06 Tc-101 2.27E-09 2.86E-09 2.83E-08 No Data 3.40E-08 1.56E-09 4.86E-07 Ru-103 1.48E-06 No Data 4.95E-07 No Data 3.08E-06 No Data 1.80E-05 Ru-105 1.36E-07 No Data 4.58E-08 No Data 1.OOE-06 No Data 5.41 E-05 Ru-106 2.41E-05 No Data 3.01E-06 No Data 2.85E-05 No Data 1.83E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-110m 9.96E-07 7.27E-07 4.81E-07 No Data 1.04E-06 No Data 3.77E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 2.33E-05 7.79E-06 3.15E-06 7.84E-06 No Data No Data 1.11E-05 Te-127m 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 No Data 2.36E-05 Te-127 1.OOE-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 No Data 2.1OE-05 Te-129m 1.OOE-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 No Data 5.97E-05 Te-129 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 No Data 2.27E-05 Te-131rm 1.52E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 No Data 1.03E-04 Te-131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 No Data 7.11E-06 9-29 Version 23 2/13 9-29 Version 23 2/13 Table 9-11 (contd) Ingestion Dose Factors for the Infant Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 2.08E-05 1.03E-05 9.61E-06 1.52E-05 6.44E-05 No Data 3.81E-05 1-130 6.OOE-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 No Data 2.83E-06 1-131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 No Data 1.51E-06 1-132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-06 No Data 2.73E-06 1-133 1.25E-05 1.82E-05 5.33E-06 3.31E-03 2.14E-05 No Data 3.08E-06 1-134 8.69E-07 1.78E-06 6.33E-07 4.15E-05 1.99E-06 No Data 1.84E-06 1-135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 No Data 2.62E-06 Cs-134 3.77E-04 7.03E-04 7.1OE-05 No Data 1.81E-04 7.42E-05 1.91E-06 Cs-136 4.59E-05 1.35E-04 5.04E-05 No Data 5.38E-05 1.10E-05 2.05E-06 Cs-137 5.22E-04 6.11E-04 4.33E-05 No Data 1.64E-04 6.64E-05 1.91 E-06 Cs-138 4.81E-07 7.82E-07 3.79E-07 No Data 3.90E-07 6.09E-08 1.25E-06 Ba-139 8.81E-07 5.84E-10 2.55E-08 No Data 3.51E-10 3.54E-10 5.58E-05 Ba-140 1.71E-04 1.71E-07 8.81E-06 No Data 4.06E-08 1.05E-07 4.20E-05 Ba-141 4.25E-07 2.91E-10 1.34E-08 No Data 1.75E-10 1.77E-10 5.19E-06 Ba-142 1.84E-07 1.53E-10 9.06E-09 No Data 8.81E-11 9.26E-11 7.59E-07 La-140 2.11E-08 8.32E-09 2.14E-09 No Data No Data No Data 9.77E-05 La-142 1.1OE-09 4.04E-10 9.67E-11 No Data No Data No Data 6.86E-05 Ce-141 7.87E-08 4.80E-08 5.65E-09 No Data 1.48E-08 No Data 2.48E-05 Ce-143 1.48E-08 9.82E-06 1.12E-09 No Data 2.86E-09 No Data 5.73E-05 Ce-144 2.98E-06 1.22E-06 1.67E-07 No Data 4.93E-07 No Data 1.71E-04 Pr-143 8.13E-08 3.04E-08 4.03E-09 No Data 1.13E-08 No Data 4.29E-05 Pr-144 2.74E-10 1.06E-10 1.38E-11 No Data 3.84E-11 No Data 4.93E-06 Nd-147 5.53E-08 5.68E-08 3.48E-09 No Data 2.19E-08 No Data 3.60E-05 W-187 9.03E-07 6.28E-07 2.17E-07 No Data No Data No Data 3.69E-05 Np-239 1.11E-08 9.93E-10 5.61E-10 No Data 1.98E-09 No Data 2.87E-05 9-30 Version 23 2/13 Table 9-12 Ingestion Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C-14 1.21E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 Na-24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 P-32 8.25E-04 3.86E-05 3.18E-05 No Data No Data No Data 2.28E-05 Cr-51 No Data No Data 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 Mn-54 No Data 1.07E-05 2.85E-06 No Data 3.OOE-06 No Data 8.98E-06 Mn-56 No Data 3.34E-07 7.54E-08 No Data 4.04E-07 No Data 4.84E-05 Fe-55 1.15E-05 6.1OE-06 1.89E-06 No Data No Data 3.45E-06 1.13E-06 Fe-59 1.65E-05 2.67E-05 1.33E-05 No Data No Data 7.74E-06 2.78E-05 Co-58 No Data 1.80E-06 5.51 E-06 No Data No Data No Data 1.05E-05 Co-60 No Data 5.29E-06 1.56E-05 No Data No Data No Data 2.93E-05 Ni-63 5.38E-04 2.88E-05 1.83E-05 No Data No Data No Data 1.94E-06 Ni-65 2.22E-06 2.09E-07 1.22E-07 No Data No Data No Data 2.56E-05 Cu-64 No Data 2.45E-07 1.48E-07 No Data 5.92E-07 No Data 1.15E-05 Zn-65 1.37E-05 3.65E-05 2.27E-05 No Data 2.30E-05 No Data 6.41 E-06 Zn-69 4.38E-08 6.33E-08 5.85E-09 No Data 3.84E-08 No Data 3.99E-06 Br-83 No Data No Data 1.71E-07 No Data No Data No Data No Data Br-84 No Data No Data 1.98E-07 No Data No Data No Data No Data Br-85 No Data No Data 9.12E-09 No Data No Data No Data No Data Rb-86 No Data 6.70E-05 4.12E-05 No Data No Data No Data 4.31 E-06 Rb-88 No Data 1.90E-07 1.32E-07 No Data No Data No Data 9.32E-09 Rb-89 No Data 1.17E-07 1.04E-07 No Data No Data No Data 1.02E-09 Sr-89 1.32E-03 No Data 3.77E-05 No Data No Data No Data 5.11E-05 Sr-90 1.70E-02 No Data 4.31 E-03 No Data No Data No Data 2.29E-04 Sr-91 2.40E-05 No Data 9.06E-07 No Data No Data No Data 5.30E-05 All values are in (mrem/pCi ingested).
They are obtained from Reference 3 (Table E-13).Neither Reference 2 nor Reference 3 contains data for Rh-1 05, Sb-124, or Sb-125.9-31 Version 23 2/13 Table 9-12 (contd) Ingestion Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 9.03E-06 No Data 3.62E-07 No Data No Data No Data 1.71E-04 Y-90 4.11E-08 No Data 1.1OE-09 No Data No Data No Data 1.17E-04 Y-91 m 3.82E-10 No Data 1.39E-1 1 No Data No Data No Data 7.48E-07 Y-91 6.02E-07 No Data 1.61E-08 No Data No Data No Data 8.02E-05 Y-92 3.60E-09 No Data 1.03E-10 No Data No Data No Data 1.04E-04 Y-93 1.14E-08 No Data 3.13E-10 No Data No Data No Data 1.70E-04 Zr-95 1.16E-07 2.55E-08 2.27E-08 No Data 3.65E-08 No Data 2.66E-05 Zr-97 6.99E-09 1.01E-09 5.96E-10 No Data 1.45E-09 No Data 1.53E-04 Nb-95 2.25E-08 8.76E-09 6.26E-09 No Data 8.23E-09 No Data 1.62E-05 Mo-99 No Data 1.33E-05 3.29E-06 No Data 2.84E-05 No Data 1.1OE-05 Tc-99m 9.23E-10 1.81E-09 3.OOE-08 No Data 2.63E-08 9.19E-10 1.03E-06 Tc-101 1.07E-09 1.12E-09 1.42E-08 No Data 1.91E-08 5.92E-10 3.56E-09 Ru-103 7.31 E-07 No Data 2.81 E-07 No Data 1.84E-06 No Data 1.89E-05 Ru-105 6.45E-08 No Data 2.34E-08 No Data 5.67E-07 No Data 4.21E-05 Ru-106 1.17E-05 No Data 1.46E-06 No Data 1.58E-05 No Data 1.82E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-110m 5.39E-07 3.64E-07 2.91E-07 No Data 6.78E-07 No Data 4.33E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 1.14E-05 3.09E-06 1.52E-06 3.20E-06 No Data No Data 1.10E-05 Te-127m 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 No Data 2.34E-05 Te-127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 No Data 1.84E-05 Te-129m 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 No Data 5.94E-05 Te-129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 No Data 8.34E-06 Te-131m 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 No Data 1.01E-04 Te-131 8.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 No Data 4.36E-07 9-32 Version 23 2/13 Table 9-12 (contd) Ingestion Dose Factors for the Child Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 1.01E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 No Data 4.50E-05 1-130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 No Data 2.76E-06 1-131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 No Data 1.54E-06 1-132 8.OOE-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 No Data 1.73E-06 1-133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 No Data 2.95E-06 1-134 4.19E-07 7.78E-07 3.58E-07 1.79E-05 1.19E-06 No Data 5.16E-07 1-135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 No Data 2.40E-06 Cs-134 2.34E-04 3.84E-04 8.1OE-05 No Data 1.19E-04 4.27E-05 2.07E-06 Cs-136 2.35E-05 6.46E-05 4.18E-05 No Data 3.44E-05 5.13E-06 2.27E-06 Cs-137 3.27E-04 3.13E-04 4.62E-05 No Data 1.02E-04 3.67E-05 1.96E-06 Cs-138 2.28E-07 3.17E-07 2.01E-07 No Data 2.23E-07 2.40E-08 1.46E-07 Ba-139 4.14E-07 2.21E-10 1.20E-08 No Data 1.93E-10 1.30E-10 2.39E-05 Ba-140 8.31E-05 7.28E-08 4.85E-06 No Data 2.37E-08 4.34E-08 4.21E-05 Ba-141 2.OOE-07 1.12E-10 6.51E-09 No Data 9.69E-11 6.58E-10 1.14E-07 Ba-142 8.74E-08 6.29E-11 4.88E-09 No Data 5.09E-11 3.70E-11 1.14E-09 La-140 1.01E-08 3.53E-09 1.19E-09 No Data No Data No Data 9.84E-05 La-142 5.24E-10 1.67E-10 5.23E-11 No Data No Data No Data 3.31E-05 Ce-141 3.97E-08 1.98E-08 2.94E-09 No Data 8.68E-09 No Data 2.47E-05 Ce-143 6.99E-09 3.79E-06 5.49E-10 No Data 1.59E-09 No Data 5.55E-05 Ce-144 2.08E-06 6.52E-07 1.11E-07 No Data 3.61E-07 No Data 1.70E-04 Pr-143 3.93E-08 1.18E-08 1.95E-09 No Data 6.39E-09 No Data 4.24E-05 Pr-144 1.29E-10 3.99E-11 6.49E-12 No Data 2.11E-11 No Data 8.59E-08 Nd-147 2.79E-08 2.26E-08 1.75E-09 No Data 1.24E-08 No Data 3.58E-05 W-187 4.29E-07 2.54E-07 1.14E-07 No Data No Data No Data 3.57E-05 Np-239 5.25E-09 3.77E-10 2.65E-10 No Data 1.09E-09 No Data 2.79E-05 9-33 Version 23 2/13 9-33 Version 23 2/13 Table 9-13 Ingestion Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C-14 4.06E-06 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 8.12E-07 Na-24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 P-32 2.76E-04 1.71E-05 1.07E-05 No Data No Data No Data 2.32E-05 Cr-51 No Data No Data 3.60E-09 2.OOE-09 7.89E-10 5.14E-09 6.05E-07 Mn-54 No Data 5.90E-06 1.17E-06 No Data 1.76E-06 No Data 1.21E-05 Mn-56 No Data 1.58E-07 2.81E-08 No Data 2.OOE-07 No Data 1.04E-05 Fe-55 3.78E-06 2.68E-06 6.25E-07 No Data No Data 1.70E-06 1 .16E-06 Fe-59 5.87E-06 1.37E-05 5.29E-06 No Data No Data 4.32E-06 3.24E-05 Co-58 No Data 9.72E-07 2.24E-06 No Data No Data No Data 1.34E-05 Co-60 No Data 2.81E-06 6.33E-06 No Data No Data No Data 3.66E-05 Ni-63 1.77E-04 1.25E-05 6.OOE-06 No Data No Data No Data 1.99E-06 Ni-65 7.49E-07 9.57E-08 4.36E-08 No Data No Data No Data 5.19E-06 Cu-64 No Data 1.15E-07 5.41E-08 No Data 2.91E-07 No Data 8.92E-06 Zn-65 5.76E-06 2.OOE-05 9.33E-06 No Data 1.28E-05 No Data 8.47E-06 Zn-69 1.47E-08 2.80E-08 1.96E-09 No Data 1.83E-08 No Data 5.16E-08 Br-83 No Data No Data 5.74E-08 No Data No Data No Data No Data Br-84 No Data No Data 7.22E-08 No Data No Data No Data No Data Br-85 No Data No Data 3.05E-09 No Data No Data No Data No Data Rb-86 No Data 2.98E-05 1.40E-05 No Data No Data No Data 4.41 E-06 Rb-88 No Data 8.52E-08 4.54E-08 No Data No Data No Data 7.30E-15 Rb-89 No Data 5.50E-08 3.89E-08 No Data No Data No Data 8.43E-17 Sr-89 4.40E-04 No Data 1.26E-05 No Data No Data No Data 5.24E-05 Sr-90 8.30E-03 No Data 2.05E-03 No Data No Data No Data 2.33E-04 Sr-91 8.07E-06 No Data 3.21 E-07 No Data No Data No Data 3.66E-05 All values are in (mrem/pCi ingested).
They are obtained from Reference 3 (Table E-12).Neither Reference 2 nor Reference 3 contains data for Rh-105, Sb-124, or Sb-125.9-34 Version 23 2/13 Table 9-13 (contd) Ingestion Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 3.05E-06 No Data 1.30E-07 No Data No Data No Data 7.77E-05 Y-90 1.37E-08 No Data 3.69E-10 No Data No Data No Data 1.13E-04 Y-91m 1.29E-10 No Data 4.93E-12 No Data No Data No Data 6.09E-09 Y-91 2.01E-07 No Data 5.39E-09 No Data No Data No Data 8.24E-05 Y-92 1.21 E-09 No Data 3.50E-11 No Data No Data No Data 3.32E-05 Y-93 3.83E-09 No Data 1.05E-10 No Data No Data No Data 1.17E-04 Zr-95 4.12E-08 1.30E-08 8.94E-09 No Data 1.91 E-08 No Data 3.OOE-05 Zr-97 2.37E-09 4.69E-10 2.16E-10 No Data 7.11E-10 No Data 1.27E-04 Nb-95 8.22E-09 4.56E-09 2.51E-09 No Data 4.42E-09 No Data 1.95E-05 Mo-99 No Data 6.03E-06 1.15E-06 No Data 1.38E-05 No Data 1.08E-05 Tc-99m 3.32E-10 9.26E-10 1.20E-08 No Data 1.38E-08 5.14E-10 6.08E-07 Tc-101 3.60E-10 5.12E-10 5.03E-09 No Data 9.26E-09 3.12E-10 8.75E-17 Ru-103 2.55E-07 No Data 1.09E-07 No Data 8.99E-07 No Data 2.13E-05 Ru-105 2.18E-08 No Data 8.46E-09 No Data 2.75E-07 No Data 1.76E-05 Ru-1 06 3.92E-06 No Data 4.94E-07 No Data 7.56E-06 No Data 1.88E-04 Rh-105 No Data No Data No Data No Data No Data No Data No Data Ag-110m 2.05E-07 1.94E-07 1.18E-07 No Data 3.70E-07 No Data 5.45E-05 Sb-124 No Data No Data No Data No Data No Data No Data No Data Sb-125 No Data No Data No Data No Data No Data No Data No Data Te-125m 3.83E-06 1.38E-06 5.12E-07 1.07E-06 No Data No Data 1.13E-05 Te-127m 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 No Data 2.41E-05 Te-127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 No Data 1.22E-05 Te-129m 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 No Data 6.12E-05 Te-129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 No Data 2.45E-07 Te-131m 2.44E-06 1. 17E-06 9.76E-07 1.76E-06 1.22E-05 No Data 9.39E-05 Te-131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 No Data 2.29E-09 9-35 Version 23 2/13 9-35 Version 23 2/13 Table 9-13 (contd) Ingestion Dose Factors for the Teenager Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 No Data 7.00E-05 1-130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 No Data 2.29E-06 1-131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 No Data 1.62E-06 1-132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 No Data 3.18E-07 1-133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 No Data 2.58E-06 1-134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.1OE-07 No Data 5.10E-09 1-135 6.10E-07 1.57E-06 5.82E-07 1.01E-04 2.48E-06 No Data 1.74E-06 Cs-134 8.37E-05 1.97E-04 9.14E-05 No Data 6.26E-05 2.39E-05 2.45E-06 Cs-136 8.59E-06 3.38E-05 2.27E-05 No Data 1.84E-05 2.90E-06 2.72E-06 Cs-137 1.12E-04 1.49E-04 5.19E-05 No Data 5.07E-05 1.97E-05 2.12E-06 Cs-138 7.76E-08 1.49E-07 7.45E-08 No Data 1.10E-07 1.28E-08 6.76E-11 Ba-139 1.39E-07 9.78E-11 4.05E-09 No Data 9.22E-11 6.74E-11 1.24E-06 Ba-140 2.84E-05 3.48E-08 1.83E-06 No Data 1.18E-08 2.34E-08 4.38E-05 Ba-141 6.71E-08 5.01E-11 2.24E-09 No Data 4.65E-11 3.43E-11 1.43E-13 Ba-142 2.99E-08 2.99E-11 1.84E-09 No Data 2.53E-11 1.99E-11 9.18E-20 La-140 3.48E-09 1.71E-09 4.55E-10 No Data No Data No Data 9.82E-05 La-142 1.79E-10 7.95E-11 1.98E-11 No Data No Data No Data 2.42E-06 Ce-141 1.33E-08 8.88E-09 1.02E-09 No Data 4.18E-09 No Data 2.54E-05 Ce-143 2.35E-09 1.71E-06 1.91E-10 No Data 7.67E-10 No Data 5.14E-05 Ce-144 6.96E-07 2.88E-07 3.74E-08 No Data 1.72E-07 No Data 1.75E-04 Pr-143 1.31E-08 5.23E-09 6.52E-10 No Data 3.04E-09 No Data 4.31 E-05 Pr-144 4.30E-11 1.76E-11 2.18E-12 No Data 1.01E-11 No Data 4.742-14 Nd-147 9.38E-09 1.02E-08 6.11E-10 No Data 5.99E-09 No Data 3.68E-05 W-187 1.46E-07 1.19E-07 4.17E-08 No Data No Data No Data 3.22E-05 Np-239 1.76E-09 1.66E-10 9.22E-11 No Data 5.21E-10 No Data 2.67E-05 9-36 Version 23 2/13 Table 9-14 Ingestion Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI H-3 No Data 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C-14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 Na-24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P-32 1.93E-04 1.20E-05 7.46E-06 No Data No Data No Data 2.17E-05 Cr-51 No Data No Data 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 Mn-54 No Data 4.57E-06 8.72E-07 No Data 1.36E-06 No Data 1.40E-05 Mn-56 No Data 1.15E-07 2.04E-08 No Data 1.46E-07 No Data 3.67E-06 Fe-55 2.75E-06 1.90E-06 4.43E-07 No Data No Data 1.06E-06 1.09E-06 Fe-59 4.34E-06 1.02E-05 3.91 E-06 No Data No Data 2.85E-06 3.40E-05 Co-58 No Data 7.45E-07 1.67E-06 No Data No Data No Data 1.51 E-05 Co-60 No Data 2.14E-06 4.72E-06 No Data No Data No Data 4.02E-05 Ni-63 1.30E-04 9.01E-06 4.36E-06 No Data No Data No Data 1.88E-06 Ni-65 5.28E-07 6.86E-08 3.13E-08 No Data No Data No Data 1.74E-06 Cu-64 No Data 8.33E-08 3.91E-08 No Data 2.1OE-07 No Data 7.1OE-06 Zn-65 4.84E-06 1.54E-05 6.96E-06 No Data 1.03E-05 No Data 9.70E-06 Zn-69 1.03E-08 1.97E-08 1.37E-09 No Data 1.28E-08 No Data 2.96E-09 Br-83 No Data No Data 4.02E-08 No Data No Data No Data 5.79E-08 Br-84 No Data No Data 5.21E-08 No Data No Data No Data 4.09E-13 Br-85 No Data No Data 2.14E-09 No Data No Data No Data No Data Rb-86 No Data 2.11E-05 9.83E-06 No Data No Data No Data 4.16E-06 Rb-88 No Data 6.05E-08 3.21E-08 No Data No Data No Data 8.36E-19 Rb-89 No Data 4.01E-08 2.82E-08 No Data No Data No Data 2.33E-21 Sr-89 3.08E-04 No Data 8.84E-06 No Data No Data No Data 4.94E-05 Sr-90 7.58E-03 No Data 1.86E-03 No Data No Data No Data 2.19E-04 Sr-91 5.67E-06 No Data 2.29E-07 No Data No Data No Data 2.70E-05 All values are in (mrem/pCi ingested).
They are obtained from Reference 3 (Table E-1 1), except as follows: Reference 2 (Table A-3) for Rh-105, Sb-124, and Sb-125.9-37 Version 23 2/13 9-37 Version 23 2/13 Table 9-14 (contd) Ingestion Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Sr-92 2.15E-06 No Data 9.30E-08 No Data No Data No Data 4.26E-05 Y-90 9.62E-09 No Data 2.58E-10 No Data No Data No Data 1.02E-04 Y-91m 9.09E-11 No Data 3.52E-12 No Data No Data No Data 2.67E-10 Y-91 1.41 E-07 No Data 3.77E-09 No Data No Data No Data 7.76E-05 Y-92 8.45E-10 No Data 2.47E-11 No Data No Data No Data 1.48E-05 Y-93 2.68E-09 No Data 7.40E-1 1 No Data No Data No Data 8.50E-05 Zr-95 3.04E-08 9.75E-09 6.60E-09 No Data 1.53E-08 No Data 3.09E-05 Zr-97 1.68E-09 3.39E-10 1.55E-10 No Data 5.12E-10 No Data 1.05E-04 Nb-95 6.22E-09 3.46E-09 1.86E-09 No Data 3.42E-09 No Data 2.1OE-05 Mo-99 No Data 4.31E-06 8.20E-07 No Data 9.76E-06 No Data 9.99E-06 Tc-99m 2.47E-10 6.98E-10 8.89E-09 No Data 1.06E-08 3.42E-10 4.13E-07 Tc-101 2.54E-10 3.66E-10 3.59E-09 No Data 6.59E-09 1.87E-10 1.1OE-21 Ru-1 03 1.85E-07 No Data 7.97E-08 No Data 7.06E-07 No Data 2.16E-05 Ru-105 1.54E-08 No Data 6.08E-09 No Data 1.99E-07 No Data 9.42E-06 Ru-1 06 2.75E-06 No Data 3.48E-07 No Data 5.31E-06 No Data 1.78E-04 Rh-1 05 1.22E-07 8.86E-08 5.83E-08 No Data 3.76E-07 No Data 1.41 E-05 Ag-110m 1.60E-07 1.48E-07 8.79E-08 No Data 2.91E-07 No Data 6.04E-05 Sb-124 2.81E-06 5.30E-08 1.11E-06 6.79E-09 No Data 2.18E-06 7.95E-05 Sb-125 2.23E-06 2.40E-08 4.48E-07 1.98E-09 No Data 2.33E-04 1.97E-05 Te-125m 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 No Data 1.07E-05 Te-127m 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-05 No Data 2.27E-05 Te-127 1.1OE-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 No Data 8.68E-06 Te-129m 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 No Data 5.79E-05 Te-129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 No Data 2.37E-08 Te-131m 1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 No Data 8.40E-05 Te-131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 No Data 2.79E-09 9-38 Version 23 2/13 9-38 Version 23 2/13 Table 9-14 (contd) Ingestion Dose Factors for the Adult Age Group Nuclide Bone Liver T. Body Thyroid Kidney Lung GI-LLI Te-132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 No Data 7.71E-05 1-130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 No Data 1.92E-06 1-131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-05 No Data 1.57E-06 1-132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 No Data 1.02E-07 1-133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 No Data 2.22E-06 1-134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 No Data 2.51 E-10 1-135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 No Data 1.31 E-06 Cs-134 6.22E-05 1.48E-04 1.21E-04 No Data 4.79E-05 1.59E-05 2.59E-06 Cs-136 6.51E-06 2.57E-05 1.85E-05 No Data 1.43E-05 1.96E-06 2.92E-06 Cs-137 7.97E-05 1.09E-04 7.14E-05 No Data 3.70E-05 1.23E-05 2.11E-06 Cs-138 5.52E-08 1.09E-07 5.40E-08 No Data 8.01E-08 7.91E-09 4.65E-13 Ba-139 9.70E-08 6.91E-11 2.84E-09 No Data 6.46E-11 3.92E-11 1.72E-07 Ba-140 2.03E-05 2.55E-08 1.33E-06 No Data 8.67E-09 1.46E-08 4.18E-05 Ba-141 4.71E-08 3.56E-11 1.59E-09 No Data 3.31E-11 2.02E-11 2.22E-17 Ba-142 2.13E-08 2.19E-11 1.34E-09 No Data 1.85E-11 1.24E-11 3.OOE-26 La-140 2.50E-09 1.26E-09 3.33E-10 No Data No Data No Data 9.25E-05 La-142 1.28E-10 5.82E-11 1.45E-11 No Data No Data No Data 4.25E-07 Ce-141 9.36E-09 6.33E-09 7.18E-10 No Data 2.94E-09 No Data 2.42E-05 Ce-143 1.65E-09 1.22E-06 1.35E-10 No Data 5.37E-10 No Data 4.56E-05 Ce-144 4.88E-07 2.04E-07 2.62E-08 No Data 1.21E-07 No Data 1.65E-04 Pr-143 9.20E-09 3.69E-09 4.56E-10 No Data 2.13E-09 No Data 4.03E-05 Pr-144 3.01E-11 1.25E-11 1.53E-12 No Data 7.05E-12 No Data 4.33E-18 Nd-147 6.29E-09 7.27E-09 4.35E-10 No Data 4.25E-09 No Data 3.49E-05 W-187 1.03E-07 8.61E-08 3.01E-08 No Data No Data No Data 2.82E-05 Np-239 1.19E-09 1.17E-10 6.45E-11 No Data 3.65E-10 No Data 2.40E-05 9-39 Version 23 2/13 9-39 Version 23 2/13 Table 9-15 External Dose Factors for Standing on Contaminated Ground Nuclide T. Body Skin H-3 0.00 0.00 C-14 0.00 0.00 Na-24 2.50E-08 2.90E-08 P-32 0.00 0.00 Cr-51 2.20E-10 2.60E-10 Mn-54 5.80E-09 6.80E-09 Mn-56 1.10E-08 1.30E-08 Fe-55 0.00 0.00 Fe-59 8.OOE-09 9.40E-09 Co-58 7.OOE-09 8.20E-09 Co-60 1.70E-08 2.OOE-08 Ni-63 0.00 0.00 Ni-65 3.70E-09 4.30E-09 Cu-64 1.50E-09 1.70E-09 Zn-65 4.OOE-09 4.60E-09 Zn-69 0.00 0.00 Br-83 6.40E-1 1 9.30E-1 1 Br-84 1.20E-08 1.40E-08 Br-85 0.00 0.00 Rb-86 6.30E-10 7.20E-10 Rb-88 3.50E-09 4.OOE-09 Rb-89 1.50E-08 1.80E-08 Sr-89 5.60E-13 6.50E-13 Sr-90 0.00 0.00 Nuclide T. Body Skin Sr-91 7.1OE-09 8.30E-09 Sr-92 9.OOE-09 1.OOE-08 Y-90 2.20E-12 2.60E-12 Y-91 m 3.80E-09 4.40E-09 Y-91 2.40E-11 2.70E-11 Y-92 1.60E-09 1.90E-09 Y-93 5.70E-10 7.80E-10 Zr-95 5.OOE-09 5.80E-09 Zr-97 5.50E-09 6.40E-09 Nb-95 5.1OE-09 6.OOE-09 Mo-99 1.90E-09 2.20E-09 Tc-99m 9.60E-10 1.1OE-09 Tc-101 2.70E-09 3.OOE-09 Ru-103 3.60E-09 4.20E-09 Ru-105 4.50E-09 5.1OE-09 Ru- 106 1.50E-09 1.80E-09 Rh-105 6.60E-10 7.70E-10 Ag-110m 1.80E-08 2.1OE-08 Sb-124 1.30E-08 1.50E-08 Sb-125 3.1OE-09 3.50E-09 Te-125m 3.50E-11 4.80E-11 Te-127m 1.10E-12 1.30E-12 Te-127 1.OOE-11 1.10E-11 Te-129m 7.70E-10 9.OOE-10 All values are in (mrem/h) per (pCi/m').
They are obtained from Reference 3 (Table E-6), except as follows: Reference 2 (Table A-7) for Rh-105, Sb-124, and Sb-125.9-40 Version 23 2/13 Table 9-15 (contd) External Dose Factors for Standing on Contaminated Ground Nuclide T. Body Skin Te-129 7.1OE-10 8.40E-10 Te-131m 8.40E-09 9.90E-09 Te-131 2.20E-09 2.60E-06 Te-132 1.70E-09 2.OOE-09 1-130 1.40E-08 1.70E-08 1-131 2.80E-09 3.40E-09 1-132 1.70E-08 2.OOE-08 1-133 3.70E-09 4.50E-09 1-134 1.60E-08 1.90E-08 1-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Cs-138 2.1OE-08 2.40E-08 Ba-139 2.40E-09 2.70E-09 Ba-140 2.10E-09 2.40E-09 Ba-141 4.30E-09 4.90E-09 Ba-142 7.90E-09 9.OOE-09 La-140 1.50E-08 1.70E-08 La-142 1.50E-08 1.80E-08 Ce-141 5.50E-10 6.20E-10 Ce-143 2.20E-09 2.50E-09 Ce-144 3.20E-10 3.70E-10 Pr-143 0.00 0.00 Pr-144 2.OOE-10 2.30E-10 Nd-147 1.OOE-09 1.20E-09 W-187 3.1OE-09 3.60E-09 Np-239 9.50E-10 1.1OE-09 9-41 Version 23 2/13 9-41 Version 23 2/13 CHAPTER 10 DEFINITIONS OF EFFLUENT CONTROL TERMS The terms defined in this chapter are used in the presentation of the above chapters.
These terms are shown in all capital letters to indicate that they are specifically defined.10.1 TERMS SPECIFIC TO THE ODCM The following terms are used in the ODCM, but are not found in the Technical Specifications:
BATCH RELEASE A BATCH RELEASE is the discharge of wastes of a discrete volume. Prior to sampling for analyses, each liquid batch shall be isolated and then thoroughly mixed by a method described in the ODCM to assure representative sampling.COMPOSITE SAMPLE A COMPOSITE SAMPLE is one which contains material from multiple waste releases, in which the quantity of sample is proportional to the quantity of waste discharged, and in which the method of sampling employed results in a specimen that is representative of the wastes released.
Prior to analyses, all liquid samples that are to be aliquotted for a COMPOSITE SAMPLE shall be mixed thoroughly, in order for the COMPOSITE SAMPLE to be representative of the effluent release.When assessing the consequences of a waste release at the pre-release or post-release stage, the most recent available COMPOSITE SAMPLE results for the applicable release pathway may be used.CONTINUOUS RELEASE A CONTINUOUS RELEASE is the discharge of wastes of a non-discrete volume, e.g., from a volume within a system that has an input flow during the continuous release.FREQUENCY NOTATION The FREQUENCY NOTATION specified for the performance of surveillance requirements shall correspond to the intervals defined below, with a maximum allowable extension not to exceed 25% of the surveillance interval.NOTATION FREQUENCY S (Once per shift) At least once per 12 hours.D (Daily) At least once per 24 hours.W (Weekly) At least once per 7 days.M (Monthly)
At least once per 31 days.Q (Quarterly)
At least once per 92 days.SA (Semi-annually)
At least once per 184 days.18M At least once per 18 months.R (Refueling)
At least once per 24 months.S/U (Startup)
Prior to each reactor startup.NA Not Applicable.
P (Prior) Completed prior to each release.10-1 Version 23 2/13 GASEOUS RADWASTE TREATMENT SYSTEM The GASEOUS RADWASTE TREATMENT SYSTEM is the offgas holdup system designed and installed to reduce radioactive gaseous effluents by collecting primary coolant system offgases from the primary system and providing for delay or holdup for the purpose of reducing the total radioactivity prior to release to the environment.
LIQUID RADWASTE TREATMENT SYSTEM A LIQUID RADWASTE TREATMENT SYSTEM is any system designed and installed to reduce radioactive materials in liquid effluents by systematic collection, retention, and processing through filtration, evaporation, separation and/or ion exchange treatment.
This system consists of at least one collection tank, one evaporator or demineralizer system, one post-treatment tank and associated components providing for treatment flow and functional control.MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS For the purposes of the ODCM, MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS include the following changes to such systems: (1) Major changes in process equipment, components, structures, or effluent monitoring instrumentation as described in the Final Safety Analysis Report (FSAR) or as evaluated in the Nuclear Regulatory Commission staffs Safety Evaluation Report (SER) (e.g., deletion of evaporators and installation of demineralizer);
(2) Changes in the design of radwaste treatment systems that could significantly increase quantities of effluents released from those previously considered in the FSAR and SER;(3) Changes in system design which may invalidate the accident analysis as described in the SER (e.g., changes in tank capacity that would alter the curies released);
or (4) Changes in system design that could potentially result in a significant increase in occupational exposure of operating personnel (e.g., use of temporary equipment without adequate shielding provisions).
MEMBER(S)
OF THE PUBLIC 1 A MEMBER OF THE PUBLIC shall be an individual in a controlled area or an UNRESTRICTED AREA. However, an individual is not a MEMBER OF THE PUBLIC during any period in which the individual receives an occupational dose. This category may include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.MILK ANIMAL A MILK ANIMAL is a cow or goat that is producing milk for human consumption.
The italicized terms in this definition, which are not otherwise used in this ODCM, shall have the definitions assigned to them by 10 CFR 20.1003.10-2 Version 23 2/13 MINIMUM DETECTABLE CONCENTRATION The MINIMUM DETECTABLE CONCENTRATION (MDC) is defined, for purposes of the controls in this ODCM, as the smallest concentration of radioactive material in a sample that will yield a net count above system background and that will be detected with 95-percent probability, with only 5-percent probability of falsely concluding that a blank observation represents a "real" signal.For a particular measurement system, which may include radiochemical separation, the MDC for a given radionuclide is determined as follows (Reference 17): 2.1+3.29 R4b f t (10.1)MDC = s E.V.2.22x10 .Y-e -AYe where: MDC = the a priori MINIMUM DETECTABLE CONCENTRATION (pCi per unit mass or volume).Rb = the background counting rate, or the counting rate of a blank sample, as appropriate (counts per minute).= the length of the sample counting period (minutes).
tb = the length of the background counting period (minutes).
E = the counting efficiency (counts per disintegration)
V = the sample size (units of mass or volume).2.22 x 106 = the number of disintegrations per minute per jiCi.Y = the fractional radiochemical yield, when applicable.
= the radioactive decay constant for the given radionuclide (h-1). Values of X used in effluent calculations should be based on decay data from a recognized and current source, such as Reference 26.At = for effluent samples, the elapsed time between the midpoint of sample collection and the time of counting (h); for environmental samples, the elapsed time between the end of sample collection and the time of counting (h).10-3 Version 23 2/13 Typical values of E, V, Y, and At should be used in the calculation.
It should be recognized that the MDC is defined as an a priori (before the fact) limit representing the capability of a measurement system, and not as an a posteriori (after the fact) limit for a particular measurement.
PRINCIPAL GAMMA EMITTERS The PRINCIPAL GAMMA EMITTERS for which the MINIMUM DETECTABLE CONCENTRATION (MDC) limit applies include exclusively the following radionuclides:
For liquid radioactive effluents:
Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, and Ce-141. Ce-144 shall also be measured, but with an MDC of 5 x 10-6 ;iCi/mL.For gaseous radioactive effluents:
In noble gas releases, Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-138; and in particulate releases, Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141, and Ce-144.For environmental media: The gamma emitters specifically listed in Table 4-3.These lists do not mean that only these nuclides are to be considered.
Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report, the Annual Radiological Environmental Operating Report, or other applicable report(s).
OPERATIONAL CONDITION An OPERATIONAL CONDITION shall be any one inclusive combination of Mode Switch position and average reactor coolant temperature, as defined in Table 1.1-1 of the Technical Specifications.
REACTOR MODE The REACTOR MODE is established by the Mode Switch position.
The four Mode Switch positions are REFUEL, SHUTDOWN, START & HOT STANDBY, and RUN.(See Technical Specifications Table 1.1-1 for definitions of these MODES.)SITE BOUNDARY The SITE BOUNDARY shall be that line beyond which the land is not owned, leased or otherwise controlled by Georia Power Company as shown in Figure 10-1.SOURCE CHECK A SOURCE CHECK shall be the qualitative assessment of channel response when the channel sensor is exposed to a source of increased radioactivity.
UNRESTRICTED AREA The UNRESTRICTED AREA shall be any area access to which is neither limited nor controlled by the licensee, or any area within the SITE BOUNDARY used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.10-4 Version 23 2/13 10.2 TERMS DEFINED IN THE TECHNICAL SPECIFICATIONS The following terms are defined in the Technical Specifications, Section 1.1. Because they are used throughout the Limits of Operation sections of the ODCM, they are presented here for convenience.
In the event of discrepancies between the definitions below and those in the Technical Specifications, the Technical Specification definitions shall take precedence.
ACTIONS ACTIONS shall be that part of a Specification that prescribes Required Actions to be taken under designated Conditions within specified Completion Times.CHANNEL CALIBRATION A CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel output, such that it responds within the necessary range and accuracy to known values of the parameter that the channel monitors.
The CHANNEL CALIBRATION shall encompass the entire channel, including the required sensor, alarm, display, and trip functions, and shall include the CHANNEL FUNCTIONAL TEST. Calibration of instrument channels with resistance temperature detector (RTD) or thermocouple sensors may consist of an inplace qualitative assessment of sensor behavior and normal calibration of the remaining adjustable devices in the channel. The CHANNEL CALIBRATION may be performed by any means of any series of sequential, overlapping, or total channel steps so that the entire channel is calibrated.
CHANNEL CHECK A CHANNEL CHECK shall be the qualitative assessment, by observation, of channel behavior during operation.
This determination shall include, where possible, comparison of the channel indication and status to other indications or status derived from independent instrument channels measuring the same parameter.
CHANNEL FUNCTIONAL TEST A CHANNEL FUNCTIONAL TEST shall be the injection of a simulated or actual signal into the channel as close to the sensor as practicable to verify OPERABILITY, including required alarm, interlock, display, and trip functions, and channel failure trips. The CHANNEL FUNCTIONAL TEST may be performed by means of any series of sequential, overlapping, or total channel steps so that the entire channel is tested.DOSE EQUIVALENT 1-131 DOSE EQUIVALENT 1-131 shall be that concentration of 1-131 EQUIVALENT (microcuries/gram) that alone would produce the same Committted 1-131 Effective Dose Equivalent as the quantity and isotopic mixture of 1-131, 1-132, 1-133, 1-134, and 1-135 actually present. The dose conversion factors used for this calculation shall be those listed in Federal Guidance Report (FGR) 11, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors for Inhalation, Submersion, and Ingestion," 1988.OPERABLE (or OPERABILITY)
A system, subsystem, division, component, or device shall be OPERABLE or have OPERABILITY when it is capable of performing its specified safety function(s) and when all necessary attendant instrumentation, controls, normal or emergency electrical power, cooling or seal water, lubrication or other auxiliary equipment that are required for the system, subsystem, division, component or device to perform its specified safety 10-5 Version 23 2/13 function(s) are also capable of performing their related support function(s).
RATED THERMAL POWER RATED THERMAL POWER shall be a total reactor core heat transfer rate to the reactor coolant of 2804 MWt.THERMAL POWER THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant.10-6 Version 23 2/13 10-6 Version 23 2/13 II II U U *UU r I I I.I)c 2 1.*0U c"I C'9 I ~I 60 mm-(I r I I.\ i I I I I#II i 8'.... -__/ "-Figure 10-1 Site Map for Effluent Controls}}